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ABSTRACT 
 Vesicular trafficking, the movement of vesicles between organelles and the 
plasma membrane for secretion, consists of multiple highly regulated processes.  Many 
protein families function as specificity and regulatory determinants to ensure correct 
vesicle targeting and timing of trafficking events.  The SNARE proteins dock and fuse 
vesicles to their target membranes.  Sec1/Munc18 (SM) proteins regulate membrane 
fusion through interactions with the SNAREs—SM proteins have been shown to act as 
both inhibitors and stimulators of SNARE assembly and membrane fusion.  However, the 
details of these SM protein functions are not understood. 
 Constructing a model of SM protein function has been challenging due to the 
various modes of interactions reported between SM proteins and their SNAREs.  SM 
proteins interact with their cognate SNAREs and SNARE complexes through several 
distinct modes.  The most conserved mode is an interaction with the syntaxin N-peptide; 
other modes of binding, such as the syntaxin closed conformation, are hypothesized to be 
specific for specialized cell types.  In order to elucidate the general function of SM 
proteins, I investigated the function of the endosomal SM protein Vps45p by analyzing 
its interactions with its cognate syntaxin Tlg2p and its role in SNARE assembly. 
 I had two main hypotheses:  that the Tlg2p N-peptide does not solely mediate the 
interaction between Vps45p and Tlg2p; and that Vps45p functions to stimulate SNARE 
complex assembly.  I systematically mapped the interaction between Vps45p and Tlg2p 
using various Tlg2p truncations containing the different domains of Tlg2p and discovered 
a second binding site on Tlg2p that corresponds to the closed conformation. The neuronal 
viii 
SM-syntaxin pair interacts in a similar manner, indicating that this interaction mode is 
conserved.  To characterize the closed conformation binding mode further, and determine 
its relationship to the N-peptide binding mode, I developed a quantitative fluorescent 
electrophoretic mobility shift assay.  Results indicate that these two sites do not bind 
simultaneously and that the N-peptide binding modulates the closed conformation 
affinity.  Furthermore, I monitored the effect of Vps45p on SNARE complex assembly 
using size exclusion chromatography.  Under the conditions tested, Vps45p did not 
appear to stimulate SNARE complex assembly.  The work presented here addresses 
several puzzling issues in the field and significantly contributes to the construction of a 
new mechanistic model for SM protein function.  In this new model, the SM protein is 
recruited to the membrane by its interaction with the syntaxin N-peptide.  The SM protein 
then binds the syntaxin closed conformation thus inhibiting SNARE complex assembly.  
Upon dissociation of the SM protein from the closed conformation, an event perhaps 
regulated by the SM protein, syntaxin opens and interacts with the other SNAREs to form 
a SNARE complex.  Fusion ensues, stimulated by the SM protein. 
ix 
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Introduction 
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INTRACELLULAR TRAFFICKING 
Overview 
 Eukaryotes contain membrane bound compartments known as organelles.  Each 
type of organelle performs specialized functions and is required for normal cell growth 
and survival.  Several organelles function within the secretory pathway of a cell to ensure 
the proper transport of proteins and membrane.  The endoplasmic reticulum (ER) is the 
site for much of the protein synthesis within the cell and ensures that secretory and 
membrane proteins are properly folded.  The Golgi apparatus functions in carbohydrate 
synthesis and post-translational modification of proteins.  Early and late endosomes act as 
stopover points for proteins targeted to/from the lysosome or plasma membrane; 
endosomes may also mature into lysosomes.  The lysosome, or vacuole in yeast, degrades 
proteins, macromolecules and dead organelles using resident enzymes.  Finally, the 
plasma membrane allows the secretion and endocytosis of proteins and molecules.  Each 
organelle is surrounded by a membrane, creating a distinct environment for its resident 
proteins.  This characteristic, however poses a problem:  how do cells properly transport 
proteins, and lipids between organelles, and to the plasma membrane, to sustain proper 
function and growth of each organelle and the cell itself? 
 Intracellular trafficking is the movement of proteins and lipids between different 
organelles within the cell and to/from the plasma membrane.  Intracellular trafficking 
fulfills many purposes within the cell:  it sustains the function, integrity and growth of 
organelles and the plasma membrane by transporting membrane and proteins to these 
sites; it also allows secretion into the extracellular environment of both metabolic waste 
3 
products and signaling molecules, such as hormones and neurotransmitters.  In this thesis, 
I focus on the movement of proteins and molecules between organelles and to the plasma 
membrane using membrane-bound vesicles, a process referred to as vesicular trafficking.  
Many vesicular trafficking pathways exist, including transport between the ER and Golgi, 
between the Golgi and endosomes, and between the Golgi and the plasma membrane.  
Vesicular trafficking is conserved among eukaryotes and between the different trafficking 
pathways within the cell
1, 2
.  This makes Saccharomyces cerevisiae a useful model; 
results from yeast can be applied to humans.  The ease of biochemical and genetic studies 
in yeast compared to mammalian cells adds to its attractiveness as a model organism.  My 
thesis focuses on vesicular trafficking within S. cerevisiae.   
The conserved steps in vesicular trafficking 
 A typical trafficking pathway consists of several conserved mechanisms.  For the 
purpose of this introduction, these mechanisms have been divided into five general steps 
(Figure 1.1).  (1) Budding is the formation of cargo-containing membrane-bound vesicles 
from the donor organelle membrane.  Coat proteins, such as clathrin, COPI and COPII 
complexes, associate with each other and the donor organelle, to form the vesicle
3
.  Coat 
proteins play several roles during the initial steps of vesicular trafficking:  through 
interactions with receptors in the membrane and cargo, they ensure that the correct 
proteins are trafficked to the appropriate organelle
3
.  They help regulate the timing of 
vesicle formation through their interactions with small GTPases, if coat proteins 
dissociate from the membrane before fission, the vesicle does not form
4
.  Coat proteins 
also confer specificity through interactions with motor proteins and tethering factors
4
.  
4 
Figure 1.1.  The five general steps in a typical trafficking pathway require several 
conserved protein families.  The conserved steps and several protein families that 
function within a typical trafficking pathway are diagrammed.  (1) Vesicles bud from the 
donor membrane, a process mediated by vesicle coat proteins, followed by (2) trafficking 
of the vesicle along the cytoskeleton to its target membrane. After arrival at its target, (3) 
the vesicle is tethered to the target membrane by tethering factors; interactions between 
the tethering factors and small GTPases on both membranes may mediate tethering. (4)  
SNAREs on the vesicle and target membrane interact to dock the vesicle and (5) mediate 
fusion and release of vesicle contents into the target compartment
1
. 
5 
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(2) After budding from the donor membrane, vesicles travel to their targets through 
interactions with motor proteins such as kinesins and myosins
5-8
.  Motor proteins 
transport vesicles along microtubules, or actin filaments, to the target membrane where 
the third step in vesicular trafficking takes place. 
 (3) Tethering, the formation of a reversible physical link between the vesicle and 
target membranes that occurs before docking, is thought to be mediated by tethering 
factors
9, 10
.  (4)  After tethering, SNARE proteins on the vesicle and target membranes 
interact to form a four-helix bundle, a process defined as “docking”1, 11, 12.  SNAREs and 
their regulation will be discussed in greater detail later.  (5) Fusion, occurring after the 
SNAREs interact, is defined as the merging of the two membranes and release of vesicle 
cargo
1, 13
.  After fusion, the SNARE complexes are disassembled and re-used for 
additional rounds of fusion
13
. 
 These five steps are conserved among eukaryotes and between trafficking 
pathways within the cell.  This presents several challenges for the cell, including:  how to 
ensure that the correct cargo is packaged into the appropriate vesicle; how to direct the 
vesicle to its correct target; and how to ensure that vesicles form and fuse with their target 
membranes at the appropriate times.  Multiple conserved protein families, working 
together, ensure that the appropriate cargo is packaged into vesicles and that these 
vesicles are trafficked to, and fuse with, their specific organelles.  These families also aid 
in the temporal regulation of these steps to ensure that specific trafficking events occur 
when required
1, 2
.  Most of these proteins are essential for normal cell growth and 
survival; mutations causing defects in these proteins lead to numerous human    
7 
diseases
14-18
.  In this introduction, I focus on specific protein families that regulate the 
final three stages of vesicle trafficking:  small GTPases, tethering factors, SNAREs, and 
Sec1/Munc18 proteins. 
REGULATORS OF VESICULAR TRAFFICKING 
Small GTPases 
 Small Ras superfamily GTPases have been divided into several subfamilies and 
play many different roles in the cell, from regulating gene expression and cell cycle 
progression, to regulating vesicle coat formation and vesicle trafficking between 
organelles
19, 20
.  The Rho subfamily, which includes Cdc42p, regulates actin organization, 
cell polarity and movement, cell cycle progression, and gene expression
19, 20
.  The 
Arf/Sar subfamily regulates vesicle budding by regulating vesicle coat formation
19, 20
.  
The Rab subfamily regulates vesicle trafficking—they are localized to specific 
compartments and act to identify different types of vesicles
20
.   
 Small GTPases act as specificity determinants and regulatory elements to ensure 
correct targeting and proper timing of intracellular trafficking events.  Small GTPases 
cycle between an active and inactive state.  Small GTPases are active when bound to 
GTP; while active, they interact with specific proteins, defined as effectors.  When bound 
to the activated GTPase, these effectors perform specialized functions.  Upon GTP 
hydrolysis, GTPases switch to an inactive state and dissociate from their effectors
20
.  
Thus, GTPases act as molecular switches, temporally regulating the functions of their 
effectors.  Examples of effectors include vesicle coat complexes, motor proteins, and 
tethering factors
3, 7, 21
.  Small GTPases play a role in regulation and specificity throughout 
8 
the steps of vesicular trafficking, helping to ensure that that the vesicle reaches and fuses 
with its correct membrane at the proper time. 
Tethering factors 
 Tethering factors serve as another layer of regulation within vesicular trafficking.  
They are defined as proteins, or protein complexes, that associate with both the vesicle 
and target membrane, and are hypothesized to function by stabilizing the reversible 
association between the membranes, thus allowing the SNAREs to interact and docking 
to occur
9, 10
.  Tethering factors have been identified in many distinct trafficking pathways 
in eukaryotes and provide another layer of specificity between the vesicle and its target 
membrane.  They exist as individual coiled-coil proteins or as large protein complexes
22
.  
The subunits of most complexes share less than 10% sequence identity with other 
proteins, although some tethering complexes, such as the exocyst and COG (conserved 
oligomeric Golgi) complexes, do show limited sequence similarity within their N-
termini
23, 24
.  The exocyst and COG complexes also show an overall structural similarity, 
consisting of helical bundle motifs, supporting the hypothesis for conserved functions
9, 25, 
26
.  The proposed tethering factor for exocytosis is the exocyst complex. 
 The exocyst complex is conserved from yeast to mammals
26
.  It is proposed to act 
as a tethering factor between secretory vesicles and the plasma membrane because of its 
interactions with small GTPases localized to the vesicle and plasma membrane; however, 
there is little evidence that the exocyst is responsible for bringing these two membranes 
into close proximity
21, 27-30
.  The exocyst localizes to sites of polarized secretion in yeast:  
the bud tip during growth and the mother-daughter neck during cytokinesis
31, 32
.  It 
9 
comprises eight proteins:  Sec3p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo84p, and 
Exo70p
21, 33, 34
.  Except Sec3p, all members of the exocyst are essential for cell survival
35
.  
Temperature-sensitive mutations in exocyst components result in an accumulation of 
vesicles that are unable to fuse with the plasma membrane, resulting in cell death
 36
.  
While one proposed function of the exocyst is to act as a tether, its other roles, and those 
of its subunits, during vesicle trafficking still need to be determined. 
 The function each member plays within the complex and individually has been 
challenging to determine.  In recent years, data from both in vivo and in vitro techniques 
has moved the field forward.  These findings have generated an interaction map between 
members of the exocyst and have suggested functions for some of the subunits
9
.  Sec3p 
and Exo70p associate with the plasma membrane by interacting with the small Rho 
family GTPases, Rho1p, Cdc42p, and Rho3p localized there
27-30
.  Exo70p has also been 
shown to interact with phospholipids
37
.  Sec15p associates with the vesicle membrane 
through its interactions with the small Rab GTPase, Sec4p, localized on secretory 
vesicles
21
.  The interactions between exocyst subunits and small GTPases may enable the 
exocyst to tether secretory vesicles to the plasma membrane.  Sec10p appears to play a 
role in the morphology of the cell, as overexpression of a C-terminal region led to an 
elongated phenotype but no defect in vesicular trafficking
21, 38
.  Sec10p also interacts 
with Sec15p in a sub-complex which may stabilize the two proteins in vivo
21, 38
.  The 
crystal structures of nearly full-length Exo70p and the C-terminal domains of Exo84p, 
Sec6p and Drosophila Sec15 show a conserved helical bundle topology, even though 
there is less that 10% sequence identity between them
9, 39-41
.  This has led to the 
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hypothesis that all exocyst subunits contain similar folds.  Supporting this hypothesis, 
bioinformatics analyses of the yeast exocyst subunits and their homologues in other 
eukaryotes indicate conserved regions within the N- and C-termini
42
.  For part of my 
thesis, I examined the interactions between individual subunits, specifically Sec10p, 
Sec15p, and Sec6p, in order to elucidate exocyst assembly and the importance of these 
interactions for function in vivo. 
 Tethering may not be the only role for complexes like the exocyst.  Increasing 
evidence has detected interactions between tethering complexes and other trafficking 
proteins.  In addition to interactions with small GTPases, tethering factors also interact 
with coat proteins; for example, the TRAPP I tethering complex interacts with the COPII 
vesicle coat complex
2, 21
.  Also, several tethering factors have been shown to interact with 
SNARE proteins.  Examples include:  Vps51p, a subunit of the GARP (Golgi-associated 
retrograde protein) tethering complex, which interacts with Tlg1p, a SNARE that 
mediates endosomal trafficking
11, 43
; the COG tethering complex interacts with Sed5p, a 
Golgi SNARE
44
; and the exocyst subunit, Sec6p, interacts with Sec9p, an exocytic 
SNARE
45
.  The exocyst complex also interacts with Sec1p, the exocytic Sec1/Munc18 
protein
46
.  Although the purposes of these interactions are still unclear, they suggest that 
tethering complexes play multiple roles in vesicular trafficking, perhaps by regulating 
SNARE assembly and/or the function of SM proteins. 
11 
SNAREs 
 The SNARE family of proteins is conserved throughout eukaryotic trafficking 
pathways.  SNAREs on the target and vesicle membranes interact to form a four-helix 
bundle termed the SNARE complex (Figure 1.2)
12
.  While individual SNAREs may 
function in multiple trafficking pathways, distinct assembled SNARE complexes function 
in specific pathways
47-49
.  SNARE proteins are the core component of the fusion 
machinery and it is hypothesized that formation of the highly stable SNARE complex 
supplies the energy needed to fuse the vesicle to its target membrane
50-52
.  Most SNAREs 
associate with their respective membranes through transmembrane regions or post-
translational lipid modifications
13, 53
.  Each SNARE contains at least one region of ~60 
amino acids that has a high propensity to form a coiled-coil, termed a SNARE motif
54, 55
.  
One SNARE motif interacts with three other SNARE motifs
12, 54, 56
; studies suggest that 
assembly occurs in a zipper-like manner from the N to C-termini
57-59
.  Structures of 
SNARE complexes from various pathways reveal that SNAREs associate in a parallel 
orientation
12, 60-62
.  While the SNARE complex contains four helices, the number of 
proteins needed to form the complex differs.  Some pathways, such as exocytosis in 
yeast, use three proteins while other pathways use four
47, 48, 63
.   
 Two types of SNAREs are required to form a SNARE complex.  In my thesis, for 
simplicity, I will use the SNARE classification system based on their location, although 
other classifications exist
54
.  Those SNAREs on the target membrane are defined as t-
SNAREs while those on the vesicle are defined as v-SNAREs
64
.  The t-SNAREs are 
divided into two groups:  those showing strong sequence similarity to the neuronal t-  
12 
Figure 1.2.  The neuronal SNARE complex is a parallel four-helix bundle.  The 
crystal structure of the neuronal SNARE complex, consisting of the syntaxin t-SNARE 
syntaxin 1a; the non-syntaxin t-SNARE SNAP-25; and the v-SNARE synaptobrevin 
(PDB ID 1sfc)
12
.  Syntaxin 1a and synaptobrevin are anchored to their respective 
membranes through transmembrane domains; SNAP-25 is anchored to the plasma 
membrane through a post-translational modification
53
.  The loop connecting the two 
helices of SNAP-25, the transmembrane domains, and the linker regions between the 
SNAREs and their transmembrane domains have been modeled in as they were not 
included in the crystallized complex
12
.  All graphic displays of protein structures, within 
this thesis, were rendered using PyMOL (http://www.pymol.org). 
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SNARE syntaxin 1a are labeled as “syntaxin t-SNAREs”; the others are often labeled as 
“non-syntaxin t-SNAREs”.  A SNARE complex consists of three t-SNARE helices (one  
helix contributed by the syntaxin t-SNARE and two by the non-syntaxin t-SNAREs) and 
one v-SNARE helix
12
. 
 While all SNAREs contain a SNARE motif region, other domains may be present 
which vary between the different types of SNAREs.  These domains play multiple roles; 
they are thought to regulate the SNAREs, either directly or through interactions with 
other proteins.  Most syntaxin t-SNAREs contain an N-peptide region comprising the 
first 20-40 residues, a three-helix bundle Habc domain, a linker region, the SNARE motif 
that is followed closely by the transmembrane domain, and a short lumenal region 
(Figure 1.3A)
65-67
.  The non-syntaxin t-SNARE(s) contain SNARE motifs, 
transmembrane domains, and lumenal regions, but their N-terminal regions differ.  Some 
contain predicted Habc domains, while others contain different types of domains
43, 67, 68
.  
The v-SNARE contains a short variable N-terminal domain, a SNARE motif, a 
transmembrane domain, and a short lumenal region (Figure 1.3A)
67
.  Each SNARE is 
anchored to its respective membrane through its transmembrane region.  When a 
transmembrane domain is absent, a SNARE can be anchored to its membrane through a 
post-translational lipid modification, as in the case of SNAP-25, a neuronal t-SNARE
53
. 
 Several pathways and systems have been intensely studied in order to further 
understand the mechanisms of vesicular trafficking and membrane fusion.  Neuronal 
secretion is one of the best characterized pathways.  In neuronal secretion, synaptic 
vesicles fuse with the plasma membrane and release neurotransmitters into the synapse.   
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Figure 1.3.  SNARE topology reveals a conserved SNARE motif which is required 
for SNARE complex assembly.  (A)  Schematic of SNAREs involved in an assembled 
SNARE complex.  SNAREs and their domains are color-coded.  A similar color scheme 
is kept throughout this chapter for clarity.  Syntaxin t-SNAREs contain an N-peptide 
consisting of the first 10-30 residues, a Habc domain which can act as an autoinhibitory 
region, a linker region followed by a conserved SNARE motif, a transmembrane domain, 
and a short lumenal region
65-67
.  The other SNAREs contain SNARE motifs and most 
contain transmembrane domains.  (B)  Cartoon model of SNARE complex assembly.  
Interactions between the Habc domain and the SNARE motif inhibit SNARE assembly.  
Dissociation of the Habc domain and the SNARE motif allows the syntaxin SNARE motif 
to interact with the other t-SNAREs to form a t-SNARE complex.  The t-SNARE 
complex then interacts with the v-SNARE to form an assembled SNARE complex. 
16 
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The structure of an assembled SNARE complex was first determined using neuronal 
SNAREs (Figure 1.2)
12
.  The neuronal SNARE complex consists of the syntaxin t-  
SNARE, syntaxin 1a; the non-syntaxin t-SNARE that contributes two helices, SNAP-25; 
and the v-SNARE, synaptobrevin (Figure 1.2)
64
.  Another system tractable to both 
biochemical and genetic manipulations is the yeast secretory system.  In the yeast 
exocytic pathway, secretory vesicles are trafficked from the Golgi to the plasma 
membrane
48
.  These secretory vesicles add membrane and membrane proteins to the 
plasma membrane, and release their soluble cargo into the extracellular environment.  
The SNAREs used in this pathway include Sso1p, the syntaxin t-SNARE; Sec9p, the 
other t-SNARE; and Snc2p, the v-SNARE
69-71
.  Like neurotransmitter release, the yeast 
exocytic pathway contains a t-SNARE, Sec9p, which contributes two helices to the 
assembled SNARE complex.  Other trafficking pathways, however, use four separate 
SNAREs to form their assembled complex.  The yeast endocytic trafficking pathway uses 
the Tlg2p, Tlg1p, Vti1p, and Snc2p SNAREs for vesicular traffic between the Golgi and 
the endosome.  Tlg2p functions as the syntaxin t-SNARE; Tlg1p and Vti1p are the other 
t-SNAREs; and Snc2p is the v-SNARE
72, 73
.  It is unclear whether these SNAREs act to 
fuse vesicles at the Golgi or at the endosome, as Tlg2p is localized to both 
compartments
74
. 
 When SNAREs were first discovered to function in membrane fusion, it was 
hypothesized that unique v-SNAREs would interact with specific t-SNAREs in distinct 
pathways and that these interactions would convey the specificity needed to ensure 
proper vesicle targeting
64
.  However, although SNAREs contribute a level of specificity, 
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it is clear that other factors must be involved.  While membrane fusion is highly specific, 
interactions between SNARE motifs can be promiscuous; recombinant non-cognate 
SNAREs form SNARE complexes in the absence of their transmembrane domains in 
vitro
75, 76
.  However, when expressed with their transmembrane domains and 
reconstituted into liposomes, only cognate SNAREs facilitated fusion; transmembrane 
domains, therefore, may provide some specificity in SNARE complex assembly
71
.  Also, 
some SNAREs, such as the t-SNAREs Sed5p and Vti1p, and the v-SNARE Snc2p, have 
roles in multiple pathways
71-73, 77, 78
.  These findings indicate a need for additional levels 
of specificity to ensure the fidelity of vesicle trafficking.  Assembly of the SNARE 
complex is essential for membrane fusion and various modes of regulation exist for 
individual SNAREs and the assembled SNARE complex. 
SNARE Regulation 
 One level of regulation occurs intramolecularly within the syntaxin t-SNAREs.  
Docking of the vesicle with the target membrane requires that the SNARE motifs are 
available to form a SNARE complex.  The Habc domain in syntaxin t-SNAREs contains 
three -helices that assemble into an anti-parallel three-helix bundle65.  In some syntaxin 
t-SNAREs, the Habc domain interacts with the SNARE motif, forming a four-helical 
bundle, defined as the “closed” conformation (Figure 1.3B)79-81.  Deletion of the Habc 
domain, or
 
mutants that destabilize the closed conformation, increase the rate of SNARE 
complex assembly, indicating that the Habc domain acts as an auto-inhibitor in SNARE 
complex assembly
70, 82-84
.  Dissociation of the SNARE motif from the Habc domain results 
in an “open” conformation, freeing the SNARE motif to interact with the other SNAREs, 
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to form the assembled SNARE complex (Figure 1.3B).  NMR studies and crystal 
structures of neuronal syntaxin 1a and yeast Sso1p revealed that they adopt closed 
conformations
79-81
.  NMR studies also indicate that syntaxin 1a readily shifts between a 
closed and open state in vitro; binding to another protein may stabilize either the opened 
or closed conformation and thus regulate SNARE complex assembly.  The transition of 
Sso1p to an open state, however, is very slow in vitro (on the order of days) and may 
reflect the need of an “opener” to allow Sso1p to participate in SNARE complex 
assembly
70, 85
.  It is unclear whether all syntaxin t-SNAREs form closed conformations 
and, if they do, whether they are as tightly closed as Sso1p, or even syntaxin 1a.  For 
example, NMR studies suggest that Tlg2p, the syntaxin t-SNARE necessary for 
endosomal fusion, contains an Habc domain but does not adopt a closed conformation
86
.  
However, the Tlg2p construct used in these studies did not contain the entire SNARE 
motif, which may have destabilized the closed conformation of Tlg2p
86
.  Because of this, 
it is still unknown whether Tlg2p can form a closed conformation.  It is clear that the 
open/closed conformation is a significant point of regulation for SNARE complex 
assembly and membrane fusion within several trafficking pathways. 
 Another level of regulation includes other protein families that regulate SNARE 
assembly and fusion.  Several families of proteins that specifically regulate neuronal 
secretion, such as complexin and synaptotagmin
87
, will not be discussed here.  Other 
more general protein families, including tethering factors and small GTPases, act as 
either direct or indirect regulators of SNARE assembly.  Another crucial family of 
proteins that regulate SNARE assembly and fusion through their interactions with 
20 
SNAREs is the Sec1/Munc18 (SM) superfamily
26, 88
.  The focus of my thesis research 
was to elucidate the function of the yeast endosomal SM protein Vps45p, by examining 
its interactions with its cognate syntaxin t-SNARE, Tlg2p, and its affect on SNARE 
complex assembly. 
SEC1/MUNC18 PROTEINS 
 The Sec1/Munc18 (SM) proteins were originally identified through genetic 
screens in two different organisms.  In the first, C. elegans Unc-18 was identified in a 
general screen for worms showing defects in various categories including growth, 
morphology, and movement
89
.  The unc-18 mutant was paralyzed and lacked the ability 
to respond to outward stimuli.  A later study implicated Unc18 in regulating the levels of 
acetylcholine in neurons
89-91.  The mammalian homologue of Unc18 was named “Munc” 
for mammalian Unc
92
.  Yeast exocytic Sec1p was identified in a genetic screen for 
mutants with increased cell density due to accumulated vesicles within the cell
36, 93
.  
Electron microscopy revealed that vesicles accumulate in the bud of sec1-1 cells and 
secretion assays showed a defect in secretion, indicating an inability to complete 
exocytosis
36, 93
.  These results suggested that the vesicles were unable to fuse to the 
plasma membrane.  The other yeast SM proteins were also identified through various 
screens.  Yeast Sly1p was identified in a screen for mutants that suppress the loss of 
Ypt1p, the small GTPase involved in trafficking between the ER and Golgi
94, 95
. The 
vacuolar and endosomal SM proteins, Vps33p and Vps45p, were identified through 
multiple screens for mutants that disrupt the sorting of vacuolar proteins, such as CPY
96-
98
.  The individual SM proteins show a significant degree of sequence identity/similarity 
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(20-60%) (Table 1.1) and the structures of several SM proteins indicate a conserved 
structure
80, 99-104
. 
 SM proteins contain three domains consisting of mixed -helices and -sheets 
oriented around a central cleft, giving the protein a horseshoe or clam-like shape (Figure 
1.4).  In domain 1, four hydrophobic residues form a conserved hydrophobic pocket.  
Mutations within this pocket appear to abrogate binding between several SM proteins and 
their cognate syntaxins, indicating that the hydrophobic pocket is important for this 
interaction
102, 103, 105, 106
.  Domain 2 forms the back of the horseshoe while domain 3 
forms the rest of the horseshoe.  Mutations in each of these domains result in both 
temperature-sensitive and gain of function phenotypes, indicating their importance in SM 
protein function
94, 95, 107
.  The central cleft formed by these three domains provides the 
binding interface between the SM protein, Munc18a, and the closed conformation of its 
cognate syntaxin t-SNARE, syntaxin 1a (Figure 1.5A)
80
. 
 The SM superfamily is divided into four subfamilies based on sequence similarity 
and their functional pathway
26
:  Sec1p, Sly1p, Vps33p, and Vps45p.  Sec1p family 
members are exocytic and consist of yeast Sec1p and the mammalian Munc18 isoforms.  
The Sly1p family functions in trafficking between the ER and Golgi, and the Vps33p 
family functions at the vacuole or lysosome.  The Vps45p family functions in endosomal 
trafficking and will be discussed last. 
 Because SM proteins are conserved in most trafficking pathways throughout 
eukaryotes, show significant sequence identity, and share a common overall structure, 
they are hypothesized to share a common function in regulating membrane fusion.  Data 
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Table 1.1.  Sequence alignments of SM proteins reveal significant sequence identity 
and similarity.  The percent identity and percent similarity of several SM protein 
sequences were analyzed using the BLAST program, blast-2-seq (bl2seq) database, and 
the blastp algorithm.  Sequences for Munc18a and Munc18c were from R. norvegicus.  
Sequences for Sec1p, Vps33p, Sly1p, and Vps45p were from S. cerevisiae
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Table 1.1.  Sequence alignments of SM proteins reveal significant sequence identity 
and similarity. 
% Identity 
Protein Munc18a Munc18c Sec1p Vps33p Sly1p Vps45p 
Munc18a 100%       
Munc18c 51% 100%      
Sec1p 24% 24% 100%     
Vps33p 21% 19% 26% 100%    
Sly1p 20% 22% 22% 26% 100%   
Vps45p 20% 20% 21% 25% 26% 100% 
 
% Similarity 
Protein Munc18a Munc18c Sec1p Vps33p Sly1p Vps45p 
Munc18a 100%       
Munc18c 73% 100%      
Sec1p 46% 44% 100%     
Vps33p 48% 44% 43% 100%    
Sly1p 43% 42% 37% 45% 100%   
Vps45p 44% 42% 39% 48% 45% 100% 
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Figure 1.4.  The structure of squid n-Sec1 reveals three domains in a horseshoe 
conformation.  The crystal structure of the squid Sec1/Munc18 protein, n-Sec1 was 
determined.  The conserved hydrophobic region in domain 1 and the cleft are noted
100
. 
(PDB ID 1epu) 
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Figure 1.5.  The structures of SM-syntaxin interactions reveal a conserved SM 
topology and different modes of interaction.  (A)  Structure of the Munc18a-syntaxin 
1a interaction
80, 106
.  The original structure only indicated the closed conformation mode 
of binding; recent re-refinement of the structure revealed the N-peptide mode of binding.  
The closed conformation of syntaxin 1a binds to the cleft of Munc18a while the N-
peptide binds to the conserved hydrophobic pocket in domain 1 (PDB ID 3c98).  (B)  
Structure of the Munc18c-syntaxin 4 N-peptide interaction
103
.  The N-peptide of syntaxin 
4 binds to the conserved hydrophobic pocket of domain 1 of Munc18c (PDB ID 2pjx).  
(C)  Structure of the Sly1p-Sed5p N-peptide interaction
102
.  The N-peptide of Sed5p 
binds to the conserved hydrophobic pocket of domain 1 of Sly1p (PDB ID 1mqs) 
27 
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from multiple groups indicate that SM proteins play both positive and negative roles in 
regulating SNARE complex assembly and membrane fusion
99, 108
.  It is clear that SM 
proteins function through interactions with both individual SNAREs and the assembled 
SNARE complex.  In this thesis, I examine the interactions between the SM protein 
Vps45p and its cognate syntaxin t-SNARE Tlg2p to determine their mode(s) of 
interaction.  Until recently, there did not appear to be a similar mechanism of interaction 
between SM proteins and their partner(s), making it difficult to construct a common 
mechanism of function between the different subfamilies.  My research has elucidated the 
binding modes used between SM proteins and their cognate syntaxin, enabling the 
construction of a new model for SM protein function. 
 Subfamily:  Sec1p: 
Sec1p 
 The Sec1p subfamily consists of mammalian Munc18a, Munc18b, Munc18c, and 
yeast Sec1p.  Sec1p functions in exocytosis at the plasma membrane in yeast
36, 93,109
.  
Deletion of Sec1p results in secretory defects and an accumulation of vesicles at the 
plasma membrane, indicating a positive role in fusion
36, 93
.  Overexpression, however,  
does not significantly affect growth or secretion
110, 111
.  Co-immunoprecipitation 
experiments with yeast cell lysates and in vitro binding assays using purified recombinant 
proteins indicated that Sec1p interacts with the assembled yeast exocytic SNARE 
complex consisting of Sso1p, Sec9p, and Snc2p
110, 112
; unlike other SMs (see below), 
however, Sec1p does not appear to interact with individual SNAREs
110, 112
.  In vitro 
liposome fusion assays, in which cognate t-SNAREs and v-SNAREs are inserted into 
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opposite liposome membranes, indicate that Sec1p can stimulate membrane fusion
113
.  
Mutations in Sec1p result in dominant negative phenotypes, affecting both growth and 
secretion
111
.  Overexpression of Snc2p suppresses the dominant negative phenotype in 
this study, but overexpression of Sso1p and Sec9p do not; these Sec1p mutations may 
decrease the affinity between Sec1p and Snc2p in the assembled SNARE complex
111
.  
Sec1p also interacts with the exocytic tethering complex, the exocyst, although the 
purpose of this interaction is currently unclear
113
.   
Munc18a 
 Munc18a, also called nSec1, functions in neuronal secretion
92, 114, 115
.  Deletion of 
Munc18a in mice leads to paralysis and death at birth.  These mutants have fully 
developed brains, but are unable to secrete neurotransmitter
116
.  The neurons degenerate 
shortly after formation, indicating a positive role for Munc18a in neurotransmission
116
.  
Deletion of Munc18a in adrenal chromaffin cells also led to a decrease in secretion
117
.  
Overexpression of Munc18a resulted in an increase in secretion in chromaffin cells, and 
an increase in synaptic transmission at neuromuscular junctions
117, 118
, but a decrease in 
neurosecretion in PC12 cells
119
, indicating cell-type dependency in Munc18a function.  In 
particular, the expression of the neuronal syntaxin t-SNARE syntaxin 1a correlates with 
the expression of Munc18a; deletion of Munc18a results in decreased levels of syntaxin 
1a, suggesting that Munc18a stabilizes syntaxin 1a in vivo
117, 120, 121
.   
 The role of Munc18a homologues in regulating fusion has also been investigated 
in other organisms.  Rop, the Munc18a homologue in Drosophila melanogaster, 
functions at neuronal synapses, but also localizes to other secretory type cells including 
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salivary glands
114, 115, 122-124
.  Null mutations in Rop result in embryonic lethality, but 
overexpression decreases neurotransmitter release, indicating both positive and negative 
roles in membrane fusion
123, 124
.  Supporting this hypothesis, one set of temperature-
sensitive mutations in Rop increases neurotransmitter release while another set decreases 
synaptic transmission in photoreceptors and reduces neurotransmission
107, 124
.  Future 
analyses of these mutations will elucidate the roles of Rop during different steps of 
SNARE assembly and membrane fusion.  Rop interacts with the neuronal syntaxin, and a 
mutation in syntaxin, I236A, results in decreased binding to Rop and an increase in 
neurotransmitter release, suggesting a negative regulatory role for Rop
125-127
.  In the 
squid, Loligo pealei, neurotransmission is decreased when recombinant s-Sec1, the 
Munc18a homologue, is injected into the presynaptic terminal of squid synapses, also 
indicating a negative role
128
.  These previous studies support both positive and negative 
roles in membrane fusion for Munc18a and its homologues; further analysis of these 
individual roles will elucidate the overall mechanism of function for Munc18a. In order 
to more fully understand its function in vivo, the interactions between Munc18a and its 
binding partner(s) have been characterized. 
 Munc18a interacts with its cognate syntaxin t-SNARE.  A variety of assays, 
including co-immunoprecipitations using rat brain extracts and binding assays using both 
in vitro translated proteins as well as purified recombinant proteins, indicate that 
Munc18a binds specifically to syntaxin 1a
92, 114, 115, 129
.  Results from mutational analyses 
and truncation analyses of syntaxin 1a led to the conclusion that both the Habc domain and 
the SNARE motif of syntaxin 1a are necessary for the Munc18a-syntaxin 1a interaction 
31 
(Figure 1.3)
114, 130
.  The structures of the neuronal SNARE complex and the syntaxin 1a 
Habc domain, both of which are helical bundles, led to the hypothesis that the SNARE 
motif and Habc domain interact to form a four-helix bundle, the closed conformation, 
which interacts with Munc18a
12, 65
.  Dulubova et al supported these hypotheses by 
examining the structure of syntaxin 1a using NMR:  spectra of a truncation containing 
both the Habc and SNARE motif shifted with respect to the spectra of a construct 
containing only the Habc domain, demonstrating an interaction between the Habc and the 
SNARE motif 
83
.  In this study, the L165A/E166A mutation in syntaxin 1a did not result 
in a shift of the Habc NMR spectra, thus appearing to destabilize the closed conformation 
and leading to a mostly open construct.  Munc18a, from rat brain extracts, was no longer 
able to bind a GST fusion of syntaxin 1a L165A/E166A, suggesting that Munc18a 
interacts with the closed conformation of syntaxin 1a
83
.  Yang et al went on to show, 
through in vitro binding assays using purified, recombinant, cytoplasmic SNAREs, that 
syntaxin 1a binding to Munc18a precluded SNARE complex assembly
131
.  The crystal 
structure of the Munc18a-syntaxin 1a interaction confirmed the closed conformation 
binding; Munc18a contacts residues from the Habc, linker region, and the SNARE motif 
of syntaxin 1a (Figure 1.5A)
80
.  Of particular interest was residue I233 (I236 in Rop) 
which is located in the SNARE motif of syntaxin 1a and contacts Munc18a.  Mutation of 
residue I233 greatly reduces binding to Munc18a and the analogous mutation in 
Drosophila increases neurotransmission
106, 125, 130, 132
.  The structure, and the I233A 
mutational analysis of syntaxin 1a, led to the hypothesis that Munc18a acts to stabilize 
the closed conformation of syntaxin 1a, which would explain the apparent negative role 
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Munc18a plays in vivo.  However, it was unclear how the Munc18a-syntaxin 1a 
interaction would have a positive role in SNARE complex assembly and membrane 
fusion, suggesting other downstream roles for Munc18a.  These downstream functions 
were not expected to include interactions with the SNARE complex as initial in vitro 
binding experiments indicated that Munc18a does not associate with the assembled 
SNARE complex
129, 131
.  Recently, great strides have been made to elucidate the 
Munc18a-syntaxin 1a interactions and their affects on SNARE complex assembly and 
fusion; these results will be discussed in more detail later.  The Munc18a-syntaxin 1a 
binding mode was also hypothesized to be the common mode of interaction between all 
SM proteins and their partner syntaxin homologues
86
.  Further study of other SM 
subfamilies, however, brought this hypothesis into question, and has led to confusion in 
the field about the mechanism of regulation by SM proteins, and whether or not this 
mechanism is conserved.  Several SM proteins interact with their cognate t-SNAREs in a 
distinctly different manner than Munc18a-syntaxin 1a. 
Munc18c 
 The SM protein, Munc18c regulates exocytosis in various cell types
133
.  A 
knockout of Munc18c results in mice that die at birth, or shortly thereafter
134
.  Analysis 
of their adipocytes indicates an increase in insulin-stimulated glucose transport
134
. 
Overexpression of Munc18c results in an inhibition of insulin-stimulated GLUT4 
translocation to the plasma membrane and an increase in Munc18c levels has been 
recorded in insulin resistant mice
135-137
.  Munc18c competes with its cognate v- and t-
SNAREs, VAMP2 and SNAP-23 respectively, for binding to the syntaxin t-SNARE 
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syntaxin 4
135, 136, 138, 139
.  As in the Munc18a system, syntaxin 4 levels are dependent on 
Munc18c levels, suggesting that Munc18a may stabilize syntaxin 4 in vivo
134
.  Munc18c 
is 51% identical to Munc18a and was originally hypothesized to bind syntaxin 4 similarly 
to the Munc18a-syntaxin 1a interaction.  However, qualitative in vitro binding assays, 
using various truncations of syntaxin 4, indicated that the syntaxin 4 N-peptide (a.a. 1-29) 
was necessary and sufficient to bind Munc18c
140
; furthermore, a mutation in the N-
peptide, L8K, greatly reduced binding, corroborating the truncation analysis data
140
.  In 
this study, a GST-tag was fused to the N-terminus of Munc18c.  Based on the crystal 
structures of several SM proteins, a GST-tag at this position could interfere with binding 
at the cleft of the SM protein
103
.  This would explain why no interaction with the syntaxin 
4 closed conformation, which would bind in the Munc18c cleft, was detected.  The co-
crystal structure of the Munc18c-syntaxin 4 N-peptide (Munc18c a.a. 1-592; syntaxin 4 
a.a. 1-19 in the structure) confirmed that the N-peptide is important for binding (Figure 
1.5B)
 103
.  In this structure, the N-peptide binds to the conserved hydrophobic pocket 
located in domain 1 of Munc18c
103
.  Although, Munc18c competes with its cognate v- 
and t- SNARE (see above) for binding to syntaxin 4, in vitro binding studies revealed that 
pre-formed Munc18c-syntaxin 4 complexes stimulate SNARE complex assembly
140
.  
Similar studies indicated that Munc18c interacts with its cognate SNARE complex
140
.  
However, this interaction mode is distinct from the Sec1p-SNARE complex interaction 
described above.  The Munc18c-SNARE complex interaction is mediated by the syntaxin 
4 N-peptide
140
, whereas the Sec1p-SNARE complex interaction is not
110, 112
.  Munc18c 
has also been shown to specifically interact with its cognate v-SNAREs, VAMP-2
184
.  
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Identification of the N-peptide mode of interaction and the ability of Munc18c to interact 
with the SNARE complex, through the syntaxin 4 N-peptide, increased the number of 
binding modes between SM proteins and their partner(s). 
Subfamily:  Vps33p 
 Vps33p regulates trafficking to the vacuole or lysosome
96, 98, 141
.  Deletion of 
Vps33p in yeast causes a loss of vacuoles, absence of vacuolar proteins, and missorting 
of the vacuolar protein carboxypeptidaseY (CPY)
96, 98, 141
.  Vps33p is a member of the 
tethering complex, HOPS (homotypic fusion and vacuole protein sorting), which 
functions in vacuole and homotypic fusion
142-144
.  Co-immunoprecipitation experiments 
with yeast lysates indicated that Vps33p interacts with the SNARE motif of the syntaxin 
t-SNARE Vam3p while present in the HOPS complex
68, 145
.  This interaction mode, i.e. 
through the t-SNARE SNARE motif, is different than previously shown for the other 
SM-syntaxin interactions, leading to speculation as to whether all SM proteins share a 
common function.  However, the Vps33p-Vam3p interaction may be unique because 
Vps33p is a stable subunit of a larger complex whereas the other SM proteins are not. 
Subfamily:  Sly1p 
 The Sly1p subfamily regulates vesicular trafficking between the ER and the 
Golgi
94, 95, 146-148
.  Deletion of Sly1p in yeast results in cell death; decreasing Sly1p levels 
leads to incomplete glycosylation of modified proteins, and accumulated ER membranes, 
indicating a positive role in fusion
94, 95
.  In yeast, a gain of function Sly1p mutation 
suppresses the deletion of the Rab GTPase Ypt1p
95, 149
.  One explanation of these results 
is that Ypt1p regulates Sly1p by altering the structure of Sly1p; in the absence of Ypt1p, 
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the mutation may alter Sly1p conformation thus abrogating the need for Ypt1p activation.  
Supporting this hypothesis, the hVps45 interacts indirectly with the Rab GTPase, Rab5 
and genetic interactions between other SM proteins and small GTPases also indicate a 
link between small GTPases and SM protein function
150-153
.  These interactions may 
modulate SM protein function in vivo, although further study is needed to determine the 
effect of GTPases on SM-partner interactions. 
 Sly1p interacts with individual SNAREs and SNARE complexes.  Co-
immunoprecipitation from yeast lysates, and in vitro binding studies using recombinant 
proteins, indicated that Sly1p acts as a specificity determinant in SNARE complex 
assembly
154
.  Sly1p specifically associated with SNARE complexes containing the 
syntaxin t-SNARE Sed5p
154, 155
 and interacted with Sed5p alone
148, 156-160
.  The Sly1p-
Sed5p interaction was identified and mapped through co-immunoprecipitation from yeast 
lysates, yeast-2-hybrid analyses, and in vitro GST pull-down binding assays using 
recombinant proteins
156, 161
.  Using these assays, truncation analyses of Sed5p indicated 
that the N-peptide region (a.a. 1-40) is necessary and sufficient for the interaction with 
Sly1p; mutating residues within the N-peptide, a.a. 9 or 10, appeared to abrogate these 
interactions
156
.  The co-crystal structure of the Sly1p-Sed5p N-peptide (Sly1p a.a. 10-
662; Sed5p a.a. 1-21 in the structure) complex indicated that Sly1p and the Sed5p N-
peptide interact similarly to Munc18c-syntaxin 4 N-peptide; Sed5p N-peptide binds the 
conserved domain 1 hydrophobic pocket of Sly1p (Figure 1.5C)
102, 103
.  However, in vivo 
analyses indicated that this interaction is not required for Sed5p or Sly1p function; a 
mutation in the domain 1 hydrophobic pocket of Sly1p, L140K, or in the N-peptide of 
36 
Sed5p, F10A, disrupted the interaction but did not result in an observable phenotype in 
vivo
162
.  These results suggest the presence of a second interaction site between Sly1p and 
Sed5p.  Yeast-2-hybrid analyses indicated that Sly1p does not interact with the closed 
conformation of Sed5p.  Because of this, the interaction between Sly1p and the closed 
conformation of Sed5p was not examined using other techniques such as GST pull-down 
assays or more quantitative assays
156
.  However, several explanations exist for why a 
negative result was obtained using the yeast-2-hybrid technique.  One explanation is that 
both Sly1p and Sed5p are yeast proteins; they may have interacted with other yeast 
proteins and therefore never reached the nucleus.  Another explanation is that the 
constructs used were degraded before reaching the nucleus.  Therefore, the lack of 
interaction between Sly1p and the closed conformation of Sed5p needs to be confirmed 
using other techniques.   
The L140K mutation also disrupted Sly1p binding to the SNARE complex, 
indicating that the N-peptide of Sed5p mediates this interaction, similar to syntaxin 4
162
.  
Similarly to Munc18a and Munc18c, Sly1p also interacted with non-syntaxin SNAREs as 
evidenced by qualitative in vitro binding studies; the L140K mutation did not affect their 
binding to Sly1p, indicating that the domain 1 hydrophobic pocket of Sly1p is not 
required for these interactions
162
. 
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Subfamily:  Vps45p 
 The focus of my thesis is the endosomal SM protein Vps45p.  Vps45p was first 
identified in a genetic screen for mutants that disrupted the processing of vacuolar 
proteins
97, 98, 163, 164
.  Deletion of Vps45p is not lethal at 25°C but does result in cell death 
at 38°C
97
.  At 25°C, vps45 cells secrete an immature form of carboxypeptidaseY 
(CPY)
97
.  Normally, CPY travels from the ER to the Golgi where it undergoes post-
translational modifications; it then traffics to the vacuole where it undergoes proteolytic 
cleavage resulting in its mature form.  In vps45 cells, most of the CPY is not sorted to 
the vacuole, instead it is secreted in its post-Golgi form (post-translationally modified 
immature form)
97, 165
.  Deletion of Vps45p also results in decreased vacuole inheritance 
and an accumulation of 40-50 nm vesicles
97, 165
.  Overexpression of Vps45p does not 
affect CPY sorting or the amount of Vps45p associated with the membrane
97, 165
.  Cell 
fractionation studies indicate that Vps45p associates with the Golgi and/or endosomal 
membranes
97, 165
.  Although the structure of Vps45p has not been determined, a 
homology model of Vps45p, based on the other SM structures, was created by M. 
Munson (Figure 1.6).  This homology model is a useful tool for designing mutations to 
analyze Vps45p function and interactions.  As with other SM proteins, Vps45p is 
hypothesized to regulate endosomal fusion through its interactions with its cognate 
SNAREs. 
 The SNAREs involved in endosomal fusion are Tlg2p, Tlg1p, Vti1p, and Snc2p.  
Tlg2p, like other syntaxin t-SNAREs, contains an N-peptide region (a.a. 1-33), an Habc 
domain, a linker region, a SNARE motif followed by a transmembrane domain, and a  
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Figure 1.6.  Homology model of Vps45p.  A homology model of Vps45p was 
constructed based on structure-based sequence alignments with the other SM proteins.  
Proposed domains are labeled, as well as the conserved hydrophobic pocket and the cleft.  
Residues L117 and W244, amino acids that are discussed in this thesis, are modeled as 
space-filled spheres. 
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lumenal region (Figure 1.3A)
86
.  Tlg1p and Vti1p function as non-syntaxin t-SNAREs 
and Snc2p is the v-SNARE.  Tlg2p and Tlg1p localize to Golgi and early endosomal 
membranes
166, 167
.  Cells lacking Tlg2p show a defect in endocytosis and in sorting CPY 
to the vacuole
168, 169
.  Tlg2p levels significantly decrease in cells lacking Vps45p, 
indicating a role for Vps45p in stabilizing Tlg2p
168, 170, 171
.  Cells lacking Tlg1p have a  
more severe phenotype
168
; in some backgrounds tlg1 cells are dead and a decrease in 
Tlg1p levels results in a CPY sorting defect
161, 168
; in other backgrounds, tlg1 cells are 
temperature-sensitive
166, 167
.  These proteins form functional SNARE complexes in vivo 
and in vitro
72-74, 166, 167, 172, 173
.  Vps45p is hypothesized to regulate endosomal fusion 
through its interactions with these SNAREs; Vps45p interacts with the individual 
SNAREs Tlg2p and Snc2p and with the assembled SNARE complex
 86, 105, 168-170
. 
 Vps45p interacts specifically with the syntaxin t-SNARE Tlg2p
86, 105, 168, 170
.  
Although Tlg2p contains a Habc domain, it is unclear whether it forms a closed 
conformation.  Initially, co-immunoprecipitation from yeast cell lysates indicated that in 
protease-deficient vps45 cells, Tlg2p is unable to form SNARE complexes.  However, 
deletion of the first 230 residues of Tlg2p (which includes the Habc domain) restored the 
ability of Tlg2p to form SNARE complexes.  These results suggested that Tlg2p forms a 
closed conformation and that Vps45p plays a positive role in SNARE assembly
170
.  In 
contrast, NMR studies detected no significant difference between spectra of a Tlg2p 
construct containing the Habc domain and a truncated SNARE motif (a.a. 60-283) and 
spectra of a construct containing only the Habc domain
86
.  An interaction between the Habc 
domain and the SNARE motif should yield a shift in the spectra of the Habc domain
83
, but
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because none was observed, it was concluded that Tlg2p does not form a closed 
conformation
86
.  This construct was chosen for NMR because of its high level of 
solubility, but, because the SNARE motif was truncated in these experiments, the closed 
conformation may have been destabilized.  Therefore, it remains unclear if Tlg2p does 
form a stable closed conformation.   
The interaction between Vps45p and Tlg2p had been previously investigated.  In 
one study using in vitro binding assays, the interaction between Vps45p and Tlg2p was 
mapped using recombinantly expressed Vps45p and GST-tagged truncations of Tlg2p
86
.  
The N-peptide region of Tlg2p (a.a. 1-33) was sufficient to bind Vps45p, in a manner 
similar to the Sly1p-Sed5p and Munc18c-syntaxin 4 interactions
86
; mutation of the Tlg2p 
N-peptide residues F9 and L10 to alanine, abrogated this interaction in a construct 
containing only the Habc domain (a.a. 1-192)
86
.  Because the NMR studies indicated that 
Tlg2p does not form a closed conformation, the ability of Vps45p to bind a construct of 
Tlg2p corresponding to the closed conformation alone was not tested in this study
86
.  In a 
later study, the Vps45p-Tlg2p interaction was further characterized using a mutation in 
Vps45p(L117R)
105
.  Residue L117 is located in the conserved domain 1 hydrophobic 
pocket of Vps45p (Figure 1.6)
105
.  Sequence alignments between Vps45p and Sly1p 
revealed conserved amino acids within this pocket that are important in the Sly1-Sed5p 
N-peptide binding
162
.  The L117R mutation led to an apparent loss of the Vps45p and 
Tlg2p interaction
105
.  Surprisingly, similarly to the Sly1-Sed5p interaction, this mutation 
resulted in no observable phenotype in vivo, indicating that this interaction is not 
necessary for Vps45p or Tlg2p function
105
.  In addition, in vitro pull-down assays using a 
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Tlg2p construct lacking the N-peptide, and C-terminally tagged with Protein A, failed to 
bind Vps45p from yeast lysates
105
.  In these pull-down assays, the C-terminal tag may 
have interfered with the interaction between the Tlg2p closed conformation and the 
Vps45p cleft, or it may have disrupted the ability of Tlg2p to form a closed conformation.  
Because of this more quantitative assays, which do not use proteins fused to bulky tags, 
are needed to examine the Vps45p-Tlg2p interaction. However, the above studies led to 
the hypothesis that Tlg2p does not interact with Vps45p through the closed conformation 
and that the N-peptide of Tlg2p is both necessary and sufficient for the Vps45p-Tlg2p 
interaction, although it is not essential for Vps45p function. 
 Similarly to other SM proteins, Vps45p interacts with other non-syntaxin 
SNAREs
105, 162
.  Vps45p interacts with Snc2p, the v-SNARE that functions in endosomal 
and exocytic trafficking.  This interaction is distinct from the Vps45p-Tlg2p interaction:  
Snc2p does not require the hydrophobic pocket of Vps45p, as the L117R mutant still 
interacts with Snc2p
105
.  Competition data suggests that the affinity of Vps45p-Snc2p is 
weaker than Vps45p-Tlg2p; Tlg2p is able to compete for binding to Vps45p in the 
presence of bound Vps45p-Snc2p, but Snc2p is unable to compete for binding to Vps45p 
in the presence of bound Vps45p-Tlg2p
105
.   
 Vps45p also interacts with assembled SNARE complexes, as indicated by in vitro 
binding assays using Vps45p from yeast lysates and purified recombinant SNARE 
complexes
105
.  The interaction between Vps45p and the SNARE complex appears to be 
through two modes.  The first uses the N-peptide of Tlg2p:  wild-type Vps45p binds to 
SNARE complexes containing full-length Tlg2p, but this interaction was lost when 
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Vps45p-L117R was used or when SNARE complexes contained a Tlg2p construct 
lacking the N-peptide
105
.  A second interaction mode was detected using a mutant of 
Vps45p, W244R
105
.  This mutation is located in the cleft region of Vps45p and was 
identified through a dominant negative screen for Vps45p mutants that caused a defect in 
CPY trafficking (Figure 1.6)
105
.  This mutant interacts with Tlg2p and Snc2p similarly to 
wild-type.  Interestingly, its ability to interact with the assembled SNARE complex 
differs from wild type Vps45p.  The W244R mutant continues to associate with the 
assembled SNARE complex when combined with the L117R mutation or when Tlg2p 
lacks the N-peptide
105
; thus, this second interaction mode does not require the N-peptide 
of Tlg2p or the hydrophobic pocket of Vps45p.  One explanation of these results is that 
the W244R mutation enhances a normally transient interaction between Vps45p and the 
assembled SNARE complex, similar to that of the Sec1p-SNARE complex interaction. 
 In summary, Vps45p interacts with its cognate SNAREs through multiple modes.  
Other SM subfamilies interact through similar or distinctly different modes.  Because of 
the apparent differences in binding, constructing a common mode of interaction for SM 
proteins has been challenging.   
Summary of SM-syntaxin interactions:  Recent Analyses 
 Until recently, the apparent discrepancies in binding between different SM-
syntaxin partners has made it difficult to construct a model by which SM proteins 
function to regulate SNARE complex assembly and fusion.  Five modes of interaction 
had been identified between SM proteins and their syntaxin t-SNARE partner or the 
SNARE complex (Figure 1.7 and Table 1.2):  1) the closed conformation of the syntaxin  
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Figure 1.7.  Modes of interaction between SM proteins and their cognate syntaxin t-
SNARE or the SNARE complex.  (1)  Binding of a SM protein to the closed 
conformation and the N-peptide of a syntaxin t-SNARE.  (2)  Binding to the N-peptide 
only.  (3)  Binding to the assembled SNARE complex through the N-peptide.  (4)  Model 
of the proposed interaction between the SM protein and the assembled SNARE complex.  
No structural data is available for this interaction, so the placement of the SNARE 
complex in the cleft is hypothetical, based on binding of the syntaxin 1a closed 
conformation, which is also a four helix bundle, to Munc18a.  Table 1.2 contains a list of 
SM proteins, their cognate syntaxin t-SNARE, and their mode(s) of binding. 
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Table 1.2.  Summary of Sec1/Munc18 Interactions 
Sub-
family    
Syntaxin 
Partner 
Syntaxin-           
t SNARE 
Interaction  
SNARE Complex 
Interaction 
Other 
SNAREs  Summary of SM protein information 
              
Sec1   
Sso1p  
110, 112
 
None 
 
110, 112
 
Assembled complex 
110, 112
 
None  
110, 112
 
- Stimulates fusion in vitro 
113 
              
Munc18a   
syntaxin 
1a  
92, 114, 115, 
129
 
Closed 
Conformation  
N-peptide    
80, 106, 125, 174-177  
N-peptide & 
Assembled complex 
174, 175
 
?
 
- nSec1 and Munc18a-Synatxin 1a crystal structures
80, 100, 101, 106  
- Stimulates fusion/inhibits SNARE assembly in vitro
106, 131, 174, 177 
- Positive & negative roles in vivo
116 
- Stimulates fusion in vitro
174 
              
Munc18c   
syntaxin 4 
135, 138
 
N-peptide  
103, 140, 178, 179 
Yes, unknown 
which mode(s) 
140
 
? 
- Munc18c-syntaxin 4 crystal structure 
103
 
- Munc18c increases insulin-stimulated glucose transport 134 
              
Vps33    Vam3p Binds the Vam3p SNARE motif as a member of the HOPS tethering complex 
68, 144
 
              
Sly1   Sed5p,
156
 
N-peptide  
156, 161 N-peptide 
154, 162 
v-SNARE              
t-SNARE 
162
 
- Sly1-Sed5p crystal structure 
102 
- sly1 accumulates ER membranes 94, 95 
- Confers SNARE complex specificity 
154
 
              
Vps45   
Tlg2p  
86, 168 
N-peptide  
86, 105, 106
 
 
N-peptide & 
Assembled complex 
105
 
v-SNARE 
105 
- vps45 missorts vacuolar proteins 97, 165 
- L117R & W244R affect interactions 
105 
- Stabilizes Tlg2p
170, 171
  
- N-peptide interaction not required for function in vivo
105, 171
 
47 
t-SNARE (Munc18a-syntaxin 1a)
80
; 2) the N-peptide of the syntaxin (Munc18c-syntaxin 
4, Sly1p-Sed5p, and Vps45p-Tlg2p)
86, 102, 103
; 3) binding to the assembled SNARE 
complex that is dependent on the syntaxin N-peptide (Munc18c-syntaxin 4, Sly1p-Sed5p, 
and Vps45p-Tlg2p)
105, 140, 154, 162
; 4) binding to the assembled SNARE complex that is 
independent of the syntaxin N-peptide (Sec1p-SNARE complex and Vps45p-Tlg2p)
112
;  
and 5) indirect interaction as a member of a complex (Vps33p-Vam3p) (mode not 
shown)
68, 144
.  The N-peptide mode appeared to be the most common mode for SM-
syntaxin interactions, with the exceptions being Sec1p, Vps33p, and Munc18a.  It was 
initially hypothesized that the Munc18a-syntaxin 1a closed conformation interaction was 
specific to the neuronal system, and that the N-peptide is not used at all in this 
interaction
108
. 
 The N-peptide interaction is the most conserved interaction in the SM-syntaxin 
pairs.  The interaction involves the first 20-40 residues of the syntaxin t-SNARE and a 
conserved region in domain 1 of the SM protein
86, 102, 103
.  Sequence alignments and co-
crystal structures of several SM-syntaxin interactions revealed an interface in which 
conserved residues in the SM protein form a hydrophobic pocket in domain 1 and 
conserved residues from the syntaxin N-peptide fit into the pocket
102, 103
.  Such an 
interface was identified between  Sly1p-Sed5p, Munc18c-syntaxin 4, and Vps45p-Tlg2p 
(by mutational analysis since no crystal structure is available)
86, 102, 103
.  SM-syntaxin 
pairs that lack the N-peptide interaction, including Sec1p-Sso1p, do not share this 
conserved interface
103
.  Surprisingly, sequence alignments of Munc18a and syntaxin 1a 
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revealed the presence of a similar interface, suggesting that Munc18a interacts with the 
N-peptide of syntaxin 1a
103
. 
 Interactions between Munc18a and the syntaxin 1a N-peptide had been previously 
examined
114, 130, 175
.  In vitro binding assays using purified recombinant proteins indicated 
no interaction between Munc18a and a truncation of syntaxin 1a that contained the N-
peptide region but lacked the SNARE motif, suggesting that the N-peptide was 
insufficient to interact with Munc18a
114, 130, 175
.  Also, when the co-crystal structure of 
Munc18a-syntaxin 1a was determined, an interaction with the N-peptide was not 
observed
80
.  These results led to the hypothesis that the only interaction site is through the 
closed conformation.  Recent data, however, indicate that the N-peptide is required for 
certain functions of Munc18a.  In contrast to earlier experiments, in vitro binding studies 
using purified recombinant proteins indicated that Munc18a interacts with open syntaxin 
1a, and the affinity of this interaction is decreased when the first six residues are 
truncated in the open mutant
106, 176
.  These discrepancies may have occurred because 
earlier experiments used rat brain lysate to test binding of Munc18a to N-terminally GST-
tagged syntaxin 1a constructs; the GST-tag may have interfered with binding thus leading 
to a false negative result
83
.  Furthermore, recent FRET analysis and NMR studies indicate 
that the syntaxin 1a N-peptide does interact with Munc18a
177
.  Size exclusion 
chromatography using purified recombinant proteins also showed that Munc18a interacts 
with the assembled SNARE complex and that this interaction requires the N-peptide of 
syntaxin 1a
175
.  In a liposome fusion assay, in which the t-SNARE complex was pre-
formed, Munc18a specifically stimulates fusion of proteoliposomes containing neuronal 
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SNAREs
174
.  This stimulation is N-peptide dependent, as deletion or mutation of the N-
peptide abolishes the effect; stimulation is also dependent upon residues in the SNARE 
motif of the v-SNARE
174
.  Additionally, in vitro binding assays using GST-tagged 
Munc18a and preassembled SNARE complexes with different constructs of syntaxin 1a, 
showed that Munc18a associates with the SNARE complex through the N-peptide region 
of syntaxin 1a
174
.  However, liposome floatation assays in which Munc18a and 
cytoplasmic v-SNARE were added to proteoliposomes containing cognate t-SNAREs, 
indicate that Munc18a can also bind to the SNARE complex in the absence of the N-
peptide; these results correlate with the findings that mutations in the SNARE motif of 
the v-SNARE abolish the stimulatory effect of Munc18a
174
.  Although Munc18a 
stimulates liposome fusion, fluorescence anisotropy data using the cytoplasmic regions of 
the neuronal SNAREs indicates that the N-peptide inhibits SNARE complex assembly
106
.  
In these experiments, however, the t-SNAREs were not co-expressed and so the t-
SNARE complex was not pre-formed.  Munc18a may therefore play a negative 
regulatory role before t-SNARE complex assembly and a positive role after t-SNARE 
complex assembly.  The above data indicates that Munc18a interacts with the SNARE 
complex similarly to other SM proteins.  The data also suggest that Munc18a interacts 
with the syntaxin 1a N-peptide.  Furthermore, re-refinement of the co-crystal structure of 
the Munc18a-syntaxin 1a complex revealed density at the interface between the Munc18a 
domain 1 hydrophobic pocket and the syntaxin 1a N-peptide, confirming this mode of 
binding (Figure 1.5A and Figure 1.7(1)) 
106
.  These results revealed that the assembled 
SNARE complex interaction and the N-peptide interaction in SM protein function are 
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conserved.  However it is still unclear whether the closed conformation interaction is 
unique for the Munc18a-syntaxin 1a interaction. 
GENERAL CONCLUSIONS AND HYPOTHESES 
 Vesicular trafficking is essential for the delivery of proteins and membrane 
between various organelles and to the plasma membrane.  This process requires both a 
high degree of specificity and regulation to ensure that materials reach their appropriate 
destination(s) at the correct time
1
.  Specificity and regulation are the responsibilities of 
numerous protein families
2
.  Understanding the functional mechanisms of these protein 
families is an essential step in understanding vesicular trafficking.  An important aspect 
to elucidating their functions is to understand the way in which these proteins interact 
with each other:  the domains that are used in specific interactions, the affinity of these 
interactions, and how these interactions affect other associations.  By understanding the 
interactions between proteins, models can be created to explain how the proteins 
function, and experiments performed to test these models in vivo.  My thesis focuses on a 
specific member of the Sec1/Munc18 protein family, Vps45p, and its interactions with 
one of its partners, the syntaxin t-SNARE Tlg2p, in order to elucidate the mechanism by 
which SM proteins function to regulate SNARE-mediated membrane fusion in vivo.  
 The mechanism of SM protein function has been murky due to the various modes 
of interaction identified between SM proteins and their cognate SNAREs (Figure 1.7 and 
Table 1.2); recently the picture has become clearer.  The N-peptide association is the 
common mode of interaction between most SM proteins and their cognate SNAREs, 
although the affinity for this interaction varies in different systems
86, 102, 103, 105, 106, 140, 156
.  
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This interaction mode also facilitates the association between SM proteins and the 
SNARE complex; this mode has been identified for Munc18a, Munc18c, Sly1p and 
Vps45p
105, 106, 140, 154, 174-176
.  SM proteins can also interact with the assembled SNARE 
complex; this mode has been observed for Sec1p, Munc18a, and a mutant Vps45p
105, 110, 
112, 174
.  Two additional modes of interaction seemed to be distinct for specific systems:  
Vps33p functions as a member of the tethering complex, HOPS, to interact with Vam3p, 
and Munc18a interacts with the closed conformation of syntaxin 1a. 
 It was unclear whether or not the Munc18a-syntaxin 1a closed conformation 
mode was unique to the neuronal system.  Several of the other SM-syntaxin pairs needed 
to be further examined to definitively exclude the closed conformation interaction.  In 
fact, several lines of evidence imply that Munc18c may interact with syntaxin 4 through 
multiple binding sites:  limited proteolysis of syntaxin 4 indicates that syntaxin 4 forms a 
closed conformation, and FRET analysis indicates that Munc18c binds to syntaxin 4 in 
the absence of the N-peptide
178
.  Previous GST pull-down experiments suggested that the 
closed conformation did not bind Munc18c, but this negative result may have been 
caused by the presence of the GST-tag at the N-terminus of Munc18c
140
.  Based on the 
crystal structures of SM proteins (Figure 1.4 and 1.5) the GST-tag may have blocked 
binding at the Munc18c cleft.  Because of this, the ability of Munc18c to interact with 
closed syntaxin 4 needs to be more carefully examined.  The Sly1p-Sed5p interaction 
also needs to be more closely re-examined:  qualitative yeast-2-hybrid assays suggested 
that Sly1p does not interact with the closed conformation of Sed5p, and later biochemical 
assays did not test the closed conformation
156
.  This interaction needs to be re-examined 
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using biochemical assays to determine if this negative result is true.  However, the Sly1p-
closed Sed5p affinity may be weaker than the Munc18a-syntaxin 1a closed conformation 
interaction; quantitative assays may be necessary to detect this interaction.  Finally, 
isothermal titration calorimetry (ITC) experiments recently indicated that the affinity 
between mammalian Vps45 and syntaxin 16 (the Tlg2p homologue) is increased with the 
addition of residues corresponding to the closed conformation of syntaxin 16
106
.  
Although ITC indicates that these residues alone are insufficient for binding to Vps45p, 
the results do suggest the presence of a second binding site on syntaxin 16 for mVps45. 
 The goal of my thesis was to elucidate the function of Vps45p through its 
interactions with Tlg2p and the SNARE complex.  Based on data from other SM proteins, 
I hypothesized that Vps45p functions to stimulate SNARE complex assembly.  Using 
size exclusion chromatography and qualitative in vitro binding assays, I attempted to 
analyze the effect of Vps45p on SNARE complex assembly.  Results in this area were 
limited and indicated that endosomal SNARE complex assembly depends on several 
different factors.  I also characterized the interactions between Vps45p and its cognate 
syntaxin t-SNARE Tlg2p.  I hypothesized that the N-peptide of Tlg2p is not the only 
binding interface between Vps45p and Tlg2p and mapped the Vps45p-Tlg2p interaction 
through systematically testing various Tlg2p truncations, which included different 
domains of Tlg2p.  I developed a quantitative fluorescence-based electrophoretic 
mobility shift assay to determine the affinity between Vps45p and the Tlg2p constructs. 
This assay is generally applicable for protein-protein interactions and yields an efficient 
way to determine the affinity between two proteins.  My results indicate that Vps45p 
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binds the closed conformation of Tlg2p, and that the N-peptide and closed conformation 
interactions do not occur simultaneously.  My work provides a better understanding of 
endosomal SNARE complex assembly, and contributes greatly to understanding the 
interaction between Vps45p and Tlg2p, and to constructing a general mechanism for SM 
proteins.  
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CHAPTER II: 
 
 
The N-terminal peptide of the syntaxin Tlg2p modulates 
binding of its closed conformation to Vps45p 
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ABSTRACT 
The Sec1p/Munc18 (SM) family of proteins regulates intracellular trafficking through 
interactions with individual SNARE proteins and assembled SNARE complexes.  
Revealing a common mechanism of how this regulation is achieved has been challenging, 
largely due to the multiple modes of interaction observed between different SM proteins 
and their SNARE partner(s).  These modes include:  binding of the SM to a closed 
conformation of the syntaxin SNARE protein; binding to the N-terminal peptide of 
syntaxin; binding to assembled SNARE complexes; and/or binding to non-syntaxin 
SNAREs.  The SM protein required for trafficking through the yeast endosomal system, 
Vps45p, binds the conserved N-terminal peptide of its cognate syntaxin Tlg2p.  We have 
investigated the Vps45p-Tlg2p interaction in more detail, using size exclusion 
chromatography and a quantitative fluorescent gel mobility shift assay.  These studies 
reveal an additional binding site for Vps45p on Tlg2p, which corresponds to a closed 
conformation of the syntaxin.  Furthermore, we demonstrate that the Tlg2p N-peptide 
competes with the closed conformation for binding, suggesting a fundamental regulatory 
mechanism for SM-syntaxin interactions in SNARE assembly and membrane fusion. 
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INTRODUCTION 
 Proper eukaryotic cell growth and survival requires membrane-bound vesicles to 
transport proteins and membrane between the various organelles within the cell and to the 
plasma membrane for secretion.  The mechanisms of vesicle budding, trafficking and 
fusion are conserved across the various trafficking steps within the cell, and therefore 
require exquisite regulation to ensure specificity
1
.  A crucial component of these 
trafficking mechanisms are the SNARE proteins
48, 67, 180
.  SNAREs on the vesicle 
membrane (v-SNAREs) interact with those on the target membrane (t-SNAREs) to form 
a parallel four-helix-bundle
12
, called the SNARE complex, which bridges the vesicle and 
target membranes for fusion
52
.   
 The Sec1/Munc18 (SM) protein superfamily regulates SNARE complex assembly 
and membrane fusion through direct interactions with their cognate SNAREs
108
.  The SM 
family is divided into four subfamilies: Sec1p, Vps45p, Sly1p, and Vps33p 
26, 181, 182
.  The 
Sec1p family is exocytic, and includes yeast Sec1p and mammalian Munc18 isoforms-
Munc18a is neuronal specific, while Munc18c functions in multiple cell types, such as 
the trafficking of GLUT4 glucose transporters in insulin-sensitive cells.  The Vps45p 
family regulates endosomal trafficking, while the Sly1p family regulates trafficking 
between the ER and Golgi.  The Vps33p family functions in trafficking to the vacuole or 
lysosome.  The different SM proteins show a high degree of structural similarity, 
consisting of three mixed α-helical and β-sheet domains arched around a central cleft, 
suggesting the possibility of a conserved function
80, 100, 102, 103
.   
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 Although SM proteins are thought to perform similar roles in the regulation of 
vesicle fusion, a wealth of conflicting data from SM homologues in different trafficking 
steps and species has made the mechanism of SM action unclear.  Deletion of SM 
proteins leads to the accumulation of membranes, a decrease in neurotransmitter release 
and secretion, and loss of accurate protein sorting, indicating a positive regulatory role
93, 
94, 116, 124, 165, 170
.  This is supported by in vitro experiments demonstrating that Munc18a 
and Sec1p stimulate SNARE-mediated liposome fusion
113, 174
.  Conversely, Munc18a 
binds to an inhibited, „closed‟ conformation of syntaxin 1a80, 131.  This closed 
conformation prevents the syntaxin SNARE motif region from interacting with the other 
SNAREs, thus inhibiting SNARE complex assembly
114, 183
, indicating that SM proteins 
may act as negative regulators.  Additionally, in Drosophila, overexpression of SM 
proteins in vitro leads to decreased vesicle fusion, while disruption of SM-syntaxin 
interactions results in increased fusion
123, 125
.  Clearly, SM proteins have both positive 
and negative roles in vitro, which may reflect different aspects of their function in the 
SNARE assembly/disassembly cycle.  
 Abundant evidence supports a critical role for the interactions of SMs with 
SNAREs.  SM proteins interact directly with individual SNAREs and/or assembled 
SNARE complexes
108
.  Most of the SM proteins interact directly with syntaxins at one of 
two distinct binding sites, which are separated by > 30 Å.  One interface is formed 
between the central cleft of Munc18a and the closed conformation of syntaxin 1a [Figure 
2.1A; mode (1)]
80
.  In contrast, other SMs bind individual syntaxins, as well as SNARE 
complexes, through interactions between domain 1 of the SM protein and the N-terminal  
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Figure 2.1.  Recombinant Tlg2p and Vps45p constructs are well-folded in vitro.  (A) 
Cartoon representation of the SM-syntaxin binding modes.  SM proteins bind to the 
closed syntaxin conformation [mode (1)], the N-peptide of syntaxin [mode (2)], or both 
sites of syntaxin [mode (3)].  Shading of the syntaxin regions corresponds to the Tlg2p 
domains in (B).  Not shown are additional modes of binding for which there is little 
structural information: binding of the SM to assembled SNARE complexes, and binding 
of the SM to non-syntaxin SNAREs.  (B) Schematic of the Tlg2p sequence and the 
truncations used in this study.  Shaded boxes indicate the domains; corresponding residue 
numbers are shown above the full-length diagram.  (C&D) CD analyses of Tlg2p (C) and 
Vps45p (D) constructs expressed in E. coli and purified by ion-exchange and SEC.  
Insets: purified proteins were analyzed by SDS-PAGE and stained with Coomassie blue.  
(E) The interaction between purified Vps45p and Tlg2p(1-318) was observed by SEC.  
Vps45p and Tlg2p(1-318) were incubated together and applied to a Superdex 200 gel 
filtration column.  The elution profile of the complex is shown compared to the profiles 
of the individual proteins.  Absorbance was monitored at 280 nm and molecular weight 
standards are indicated at the top.
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peptide of the syntaxin [Figure 2.1A; mode (2)].  These include Sly1p-Sed5p
102, 156
, 
Vps45p-Tlg2p
86, 105
, and Munc18c-syntaxin 4
103
.  Thus, the N-peptide interaction appears 
to be the most common mode of binding, and the closed conformation interaction is 
hypothesized to be specific to the neuronal Munc18a
108
.  An additional interaction mode 
is observed for the yeast exocytic Sec1p, which binds assembled SNARE complexes in 
the absence of the syntaxin N-peptide
112
; this mode may also be used by other SMs
105, 174
.  
Moreover, several SM proteins have been shown to interact with non-syntaxin 
SNAREs
105, 162, 184, 185
.  The multiple distinct modes of interaction between SM proteins 
and SNARE partners suggest that the SMs may not share a common mode of action
120
, 
although the high degree of sequence and structural similarity between them argues that 
SMs should have a common function in vesicular trafficking.   
 Recent studies are beginning to resolve this quandary.  Although the closed 
conformation seemed to be the predominant mode of the Munc18a-syntaxin 1a 
interaction, the N-peptide of syntaxin 1a appears to be important for the regulation of 
SNARE complex assembly, for the interaction between Munc18a and assembled 
neuronal SNARE complexes, and for stimulation of membrane fusion
106, 174-177
.  The N-
peptide alone is not sufficient for binding of syntaxin 1a to Munc18a, but these data 
suggest that Munc18a may bind the syntaxin 1a N-peptide similarly to other SM proteins.  
Additionally, when the original Munc18a-syntaxin 1a structure was re-examined, density 
corresponding to several residues of syntaxin 1a‟s N-peptide bound to Munc18a was 
observed, confirming that syntaxin 1a can bind Munc18a through dual modes [Figure 
2.1A; mode (3)]
106
.  
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 Here, we focus on yeast Vps45p, which interacts with the N-peptide of Tlg2p 
[Figure 2.1A; mode (2)].  Mutational analyses had previously suggested that this N-
peptide binding site was important for the Vps45p-Tlg2p interaction.  A mutation of 
Vps45p in a hydrophobic pocket on domain 1 (L117R), appeared to disrupt binding to 
Tlg2p
105
.  Likewise, mutations in the Tlg2p N-peptide (F9A/L10A), or deletion of the 
first 36 residues, seemed to abolish the interaction between Vps45p and Tlg2p
86, 105
.  
Additionally, NMR studies of truncated Tlg2p had suggested that, unlike syntaxin-1A 
and Sso1p
79, 81
, Tlg2p does not form a stable closed conformation
86
.  These data, along 
with homology to other SM-syntaxin pairings, led to the hypothesis that the N-peptide of 
Tlg2p is solely responsible for the interaction between Vps45p and Tlg2p.   
 However, given the absence of a phenotype for mutants that disrupt binding 
between Vps45p and Tlg2p
105
, and given the evidence for dual binding modes for 
Munc18a and syntaxin 1a , we re-examined the possibility of additional interaction 
modes between Vps45p and Tlg2p using a systematic quantitative approach.  We 
measured the ability of various constructs and mutants of Tlg2p to interact with Vps45p 
by size exclusion chromatography (SEC) and quantitative fluorescent electrophoretic 
mobility shift assay (EMSA).  Using these assays, we discovered a second binding site 
for Vps45p on Tlg2p, which corresponds to a closed conformation of Tlg2p [Figure 
2.1A; mode (1)].  Furthermore, we show that the N-peptide of Tlg2p modulates the 
affinity of the closed conformation binding site, suggesting a role for the N-peptide in 
controlling accessibility of Tlg2p for SNARE complex assembly.  Our data suggest that a 
common mechanism for SM-syntaxin interactions is a dual mode, whereby the SM 
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interacts with two distinct sites on the syntaxin:  the N-peptide and the closed 
conformation.  The relative affinity of each site is determined by the specific role each 
plays at different stages in the SNARE complex assembly and membrane fusion 
processes. 
 
MATERIALS AND METHODS 
Protein expression and purification  
 Tlg2p(1-318), Tlgp2(37-318), Tlg2p(37-192), and Tlg2p(221-318) truncations 
were generated by PCR and cloned into the NdeI and BamHI sites of pET15b (Novagen), 
creating an N-terminal His6-tag on each.  Tlg2p(37-192) also contains a C-terminal 
cysteine which did not affect its expression or solubility.  The Tlg2p(1-318)-F9AL10A, 
Tlg2p(1-318)-I285A, and Tlg2p(37-318)-I285A constructs were generated using PCR 
mutagenesis.  Cloning of His6-Vps45p and His6-Vps45p-L117R was described previously 
105
.  All constructs were confirmed by sequencing.  Tlg2p constructs were expressed in E. 
coli BL21(DE3) cells.  Vps45p constructs were expressed in E. coli BL21(DE3) cells 
containing the GroEL and GroES expressing plasmid pJK213 (a gift from J. Kahana).  
Cells containing Tlg2p(1-318), Tlg2p(37-318), Tlg2p mutants, Vps45p and Vps45p-
L117R, were shifted to 15°C at an OD600 of ~0.3, protein expression was induced at an 
OD600 of 0.6-0.8 with 0.1 mM IPTG, and expression continued for 12-16 h.  Cells 
expressing Tlg2p(37-192) and Tlg2p(221-318) were induced at 37°C for 3 h.  All 
proteins were purified by affinity chromatography and ion-exchange chromatography.  
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Protease inhibitor tablets (Roche) were included in the lysis and affinity chromatography 
buffers used for all Tlg2p proteins except Tlg2p(37-192) and Tlg2p(221-318).  Glycerol 
was added to 10% in all buffers, except for those used for Tlg2p(1-318) and Tlg2p(221-
318).  All proteins, except Tlg2p(221-318), were further purified by Superdex 200 (GE) 
SEC.  Kphos (10 mM potassium phosphate, 140 mM potassium chloride) buffer and 1 
mM DTT was used for Tlg2p(1-318).  Kphos plus 10% glycerol and 1 mM DTT was 
used for the other constructs.  Protein concentrations were determined by a quantitative 
ninhydrin protein assay
186
.  All proteins were stored at -80°C in Kphos plus 10% glycerol 
with either 1 mM DTT or 2 mM tris(2-carboxyethyl)phosphine (TCEP).  The Tlg2p(1-
33) peptide containing a cysteine at the C-terminus was synthesized (QCB).  Purity was 
confirmed by HPLC and mass spectrometry (data not shown).  The peptide was 
lyophilized and stored at -80°C.  Before use in the competition experiments, the peptide 
was resuspended in binding buffer (see below).  The concentration was determined by 
quantitative amino acid analysis (Keck Biotechnology Resource Laboratory, Yale 
University), and confirmed by titration of the cysteine using Ellman‟s reagent (Pierce).  
Attempts to label the peptide with maleimide-Alexa 488 [as described below for 
Tlg2p(37-318)] resulted in substantial aggregation and precipitation, which precluded 
further analysis of the direct binding between the peptide and Vps45p. 
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Circular dichroism spectroscopy and size exclusion chromatography  
 CD spectra were recorded as described in Sivaram et al 2005
45 
in Kphos buffer, 
10% glycerol, and 0.5 mM TCEP, using protein concentrations of 1-5 µM.  The mean 
residue ellipticity values at 222 nm were used to estimate percent helicity
187
.  For SEC, 
protein samples (1-5 µM each) were incubated in Kphos buffer plus 1mM DTT for 1 h at 
18°C.  100 µL of each sample was loaded on a Superdex 200 10/30 column (GE) pre-
equilibrated in Kphos buffer plus 1 mM DTT and elution of the protein from the column 
was monitored using the absorbance at 280 nm.  Complex formation was verified by 
running elution fractions on SDS-PAGE and staining with Coomassie blue (data not 
shown).  The gel filtration column was calibrated using standards (thyroglobulin, 670 kD; 
γ-globulin, 158 kD; ovalbumin, 44 kD; myoglobin, 17 kD; Bio-Rad).  We observed that 
Vps45p and the L117R mutant had slightly smaller apparent molecular weights than 
expected; however, mass spectrometry confirmed that the recombinant purified Vps45p 
is full-length (data not shown).  Conversely, the Tlg2p constructs generally eluted with an 
apparent molecular weight slightly larger than calculated.  These apparent molecular 
weights were smaller than dimer, and we confirmed the monomeric status of Tlg2p(37-
318) by analytical ultracentrifugation (Appendix 1).  Each CD and SEC experiment was 
repeated at least 3 times. 
Fluorescent labeling of Tlg2p(37-318) 
 Aliquots of Tlg2p(37-318) were incubated in Kphos plus 10% glycerol and 2 mM 
TCEP (reaction buffer) for 45 min.  Maleimide conjugated Alexa Fluor 488 dye 
(Invitrogen) was resuspended in reaction buffer and added at a 14:1 molar ratio 
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(dye:Tlg2p).  Tlg2p(37-318) contains two cysteine residues.  One cysteine, Cys316, is 
close to the C-terminal end of the protein.  Based on our homology modeling of the Habc 
domain (data not shown), the other cysteine (a.a. 129) is predicted to be buried in the 
hydrophobic core.  Mass spectrometry confirmed that only a single cysteine was labeled, 
and EMSA experiments showed that Vps45p affinity for the unlabeled Tlg2p(37-318) 
was less than two-fold different (slightly weaker) than for the labeled protein.  The 
labeling reaction was incubated for 2 h in the dark at room temperature, centrifuged, and 
the supernatant purified in the dark using a Superdex 200 10/30 size exclusion column 
equilibrated in Kphos, 10% glycerol and 1 mM TCEP.  Fractions containing labeled 
Tlg2p(37-318)* were pooled and concentrated using a Stirred Ultrafiltration Cell with a 
YM regenerated cellulose membrane (MWCO 10,000) (Millipore).  Protein concentration 
was determined by quantitative ninhydrin assay
186
 and the labeled protein stored in the 
dark at -80°C. 
Electrophoretic mobility shift assay 
 The apparent affinity (Kd, app) between Vps45p and Tlg2p(37-318)* was 
determined by EMSA using the protocol adapted from Pagano et al 2007
188
.  Each 
experiment was replicated at least three times.  Increasing concentrations of Vps45p were 
incubated with ~15 nM Tlg2p(37-318)* in Kphos plus 10% glycerol, 0.01% NP-40 and 1 
mM TCEP (binding buffer) and equilibrated for 3 h at room temperature in the dark.  A 
1:9 dilution of Bromocresol green dye solution (2% w/v in 30% glycerol) was added to 
each sample, and 25 μL of each reaction was immediately loaded onto a 6% horizontal 
slab polyacrylamide native gel (29:1 acrylamide:bis-acrylamide in 8.6 mM imidazole and 
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7 mM Hepes, pH 7.4) previously equilibrated at 4°C.  Gels were run for 4 h and 45 min 
at 125V at 4°C in a Sub-Cell GT System Tank (BioRad).  The presence of Tlg2p(37-
318)* in the unbound or bound state was detected in wet gels using an FLA-5000 
Fujifilm Imaging System equipped with a blue laser at 473 nm and quantified using Multi 
Gauge software.  The fraction bound of Tlg2p(37-318)* was determined using Excel 
(Microsoft), and graphed vs. [Vps45p] using Igor Pro software.  The data were fit to a 
sigmoidal dose-response function to determine the half-maximal saturation point (Kd, app), 
using equation (1): 
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 is the fraction bound of Tlg2p(37-318)* at a given concentration of protein [P].  n is the 
apparent Hill coefficient.  m is the greatest signal for Tlg2p(37-318)* in the bound 
fraction while b is the greatest signal for Tlg2p(37-318)* in the unbound fraction. 
 Competition experiments were performed as above, except that increasing 
concentrations of unlabeled Tlg2p constructs (“competitor”) were incubated with a sub-
saturated concentration of Vps45p and Tlg2p(37-318)*.  The fraction bound of Tlg2p(37-
318)* vs. [competitor] was graphed, and the half maximal inhibition constant (IC50) was 
calculated using equation (2), where [C] is the concentration of competitor protein, and s 
is the shape factor. 
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 These values were converted to the apparent equilibrium dissociation of 
competitor (Kc, app) by applying the Lin and Riggs correction
189
, where [P] is the 
concentration of Vps45p, [T*] is the concentration of labeled Tlg2p(37-318)* and Kd, app 
is the apparent dissociation constant for Vps45p-Tlg2p(37-318)*.  Equation (3): 
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RESULTS 
Vps45p interacts with Tlg2p in the absence of the Tlg2p N-peptide 
 To test the various modes of interaction between Tlg2p and Vps45p, we purified 
recombinant Vps45p and various truncations of Tlg2p (Figure 2.1B).  Specific 
truncations of Tlg2p, created to examine the role individual domains play in the 
interaction with Vps45p, were designed using secondary structure predictions, sequence 
alignments with other syntaxin homologues, and domains delineated by NMR 
experiments
86
.  The full-length cytosolic Tlg2p(1-318) protein contains: the N-peptide 
region that interacts with Vps45p; the Habc domain, which acts as an autoinhibitory 
domain in many syntaxin-type SNAREs; a short linker region; and the SNARE motif 
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region, which is used for binding to the other SNARE proteins (Figure 2.1B).  Each 
protein is monomeric, as determined by SEC.  Their secondary structures were analyzed 
by CD (Figure 2.1C).  The α-helicity for each construct is similar to its predicted α-
helical content (http://npsapbil.ibcp.fr/).  The exception is Tlg2p(221-318), which is 
predominantly unfolded, as expected for an isolated SNARE motif region
70, 190
.  In 
addition to the Tlg2p proteins, we purified wild-type Vps45p and Vps45p-L117R, a 
mutant with abrogated binding to the Tlg2p N-peptide; both are monomeric and have 
similar -helical content to predicted values (Figure 2.1D).  Thus, the SEC and CD 
analyses indicate that the purified recombinant Tlg2p and Vps45p proteins do not 
aggregate and are well-folded.  
 The interaction between the recombinant Vps45p and Tlg2p(1-318) proteins was 
investigated.  Vps45p alone, Tlg2p(1-318) alone, or Vps45p+Tlg2p(1-318) were 
incubated for 1 h at 18°C, and SEC was used to separate the complex from the free 
proteins (Figure 2.1E).  The elution peaks of both Vps45p and Tlg2p(1-318) shift to a 
larger apparent molecular weight when these two proteins are combined, indicating that 
Vps45p interacts with the cytosolic region of Tlg2p, corroborating previous studies
86, 105
.  
We next examined whether this interaction requires the N-peptide of Tlg2p.  The 
construct lacking the N-peptide, Tlg2p(37-318), was incubated together with Vps45p and 
analyzed by SEC (Figure 2.2A).  Surprisingly, a shift was observed in the 
Vps45p+Tlg2p(37-318) elution profile, demonstrating robust complex formation.  The 
retention volume of the complex, as well as SDS-PAGE analysis of the elution fractions,  
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Figure 2.2.  The N-peptide of Tlg2p is not required for the Vps45p-Tlg2p 
interaction.  (A) The interaction between Vps45p and Tlg2p(37-318) was analyzed by 
SEC as in Figure 2.1E.  The “shoulder” in the Tlg2p(37-318)+Vps45p curve contains 
both unbound Vps45p and Tlg2p(37-318), as indicated by SDS-PAGE analysis of peak 
fractions.  (B) The Kd, app between Vps45p and Tlg2p(37-318) was determined using 
EMSA.  Increasing concentrations of Vps45p were incubated with fluorescently labeled 
Tlg2p(37-318)*.  Reactions were run on a horizontal polyacrylamide native gel (6%) and 
bound vs. free fluorescent Tlg2p(37-318)* was detected.  Data were fit to the Hill 
equation to generate the curve, the Kd, app, and the Hill coefficient (n).  “*” indicates the 
mobility of unbound Tlg2p(37-318)*.  The first lane contains no Vps45p and lanes 2-20 
contain increasing concentrations of Vps45p from 0.5 nM - 5 µM.  Representative data 
are shown for three separate replicates.  (C)  The Kd, app of the interaction described in (B) 
was determined when “n” was fixed at 1.  Representative data are shown for three 
separate replicates.  
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are consistent with a 1:1 stoichiometry and demonstrate that Vps45p interacts with Tlg2p 
in the absence of the Tlg2p N-peptide.  
 To determine the apparent affinity between Vps45p and Tlg2p(37-318), we 
developed a native gel electrophoretic mobility shift assay (EMSA) using Tlg2p(37-318) 
protein fluorescently labeled with Alexa 488 dye [Tlg2p(37-318)*].  First, increasing 
concentrations of Vps45p were incubated with a trace amount (15 nM) of Tlg2p(37-
318)*.  These reactions were then electrophoresed on a horizontal 6% non-denaturing 
polyacrylamide gel to separate the bound from unbound Tlg2p(37-318)*, detected with a 
Fuji FLA-5000 Fluor Imager, and analyzed as described in Materials and Methods 
(Figure 2.2B).  The apparent affinity (Kd, app) of Vps45p for Tlg2p(37-318)* is 150  31 
nM, with an apparent Hill coefficient (n) of 1.5  0.2.  The slightly elevated Hill 
coefficient could be due to weak positive cooperativity in binding, however, this 
interpretation is inconsistent with our SEC data, and minor deviations from unity are 
common in binding experiments with limiting labeled material
191
.  The data was also fit 
while holding “n” at 1 (Figure 2.2C).  The apparent affinity when n = 1 is similar to the 
apparent affinity when is “n” is not held constant.  However, the data fits better to a 
model where “n” is allowed to float than when n = 1. 
 Further evidence that the C-terminal binding site on Tlg2p does not require the N-
peptide is demonstrated by the interaction between Tlg2p(37-318)* and the Vps45p-
L117R mutant.  The L117R mutation resides in a hydrophobic pocket of domain 1 that is 
necessary for the interaction with the N-peptide of Tlg2p
105
.  We hypothesized that this 
mutation disrupts the ability of the N-peptide to interact with Vps45p, while retaining the 
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Tlg2p(37-318) binding site.  If so, then the affinity between Vps45p-L117R and 
Tlg2p(37-318)* should be similar to wild-type Vps45p.  When measured by EMSA, the 
apparent affinity is similar to Vps45p (Kd, app = 200 ± 13 nM, n = 1.1  0.1), indicating 
that the L117R mutation does not significantly disrupt binding of Vps45p to the C-
terminal binding site on Tlg2p.  Collectively, these results describe a previously 
unidentified mode of interaction between Vps45p and Tlg2p, one that does not require 
the N-peptide of Tlg2p, nor the hydrophobic pocket on domain 1 of Vps45p.  
The Tlg2p N-terminal peptide modulates affinity of the C-terminal binding site 
 To further map the C-terminal binding site on Tlg2p, we analyzed the ability of 
various Tlg2p truncations, and mutants thereof, to compete with Tlg2p(37-318)* for 
binding to Vps45p by EMSA.  In this assay, increasing concentrations of competitor 
protein were incubated with Tlg2p(37-318)* and Vps45p.  If the competitor binds 
Vps45p, the fraction of bound Tlg2p(37-318)* decreases as the concentration of 
competitor increases.  The fraction of bound Tlg2p(37-318)* was determined as 
described above and in Materials & Methods.  The apparent affinity (Kc, app) of the 
Vps45p-competitor interaction can be calculated from a fit of the fraction bound Tlg2(37-
318)* versus the concentration of competitor.  
 To validate this competition assay, we tested the ability of unlabeled Tlg2p(37-
318) to compete with labeled Tlg2p(37-318)* for binding to Vps45p.  The Kc, app of this 
interaction is 280  4 nM, which is less than a two-fold difference from the Kd, app 
measured by direct titration (Figure 2.3A; Table 2.1).  This difference is the equivalent of 
less than a 0.5 kcal/mole change in free energy (∆G) between unlabeled and labeled 
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Tlg2p(37-318).  The change in free energy is less than what would be lost if one 
hydrogen bond was removed.  Alternatively, the slightly weaker affinity may be caused 
by a decrease in the percent of active unlabeled Tlg2p(37-318).  Another possibility is 
that Tlg2p(37-318) is in equilibrium between an open and closed state and unlabeled 
Tlg2p(37-318) only competes for binding when in a closed state.  This characteristic 
would not be detected in the direct EMSA since Tlg2p(37-318)* is held in trace amounts 
and the calculations do not take into account its concentration.  We next analyzed the 
ability of full-length cytosolic Tlg2p(1-318), containing the N-peptide, to compete for 
binding to Vps45p.  Tlg2p(1-318) competes for binding to Vps45p with a similar Kc, app 
(190 ± 10 nM; Figure 2.3B; Table 2.1) to that of Tlg2p(37-318).  This similar affinity 
was surprising, as data from Munc18a and mammalian Vps45 studies
106
 led us to expect 
that the combination of both binding sites would lead to a tighter apparent affinity for 
Tlg2(1-318). In this study, the presence of both binding sites significantly increased the 
affinity between Munc18a and syntaxin 1a.  
 To elucidate the relationship (or lack thereof) between the two Tlg2p binding sites, 
we examined the binding of the N-peptide in more detail.  We intended to directly test 
binding of the N-peptide itself (a.a. 1-33, plus a C-terminal cysteine for labeling) to 
Vps45p by EMSA; however, poor solubility of the labeled peptide precluded further 
study.  Instead, we tested the ability of the unlabeled peptide to compete with Tlg2p(37-
318)* for binding to Vps45p.  We did not expect the N-peptide to compete with  
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Figure 2.3.  The N-peptide of Tlg2p negatively affects the binding of Tlg2p(37-318).  
(A) Tlg2p(37-318)-unlabeled competes with the Tlg2(37-318)*-Vps45p interaction. 
Increasing concentrations of Tlg2p(37-318) were incubated with Vps45p and Tlg2p(37-
318)*.  The presence of unbound or bound Tlg2p(37-318)* was detected as in Figure 
2.2B.  The Tlg2p(37-318)* fraction bound vs. [Tlg2p(37-318)] was graphed and the data 
fit to a modified version of the Lin and Riggs equation
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to generate the curve and Kc, app.  
“*” indicates the mobility of unbound Tlg2p(37-318)*.  The first lane contains no 
Vps45p or competitor; the second lane contains complex with no added competitor; lanes 
3-20 contain increasing concentrations (7.1 nM - 7 µM) of the competitor Tlg2p(37-318) 
protein.  Representative data are shown for three separate replicates.  (B) The full-length 
cytosolic Tlg2p(1-318) protein competes with the Tlg2p(37-318)*-Vps45p interaction.  
The ability of Tlg2p(1-318) to compete for binding to Vps45p was measured by 
competition EMSA and the Kc, app was calculated as in (A).  (C) The N-peptide of Tlg2p 
competes for binding to Vps45p.  The ability of Tlg2p(1-33) to compete for binding to 
Vps45p was measured by competition EMSA and the Kc, app was calculated as in (A).  
(D) The Tlg2p(1-318)F9AL10 mutant competes for binding to Vps45p.  The ability of 
Tlg2p(1-33) to compete for binding to Vps45p was measured by competition EMSA and 
the Kc, app was calculated as in (A).  (E) The ability of the Tlg2p-I285A mutant to 
compete for binding to Vps45p was measured using competition EMSA.  Results were 
analyzed as in (A).  The Tlg2p(37-318)-I285A and Tlg2p(1-318)-I285A data are plotted 
on the same graph for comparison. 
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Table 2.1:  Competition of various Tlg2p truncations and mutants for binding to Vps45p 
Competitor Kc, app (nM)
a 
 s
a
 
Tlg2p(37-318) unlabeled 280 ± 4 2.4 ± 0.2 
Tlg2p(1-318) 190 ± 10 4.4 ± 0.3 
Tlg2(1-33) 35 ± 3 2.6 ± 0.1 
Tlg2p(1-318)-F9A/L10A 280 ± 23 2.8 ± 0.6 
Tlg2p(37-318)-I285A  >53,000  
Tlg2p(1-318)-I285A 250 ± 12 3.7 ± 0.7 
Tlg2p(37-192)  >53,000  
Tlg2p(221-318)  >53,000   
 a
 — values ± standard deviation are calculated based on three replicates 
s — curve shape factor 
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Tlg2p(37-318)* for Vps45p binding, because the two binding sites on the SMs are not 
adjacent to each other (estimated to be > 30 Å), and because Munc18a appears to 
simultaneously bind both sites on syntaxin 1a.  Unexpectedly, Tlg2p(1-33) strongly 
competed with Tlg2p(37-318) for binding to Vps45p (Kc, app = 35 ± 3 nM) (Figure 2.3C; 
Table 2.1), suggesting that these two sites are not independent; in fact, they appear to be 
mutually exclusive.  To determine if Tlg2p(1-33) competes for binding to Vps45p 
through interactions with the hydrophobic pocket of Vps45p, we analyzed its ability to 
compete for binding to the Vps45p-L117R mutant.  Increasing concentrations of Tlg2p(1-
33) were incubated with Vps45p-L117R and Tlg2p(37-318)* as described above for 
wild-type Vps45p and in Materials & Methods.  However, Tlg2p(1-33) was unable to 
compete with Tlg2p(37-318)* for binding to the Vps45p-L1174 mutant (data not shown).  
These results suggest that the two binding sites are not independent; in fact, they appear 
to be mutually exclusive.  
 Our conclusions are supported by evidence from several critical point mutations.  
First, we examined an N-peptide mutant, Tlg2p(1-318)-F9A/L10A.  Although this 
construct contains the N-peptide, the dual alanine mutations abolish the interaction with 
the hydrophobic pocket in Vps45p
86, 105
, and therefore is not predicted to affect binding at 
the C-terminal binding site.  Accordingly, this mutant competes for binding to Vps45p 
with a Kc, app of 280 ± 23 nM, similar to the unlabeled Tlg2p(37-318) (Figure 2.3D; Table 
2.1).  Next, we took advantage of a specific point mutation (I233A) in the SNARE motif 
of syntaxin 1a that potently blocks Munc18a binding to the closed conformation of 
syntaxin 1a
106
 and introduced the analogous mutation into Tlg2p (I285A).  This mutation 
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disrupts the ability of the truncated Tlg2p(37-318)-I285A to compete for Vps45p binding 
(Figure 2.3E; Table 2.1).  In contrast, the full-length Tlg2p(1-318)-I285A mutant retains 
the ability to compete for binding to Vps45p with a Kc, app of 250 ± 12 nM (Figure 2.3E; 
Table 2.1).  Thus, even though the I285A mutation blocks C-terminal binding, the 
presence of the wild-type N-peptide is sufficient to compete with the Tlg2p(37-318)*-
Vps45p interaction.  These results support our observation that binding of the N-peptide 
can negatively affect binding at the C-terminal site. 
 For the competition experiments, a parameter that is related to but not equivalent with 
the Hill coefficient is termed the shape factor (s).  The value of “s” reflects the magnitude 
of the deviation from ideality.  Ideally, for simple direct competition between a 
competitor and a ligand in a bimolecular complex, the shape factor is expected to be one.  
The shape of the curve accounts for several complicating features of the competitions, 
including possible cooperativity in the competition mechanism, the presence of multiple 
competing half-sites per mole of competitor added, and multiple non-equivalent classes 
of binding complexes between the macromolecule and the labeled ligand.  In our 
experiments, competitor proteins that contain a single functional binding site reveal a 
shape factor of 2.4 - 2.8 (Table 2.1), whereas the presence of both binding sites in 
Tlg2p(1-318) leads to an increased shape factor of 4.4.  The profound increase in the 
shape factor in constructs that contain both binding sites is consistent with the dual 
binding site model proposed above.  Surprisingly, the Tlg2p(1-318)-I285A mutant also 
shows an elevated shape factor, suggesting that the presence of the N-terminal peptide 
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increases the local concentration of the C-terminal 37-318 region, which is sufficient to 
overcome the detrimental effect of the I285A mutation.  
Vps45p interacts with the closed conformation of Tlg2p 
 The most likely explanation for the C-terminal binding site on Tlg2p is that the 
Habc domain, linker and SNARE motif regions form a closed conformation akin to that 
observed for other syntaxins [Figure 2.1A; mode (1)].  To test this hypothesis, we used 
several Tlg2p truncations.  Tlg2p(37-192), containing the Habc domain, or Tlg2p(221-
318), containing most of the linker and the SNARE motif (Figure 2.1B), were incubated 
separately with Vps45p and their binding analyzed by SEC.  Neither construct of Tlg2p 
caused a shift in the elution pattern, indicating that neither domain alone is sufficient for 
the interaction with Vps45p (Figure 2.4A,B).  In case the interaction(s) were too weak to 
detect using SEC, the ability of each construct to compete for binding to Vps45p was 
examined using the EMSA competition assay.  Neither region is able to compete with 
Tlg2p(37-318)* for binding to Vps45p (Figure 2.4C,D; Table 2.1).  Therefore, the 
interaction between Vps45p and Tlg2p(37-318) requires the Habc domain, the linker and 
the SNARE motif, supporting the hypothesis that Vps45p binds Tlg2p in a closed 
conformation.  One prediction from this model is that residues critical for the Munc18a-
closed syntaxin interaction would also be important for Vps45p-Tlg2p(37-318) binding, 
if Tlg2p is closed.  Results from the I285A mutant constructs support this idea.  The I285 
residue is present in the SNARE motif region of Tlg2p, and, by analogy to the syntaxin 
1a-Munc18a structure, should only contact Vps45p when Tlg2p is closed.  We found that 
the I285A mutation abrogated binding to the C-terminal binding site of Tlg2p (Figure  
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Figure 2.4. Vps45p interacts with the closed conformation of Tlg2p.  (A&B) The 
interaction between Vps45p and Tlg2p(37-192) or Tlg2p(221-318) was analyzed by SEC.  
Presence of a complex was detected as in Figure 2.1D.  Failure of the elution peak(s) to 
shift indicates that no complex was formed.  (C&D) The ability of Tlg2p(37-192) or 
Tlg2p(221-318) to compete for binding to Vps45p was measured using competition 
EMSA.  Results were analyzed as in Figure 2.3A.  Failure to observe a shift in Tlg2p(37-
318)* indicates an inability of the competitor to compete for binding to Vps45p.  
Representative data are shown for three separate replicates. 
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2.3E), indicating that Tlg2p is bound to Vps45p in a conformation structurally similar to 
closed syntaxin 1a. 
DISCUSSION 
 Here we have used a quantitative fluorescent binding assay to reveal a previously 
uncharacterized binding site for the endosomal Sec1/Munc18 protein, Vps45p, on the 
syntaxin Tlg2p.  We show that a construct completely lacking the N-peptide of Tlg2p 
interacts tightly with Vps45p (Figure 2.2), demonstrating the presence of a C-terminal 
binding site.  The Vps45p-L117R mutant, which does not bind the N-peptide of Tlg2p, 
binds to Tlg2p(37-318) with a similar affinity as wild type.  Moreover, mutation of Tlg2p 
residues L9 and F10 to alanine, which disrupts binding of the N-peptide to Vps45p, 
competes for binding to Vps45p similarly to the N-peptide deletion (Figure 2.3D; Table 
2.1).  This newly discovered Tlg2p-Vps45p interaction explains the lack of a trafficking 
defect when the Vps45p-L117R mutant is expressed in yeast as the sole copy of 
Vps45p
105
.  Although previous qualitative studies suggested that the Tlg2p N-peptide was 
both necessary and sufficient
86, 105
, some of these studies did not test the appropriate 
truncated constructs, while others were performed at low concentrations with tagged 
proteins, in which binding may not have been readily detectable.  We propose that similar 
quantitative binding studies may reveal a C-terminal binding site for other SM 
homologues, such as Sly1p, which also lacks trafficking defects in non-interacting Sly1p 
and Sed5p mutants
162
.   
 Several results strongly support our finding that this C-terminal binding site for 
Vps45p is a closed conformation of Tlg2p [Figure 2.1A; mode (1)].  First, we previously 
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showed that deletion of the first 230 residues of Tlg2p in vps45Δ yeast cells leads to 
endosomal SNARE complex formation
170
, suggesting that in the absence of Vps45p, the 
closed conformation of Tlg2p inhibits SNARE complex assembly.  Here, we show that 
binding of Vps45p to the C-terminal binding site requires the Habc, linker and SNARE 
motif regions of Tlg2p.  In addition, the Tlg2p(37-318)-I285A mutant is unable to 
compete for binding to Vps45p; I285 is a residue predicted from analogous mutations in 
other SMs
80, 106, 125
, to interact directly with Vps45p only when Tlg2p is in a closed 
conformation.  In contrast, NMR evidence suggested that Tlg2p does not adopt a stable 
closed conformation
86
.  However, the Tlg2p construct used in that study (a.a. 60-283), 
lacked additional N-terminal residues, as well as a key section of the SNARE motif, 
which may destabilize the closed conformation.  Because their construct did not contain 
the entire SNARE motif, we did not use this construct in our studies.  Alternatively, it is 
possible that Tlg2p is in equilibrium between closed and open states, and the closed 
conformation is stabilized upon binding to Vps45p.   
 Thus, Vps45p now joins the group of SM proteins that possess modes (1) and (2) 
of binding to their cognate syntaxin proteins.  Munc18a interacts with both sites on 
syntaxin 1a, and mammalian Vps45 also appears to interact with two sites on syntaxin 16, 
as residues outside of the N-peptide region of syntaxin 16 increase its binding affinity
106
.  
However, unlike Tlg2p, the putative closed conformation of syntaxin 16 does not appear 
to bind tightly to mVps45 in the absence of the N-peptide
106
.  In addition to binding 
syntaxin alone, both Vps45p and Munc18a may be more akin to the yeast Sec1p than 
previously believed.  Yeast Sec1p does not bind its isolated cognate syntaxin, Sso1/2p; 
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rather, it interacts with assembled SNARE complexes
112
.  For Vps45p, a dominant 
mutation located between domains 2 and 3 (W244R) uncovered its ability to interact with 
assembled SNARE complexes, even in the absence of the N-peptide of Tlg2p
105
.  
Similarly, in a liposome floatation assay, Munc18a interacts with SNARE complexes in 
the absence of the syntaxin 1a N-peptide
174
. 
 Our results also demonstrate that the Tlg2p N-peptide modulates the affinity of the 
Tlg2p closed conformation for Vps45p, indicating that these two sites do not bind 
simultaneously, e.g. using either mode (1) binding or mode (2), but excluding mode (3).  
This result was surprising, as the two distinct binding sites in both Munc18a and 
mammalian Vps45 appear to positively influence each other [mode (3)].  In fact, re-
refinement of the original Munc18a-syntaxin 1a (closed conformation) crystal structure 
illuminated an interaction between several residues of the syntaxin 1a N-peptide and 
Munc18a
106
.  These discrepancies likely reflect real differences between the SM proteins 
in diverse organisms, and suggest that the N-peptide may be an attractive target for 
regulation of accessibility of the syntaxin SNARE motif for SNARE complex assembly 
[switching from mode (1) to (2)].  Alternatively, these results may suggest that, rather 
than the Munc18a cleft, Vps45 uses a different surface to bind to closed Tlg2p, one that 
overlaps with the N-peptide binding pocket.  The fact that the Vps45p-L117R mutant 
binds the closed Tlg2p with similar affinity to the wild type argues against this 
possibility.  Also, competition EMSA indicates that although the Tlg2p N-peptide is able 
to compete with the closed conformation for binding to wild type Vps45p, it is unable to 
compete for binding to the Vps45p-L117R mutant. These results support our conclusion 
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that the N-peptide and closed conformation binding sites on Vps45p are mutually 
exclusive. 
 These common modes of SM binding to syntaxin and to SNARE complexes may 
correspond to specific SM functions at different stages during SNARE complex assembly 
and membrane fusion.  1) The closed conformation binding modes (1) and/or (3) will 
stabilize the syntaxin t-SNARE during trafficking to sites of fusion (positive role) and/or 
maintain it in an inhibited conformation until SNARE complex assembly is needed 
(negative role).  For Vps45p, the absence of Vps45p results in increased degradation of 
Tlg2p in vivo, indicating that Vps45p is required for Tlg2p stability
170, 171
.  2) The N-
peptide interaction [mode (2)] is used as a recruiting/tethering element to maintain the 
SM association with syntaxin and assembled SNARE complexes to facilitate subsequent 
functions.  This positive role for SM proteins is supported by the fact that SMs, including 
Vps45p (but not Sec1p and Vps33p), can interact with their cognate syntaxin‟s N-peptide 
prior to and during SNARE complex assembly and fusion.  3) SM proteins may directly 
function, perhaps through the interplay between the two syntaxin binding sites, to 
facilitate the release of the SM from the closed syntaxin to drive SNARE complex 
assembly; this regulation may be used to control the specificity of SNARE complex 
assembly
80, 106, 154, 174
.  Release of SM proteins in vivo may be one function of vesicle 
tethering complexes, such as the exocyst
46
.  In keeping with this idea, the SM protein 
Vps33p functions in combination with the vacuolar vesicle tethering complex, HOPS
144
.  
4) SMs directly affect membrane fusion through their interactions with assembled 
SNARE complexes (in the presence or absence of the syntaxin N-peptide).  Stimulation 
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of in vitro liposome fusion assays has been demonstrated for both Munc18a and Sec1p
113, 
174, 185
, although similar assays suggest a negative role for purified Munc18c
184
.  For 
Vps45p, a dominant negative W244R mutation leads to interactions with assembled 
SNARE complexes lacking the Tlg2p N-peptide
105
, suggesting that Vps45p may also 
participate in this common function.  5) Furthermore, SM proteins can interact with non-
syntaxin SNAREs, although the exact function of these interactions is still unclear
105, 162, 
184, 185
. 
In conclusion, our use of quantitative in vitro binding analyses led to the discovery of a 
closed conformation binding site on Tlg2p for the yeast SM protein Vps45p.  Together 
with previous studies, these results now reveal that Vps45p uses all of the binding modes 
observed for other SM proteins and their cognate syntaxins.  These diverse modes of 
binding to SNAREs and SNARE complexes allow SM proteins to function at multiple 
key stages during the SNARE assembly and membrane fusion processes.  The plethora of 
different binding modes provide ample opportunity for exquisite regulation of SNARE-
mediated membrane fusion in diverse trafficking steps in different cell types.  Further 
quantitative in vitro studies, combined with in vivo analyses of specific SM and SNARE 
mutants will tease apart the detailed regulatory mechanisms.  A comprehensive molecular 
understanding necessitates the expansion of these studies to include the function of SMs 
in conjunction with tethering complexes, Rab GTPases, and specialized regulators, such 
as Munc13, synaptotagmins and complexins. 
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CHAPTER III: 
 
 
Assembly of the endosomal SNAREs is regulated 
by several factors  
90 
ABSTRACT 
 The Sec1/Munc18 (SM) protein family regulates SNARE assembly and 
membrane fusion through direct interactions with SNARE proteins.  Elucidating the role 
SM proteins play in SNARE assembly and membrane fusion is key to understanding the 
mechanisms of vesicular trafficking.  In vitro assays suggest that SM proteins function to 
both inhibit and stimulate SNARE assembly and membrane fusion.  I am focused on the 
endosomal SM protein Vps45p and its interactions with its cognate syntaxin t-SNARE, 
Tlg2p, and the endocytic SNARE complex consisting of Tlg2p, Tlg1p, Vti1p, and Snc2p.  
This study investigates the assembly of the Tlg2p, Tlg1p, Vti1p, and Snc2p SNARE 
complex, what factors influence assembly, and whether Vps45p stimulates or inhibits 
assembly.  SEC and GST-tagged pull-down assays with recombinant SNAREs, were 
used to monitor SNARE assembly under several conditions.  My results indicated that 
several factors, including the N-terminal region of Tlg2p, influence the assembly of 
Tlg2p, Tlg1p, Vti1p, and Snc2p and that, under the conditions tested, this assembly is not 
stimulated by Vps45p.  
91 
INTRODUCTION 
 Several protein families regulate vesicular trafficking during each step of a 
trafficking pathway, from budding of the vesicle on the donor membrane to fusion with 
the target membrane (Figure 1.1).  Small GTPases, vesicle coat proteins, and tethering 
factors act as specificity and regulatory determinants during vesicular trafficking
2
.  One 
protein family that functions during docking and is the core component of membrane 
fusion is the SNAREs
48
.  SNAREs on the vesicle (v-SNARE) and target (t-SNARE) 
membranes interact to form a conserved parallel four helix bundle termed the SNARE 
complex (Figure 1.2)
12
.  Formation of the four helix bundle is hypothesized to supply the 
energy needed to fuse the vesicle and target membranes
50-52
.  SNARE complex assembly 
is a layer of regulation that the cell uses to ensure proper vesicle fusion.   
 SNARE complex assembly is a highly regulated process.  One level of regulation 
occurs intramolecularly.  The neuronal t-SNARE syntaxin 1a, and its homologues in 
different trafficking steps in different organisms, contain an N-terminal Habc domain 
which forms an anti-parallel three helix bundle
65-67
.  In some syntaxin t-SNAREs, the 
Habc domain is autoinhibitory, associating with the SNARE motif, which locks the 
syntaxin in a closed conformation.  This closed structure precludes SNARE complex 
assembly and subsequent membrane fusion
70, 79-84
. 
 Understanding the mechanism of membrane fusion has been an area of intense 
focus within the trafficking field.  To elucidate the function of proteins that regulate 
membrane fusion, in vitro assays have been developed to monitor both SNARE complex 
assembly and membrane fusion.  One fusion assay monitors the dequenching of 
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fluorescently labeled phospholipids reconstituted into liposomes
52, 192
.  In this assay, one 
set of liposomes contains a high concentration of phospholipids fluorescently labeled 
with two different dyes (e.g. NBD and rhodamine)
52
.  Fusion with liposomes containing 
unlabeled phospholipids causes lipid mixing, decreasing the concentration of labeled 
phospholipids, thus increasing the fluorescence of the first dye.  t-SNAREs and v-
SNAREs are reconstituted into separate groups of liposomes at physiological 
concentrations and liposome fusion is monitored over time
174
.  This system allows the 
addition of various reagents to monitor their affect on membrane fusion.   
 Other types of assays monitor SNARE complex assembly.  Generally, in these 
assays, SNAREs are recombinantly expressed, or co-expressed, with or without their 
transmembrane domains.  Co-expression of the t-SNAREs has been used to pre-form the 
t-SNARE complex; addition of the v-SNARE leads to SNARE complex assembly.  
Complex assembly can be monitored by various methods including:  the formation of 
SDS-resistant SNARE complexes when analyzed by SDS-PAGE; the formation of an 
apparent higher molecular weight species when analyzed by SEC; or the presence of all 
the SNAREs when analyzed by in vitro pull-down assays
45, 56, 70, 72, 81, 106, 131
.  Using these 
assays, the effects of reagents on SNARE assembly can be monitored.  Interestingly, 
SNARE complex assembly and fusion in liposome fusion assays and SNARE assembly 
assays occurs on a time scale that is extremely slow (on the order of days), when 
compared to in vivo (on the order of seconds or faster), indicating the absence of 
necessary regulatory factors.  
93 
 SM proteins function to regulate SNARE complex assembly and membrane 
fusion through their interactions with t-SNAREs, v-SNAREs, and assembled SNARE 
complexes
99, 108
.  Various in vivo and in vitro assays have been used to elucidate the 
function of SM proteins and indicate both positive and negative roles in SNARE 
assembly and fusion
99, 108
.  In most in vivo experiments, the positive and negative 
functions of SM protein function are disrupted by deletion, temperature-sensitive 
mutants, or overexpression
36, 93, 107, 116-119, 123, 124
.  Both liposome fusion assays and 
SNARE assembly assays have been used to study SM function in vitro.  The liposome 
fusion assay, described above, was used to analyze the yeast exocytic Sec1p and neuronal 
Munc18a. They both stimulate liposome fusion, suggesting a positive role in membrane 
fusion
113, 174
.  In contrast, a SNARE assembly assay which monitored the incorporation of 
a fluorescently labeled v-SNARE into SNARE complexes by an increase in fluorescence 
anisotropy, indicated that Munc18a inhibits SNARE assembly
106
.  These two results can 
be resolved by the fact that the liposome fusion assays used preformed t-SNARE 
complexes and the SNARE assembly assay did not.  Hence, the liposome fusion assay 
monitored the role of Munc18a after t-SNARE complex formation while the fluorescence 
anisotropy experiments monitored the effect of Munc18a before t-SNARE complex 
assembly.  Results from these assays suggest that Munc18a acts as both an activator and 
inhibitor, and that its role changes during different stages of SNARE assembly and 
membrane fusion.  The role of other SM proteins in SNARE assembly and fusion needs 
to be investigated to determine if all SM proteins share similar characteristics. 
94 
 To help determine if all SM proteins share a common function, I focused on 
elucidating the effect of the endosomal SM protein Vps45p, on SNARE assembly and 
membrane fusion in S. cerevisiae
26
.  The SNAREs involved in endosomal trafficking are 
Tlg2p, Tlg1p, Vti1p, and Snc2p (Figure 3.1).  The syntaxin t-SNARE, Tlg2p, interacts 
with the other t-SNAREs, Tlg1p and Vti1p, forming a t-SNARE complex. This complex 
then interacts with the v-SNARE, Snc2p, to form a functional SNARE complex
72-74, 166, 
167, 172, 173
.  Tlg2p and Tlg1p contain Habc domains that may act as autoinhibitory 
domains
43, 86, 170
.  Vti1p may also contain an Habc domain
193
.  Liposome fusion assays 
were used to monitor the ability of these SNAREs to promote fusion and indicated that 
SNARE assembly is less efficient in the presence of the t-SNARE N-terminal regions, 
supporting the hypothesis that at least one autoinhibitory domain exists
73
.  In vitro 
binding assays indicated that Vps45p interacts with Tlg2p, Snc2p, and the assembled 
SNARE complex
86, 105
.  However, the role of Vps45p in SNARE assembly and fusion is 
unknown. 
 This study focuses on analyzing the assembly of Tlg2p, Tlg1p, Vti1p, and Snc2p 
into SNARE complexes, what factors influence assembly and whether Vps45p affects 
assembly.  Based on the results from the Sec1p and Munc18a studies, I hypothesized that 
Vps45p can act as both an inhibitor and activator of SNARE complex assembly; its 
function is dependent on whether it is added before or after the t-SNARE complex is 
formed.  I attempted to test this hypothesis by purifying recombinant Vps45p and various 
truncations of Tlg2p, Tlg1p, Vti1p, and Snc2p.  I purified the SNAREs and monitored 
their assembly in the presence and absence of Vps45p by SEC using a range of  
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Figure 3.1.  The endosomal SNARE complex contains four SNAREs.  (A)  Schematic 
diagrams of the domains in each of the SNAREs used in this study.  The cytoplasmic 
region of each SNARE is indicated.  Vti1p is proposed to contain an Habc domain based 
on the domain analysis of hVti1b
193, 194
.  (B)  Cartoon of the four SNAREs involved in 
endosomal trafficking.  Snc2p is the v-SNARE on the vesicle; Tlg2p is the syntaxin t-
SNARE at the target membrane; Tlg1p and Vti1p are the other t-SNAREs at the target 
membrane. 
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conditions.  My results indicated that assembly of the endosomal SNARE complex 
involves multiple factors, and that under the conditions I tested, Vps45p does not 
stimulate SNARE complex assembly. 
 
MATERIALS AND METHODS: 
Expression and purification of His6-Vps45p: 
 Cloning of His6-Vps45p was described previously
105
.  His6-Vps45p was purified 
as in Chapter II Materials and Methods with the following exception:  Kphos buffer 
contained 10 mM K2HPO4, 100 mM KH2PO4, and 140 mM KCl final pH 7.4. 
Expression and purification of t-SNARE cytoplasmic regions: 
 Tlg1pCyto (a.a. 1-205) cloned into the pACYC-Duet vector (Novagen) was a gift 
from Nia Bryant (University of Glasgow).  The cytoplasmic regions of Tlg2pCyto (a.a. 1-
318) and Vti1pCyto (a.a. 1-187) were generated by PCR and inserted into the NdeI and 
BamHI sites of the pET15b vector (Novagen) and the HindIII and BamHI sites of the 
pETDuet vector (Novagen), respectively.  Each vector introduces an N-terminal His6-tag.  
Cells containing His6-Tlg2pCyto, His6-Tlg1pCyto, or His6-Vti1pCyto were grown at 37°C.  
Cells expressing His6-Tlg2pCyto were moved to 15°C at an OD600 of 0.3-0.4.  Protein 
expression was induced at an OD600 of 0.6-0.8 with 0.1 mM IPTG at either 37°C for 3 h 
or 15°C for 12-16 h.  All buffers contained either 5 mM ME or 1 mM DTT.  Cells were 
lysed using a Microfluidizer cell-disrupter (model 110S) (Microfluidics Corp, Newton, 
MA) in buffer containing 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, DNase 
(Sigma) and protease inhibitors.  Proteins were first purified by affinity chromatography 
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using nickel-NTA resin (Qiagen) in buffer containing 50 mM NaH2PO4, 300 mM NaCl, 
and 10/20/200 mM imidazole pH 8.0 (Buffers for Tlg2p contained extra protease 
inhibitors throughout the affinity purification to prevent degradation).  His6-Tlg2pCyto, 
His6-Tlg1pCyto, or His6-Vti1pCyto elutions were further purified using a Mono Q 10/10 
anion-exchange column (G.E. Healthcare) in 10 mM Tris, pH 8.0 buffer and a gradient of 
increasing NaCl.  Proteins were finally purified using a Superdex 200 16/60 size 
exclusion column (G.E. Healthcare) in Kphos buffer.  His6-Tlg2pCyto was concentrated 
using a Stirred Ultrafiltration Cell with a YM regenerated cellulose membrane (10,000 
MWCO) (Millipore); His6-Tlg1pCyto, and His6-Vti1pCyto were concentrated using an 
Amicon Centrifugal Concentrator (5,000 MWCO) (Millipore).  Protein concentrations 
were determined by quantitative ninhydrin protein assay
186
.  Tlg2p could not be 
concentrated to greater than 10 M due to precipitation.  SNAREs were >95% pure as 
assayed by SDS-PAGE and Coomassie blue staining. 
Expression and purification of SNARE Motifs 
 Tlg2pHabc (a.a. 221-318) and Tlg1pHabc (a.a.118-205) were generated by PCR 
and inserted into the NdeI and BamHI sites of the pET15b vector.  Vti1pHabc (a.a 111-
187) was generated by PCR and inserted into the HindIII and BamHI sites of the 
pETDuet vector.  Each vector introduced an N-terminal His6-tag.  Expression and 
purification of the SNARE motifs were similar to the cytoplasmic regions with the 
following exceptions.  His6-Tlg2pHabc protein expression was induced for 12-16 h at 
15°C, while His6-Tlg1pHabc or His6-Vti1pHabc protein expression was induced for 3 h 
at 37°C.  Proteins were purified by affinity chromatography using nickel-NTA resin 
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followed by a MQ 5/5 anion-exchange column (G.E. Healthcare).  His6-Tlg2pHabc and 
His6-Vti1pHabc were concentrated using Amicon Centrifugal Concentrator, 5,000 
MWCO and exchanged into Kphos buffer.  His6-Tlg1pHabc was further purified using a 
Superdex 200 16/60 column in Kphos buffer and then concentrated using Amicon 
Centrifugal Concentrator, 5,000 MWCO.  Proteins were stored and concentrations 
determined as above.  Purity was assayed as above.  Molecular weights were analyzed by 
mass spectrometry.  Vti1pHabc was ~10% smaller than its calculated molecular weight, 
which may indicate the degradation of amino acids at the N- or C- termini. 
Expression and purification of v-SNARE:  Snc2p: 
 Snc2p (a.a. 1-93) was generated by PCR and inserted into pGEX-3X vector (GE 
Healthcare) creating a Factor Xa-cleavable N-terminal GST-tag.  BL21 E. coli cells 
containing GSTSnc2p were grown at 37°C and protein expression induced at an OD600 of 
1.0-1.2 with 0.1 mM IPTG for 3 h.  GSTSnc2p was lysed similarly to His6-tagged 
SNAREs in GST Lysis Buffer (20 mM Tris pH 8.0, 300 mM NaCl, DNase, protease 
inhibitors) and purified by affinity chromatography using glutathione-agarose resin 
(Sigma).  After elution with GST elution buffer (50 mM Tris pH 8.0, 5 mM reduced 
glutathione (Sigma)), the GST was cleaved from Snc2p using Factor Xa protease 
(Novagen).  The reaction was stopped by the addition of PMSF (Sigma).  Cleaved Snc2p 
was further purified using a Mono S 5/5 cation-exchange column (G.E. Healthcare) in a 
20 mM Hepes buffer at pH 7 with a gradient of increasing NaCl.  Protein was 
concentrated using an Amicon Centrifugal Concentrator, 10,000 MWCO and exchanged 
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into Kphos buffer.  Purity was assayed as above.  Protein was stored at -80°C until use.  
Protein concentration was determined by quantitative ninhydrin protein assay
186
. 
Analysis of secondary structure by circular dichroism 
 CD spectra for purified Tlg2pCyto, Tlg1pCyto, Vti1pCyto and Snc2p were recorded 
on a J810 spectropolarimeter (Jasco) fitted with a Peltier-type temperature controller. The 
protein samples were at 1.5-5 M in Kphos and 2 mM ME or 0.5 mM TCEP.  Reported 
spectra were an average of three scans from 200 to 270 nm, in a 1 mm path-length quartz 
cuvette (Hellma). 
Equilibrium analytical ultracentrifugation (AUC) analysis of SNARE motifs 
 AUC analysis was performed similarly as described in Sivaram et al 2004
45
.  
His6-Tlg2pHabc, His6-Tlg1pHabc, and His6Vti1pHabc proteins were exchanged into 
buffer containing Kphos, and 2 mM TCEP.  Protein concentrations ranged between ~20-
200 M for Tlg2pHabc, ~15-65 M for Tlg1pHabc, and ~75-665 M for Vti1pHabc. 
Samples were centrifuged to equilibrium at 20°C at 12,000, 16,000, and 22,000 rpm in an 
Optima XLI analytical ultracentrifuge (Beckman).  The absorbance at 280 nm was 
monitored.  The final scans at 22,000 rpm were analyzed by a nonlinear least-squares fit 
using WinNonlin software (version 1.06, University of Connecticut).  The partial specific 
volume of each protein and the density of the buffer were calculated by SednTerp 
(version 1.09, University of New Hampshire).  Each protein set fit to a monomer model:  
apparent molecular weight for Tlg2p(SM) = 12,562 Da (calculated = 13,763 Da) (square 
root of variance = 0.00426); apparent molecular weight for Tlg1p(SM) = 9,782 Da 
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(calculated = 12,387 Da) (square root of variance = 0.0056); apparent molecular weight 
for Vti1(SM) = 10,922 Da (calculated = 11,076 Da) (square root of variance = 0.00396). 
SNARE complex assembly using SEC 
 Purified SNAREs in various combinations were combined at equimolar 
concentrations (5-10 M) and incubated in the various buffers specified in the Results 
section for 24 h at 18°C; all buffers contained 1 mM DTT.  100-200 L of each reaction 
was loaded onto a Superdex 200 10/30 size exclusion column (G.E. Healthcare).  Protein 
elution was monitored at A280; complex formation was determined by a shift in the 
elution pattern of the mixed proteins compared to the single protein controls.  Complex 
formation was confirmed by SDS-PAGE analyses of the fractions. 
SNARE motif assembly by glutathione-S-transferase (GST) pull-down assays 
 GSTTlg1pHabc was generated by PCR and inserted into pGEX-3X, which 
introduced a GST-tag fused to the N-terminus of the protein.  BL21 E. coli cells 
containing GST or GSTTlg1pHabc were grown at 37°C and expression induced at an 
OD600 of 0.6-0.8 with 0.1 mM IPTG for 3 h at 37°C.  Cells were lysed and the lysate 
incubated with glutathione agarose resin for 1 h at 4°C.  Resin was washed first with GST 
lysis buffer and then equilibrated in Binding Buffer (Kphos, 0.5% NP-40 (Sigma), 1 mM 
DTT).  Equimolar concentrations of purified recombinant SNAREs and GST or 
GSTTlg1pHabc were incubated 24 h at 18°C in Binding Buffer.  After incubation, 
unbound material was extracted and mixed with 5x loading dye; resin was washed with 
Binding Buffer and resuspended in 1x loading dye.  Samples were analyzed by SDS-
PAGE and stained with Coomassie blue.  
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Monitoring Tlg2p or Tlg2pHabc SNARE complex assembly by GST pull-down assays 
 These experiments were performed by our collaborator Chris MacDonald in Nia 
Bryant‟s laboratory (University of Glasgow)195.  Briefly, SNARE complex assembly was 
monitored as in Carpp et al 2006.  GST, Tlg2p-GST or Tlg2pHabc-GST were expressed 
and purified from E. coli.  Snc2p-His6 and His6-Vti1p and untagged Tlg1p (cleaved from 
GSTTlg1p) were expressed and purified as in Paumet et al 2005
73
.  GST-tagged proteins 
were bound to glutathione-Sepharose resin and incubated with 10-fold molar excesses of 
Snc2p, Vti1p, and Tlg1p at 4°C for 20 min or 120 min, with mixing.  After binding, resin 
was centrifuged for 1 min at 1000g and extensively washed with binding buffer.  Bound 
samples were analyzed by SDS-PAGE.  Proteins were detected by Coomassie blue or 
immunoblot analysis using -Snc antibodies. 
 
RESULTS 
Vps45p does not stimulate cytoplasmic SNARE assembly in the absence of detergent 
 In order to determine the effect of Vps45p on SNARE complex assembly, the 
soluble cytoplasmic regions of Tlg2p, Tlg1p, Vti1p, and Snc2p were cloned (Figure 
3.1A).  Recombinant Vps45p, Tlg2pCyto, Tlg1pCyto, Vti1pCyto, and Snc2p were purified as 
described in Materials and Methods.  All proteins, except Snc2p, contain a His6-tag at 
their N-terminus.  Secondary structure analyses by CD indicated well-folded -helical 
SNAREs; Snc2p is natively unfolded in isolation in vitro
70
 (Figure 3.2A). 
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Figure 3.2.  Vps45p does not stimulate the assembly of the cytoplasmic SNAREs.  
(A)  CD analyses of purified Tlg2pCyto, Tlg1pCyto, Vit1pCyto, and Snc2p. Double minima 
at 208 and 222 nm indicate -helical secondary structure. Inset:  SDS-PAGE analysis of 
purified cytoplasmic SNAREs, stained with Coomassie blue.  The Legend can be applied 
to each figure.  (B)  SNARE complex assembly of the cytoplasmic SNAREs was 
monitored by SEC.  Tlg2pCyto, Tlg1pCyto, Vti1pCyto, and Snc2p were incubated separately 
or together for 24 h at 18°C in Kphos buffer.  Samples were applied to a Superdex 200 
10/30 size exclusion column.  Elution profiles of individual proteins and the mixed 
reaction are shown for comparison.  Absorbance was monitored at A280.  (C)  SNARE 
complex assembly of the cytoplasmic SNAREs monitored by SEC in the presence or 
absence of Vps45p.  Reactions were similar as in (B).  Fractions from each run were 
analyzed by SDS-PAGE and stained with Coomassie blue.   
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 The ability of Tlg2pCyto, Tlg1pCyto, Vti1pCyto, and Snc2p to form a SNARE 
complex was investigated.  SNAREs were incubated, either separately or together, for 24 
h at 18°C in Kphos buffer.  Similar conditions were previously determined to yield 
optimum assembly of SNAREs in other trafficking pathways
40, 70, 81
. SEC was used to 
separate complexes from free proteins.  Protein elution was monitored at 280 nm.  A shift 
in the elution pattern of individual proteins, when incubated together, is indicative of 
complex formation.  Analysis by SEC indicated no shift in the elution pattern of any of 
the SNAREs, suggesting that no complexes were formed (Figure 3.2B).  These results 
were verified by SDS-PAGE analysis of SEC fractions (data not shown).  One 
explanation of these results is that the transmembrane domains are required to facilitate 
SNARE assembly.  A second explanation is that at least one of the t-SNAREs is in a 
closed conformation and significantly retards SNARE complex formation.  A third 
hypothesis is that the SM protein, Vps45p, is necessary to stimulate SNARE assembly. 
 We first tested whether Vps45p stimulates SNARE complex assembly.  SNAREs 
were incubated either in the presence or absence of Vps45p for 24 h at 18°C in Kphos 
buffer.  Reactions were analyzed by SEC.  A shift was detected in the elution pattern 
indicating the formation of a complex (Figure 3.2C).  Two possibilities might account for 
the shift:  SNARE complex formation or the interaction between Vps45p and Tlg2p that 
had been previously reported
86, 105
.  SDS-PAGE analysis of SEC fractions revealed that 
only the elution of Vps45p and Tlg2pCyto shifted, leading to the conclusion that Vps45p 
does not stimulate SNARE complex assembly under these conditions.   
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The SNARE motifs of Tlg2p, Tlg1p, Vti1p, and Snc2p associate in the presence of 
detergent 
 SNARE complex assembly is dependent upon the availability of the SNARE 
motifs.  Tlg2p, Tlg1p, and Vti1p contain Habc domains in their N-termini.  The SNARE 
motif of each protein may interact with its respective Habc domain to form a closed 
conformation.  Liposome fusion assays in which the Habc domain of Tlg2p, Tlg1p, or 
Vti1p was cleaved resulted in increased membrane fusion, indicating an inhibitory role 
for the N-terminal domains of each t-SNARE
73
.   
 To determine if the N-terminal Habc regions of Tlg2p, Tlg1p, or Vti1p play an 
inhibitory role in SNARE complex assembly, the ability of the SNARE motifs alone to 
assemble was examined.  The SNARE motifs of Tlg2p (a.a. 221-318), Tlg1p (a.a 118-
205), and Vti1p (a.a 111-187) were expressed and purified (Figure 3.3A).  Analysis by 
SEC indicated that each SNARE, except Snc2p, eluted as a higher molecular weight 
species (Figure 3.3A).  These results may be due to self-association or, these proteins 
may be eluting as higher molecular weight species because they are unfolded.  
Preliminary sedimentation equilibrium analysis of Tlg2pHabc, Tlg1pHabc, and 
Vti1pHabc at > 15 M indicated that each is a monomer in solution (Figure 3.3B,C,D).  
CD analyses indicated that Tlg2pHabc is unfolded (Figure 2.1C), suggesting that the 
second explanation is reasonable.   
 The SNARE motifs were incubated individually or together for 24 h at 18° in 
Kphos buffer.  Analysis by SEC indicated an absence of complex formation (Figure 
3.4A).  Previous studies showing complex formation between these SNAREs had  
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Figure 3.3.  SNARE motifs do not self-associate in vitro.  (A)  SEC analysis of purified 
Tlg2pHabc, Tlg1pHabc, Vti1pHabc, and Snc2p suggested that the SNAREs may self-
associate.  Inset:  SDS-PAGE analysis of purified SNAREs, stained with Coomassie blue.  
Table:  Molecular weights of SNAREs based on different methods:  calculated from the 
amino acid sequence, SEC data, and mass spectrometry data.  Only Snc2p elutes as a 
monomer by SEC.  (B,C,D) Sedimentation equilibrium data of Tlg2pHabc, Tlg1pHabc, 
and Vti1pHabc respectively.  Representative results, at 22,000 rpm, indicate that all three 
SNARE motifs are monomeric. 
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Figure 3.4.  The SNARE motifs assemble in the presence of detergent.  (A)  SNARE 
complex assembly of the SNARE motifs was monitored by SEC as in Figure 3.2B.  
Tlg2pHabc, Tlg1pHabc, Vti1pHabc, and Snc2p were incubated separately or together 
for 24 h at 18°C in Kphos buffer and applied to a Superdex 200 10/30 size exclusion 
column.  (B)  SNARE complex assembly was repeated as in (A), but using buffer with 25 
mM Hepes-KOH (pH 7.4), 400 mM KCl, 10% glycerol (v/v), and 1% -octyl-glucoside 
(w/v).  Fractions from the SEC runs were analyzed by SDS-PAGE and stained with 
Coomassie blue. 
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analyzed SNARE complex assembly at high salt concentrations and in the presence of 
either Triton X-100 or -octyl-glucoside detergents72.  Therefore, I incubated the SNARE 
motifs for 24 h at 18°C in buffer containing 25 mM Hepes-KOH (pH 7.4), 400 mM KCl, 
10% glycerol (v/v), and 1% -octyl-glucoside (w/v).  SNARE complex assembly was 
monitored by SEC.  The elution of all four SNAREs shifted to an apparent higher 
molecular weight species, indicating formation of a complex.  SDS-PAGE analysis of the 
SEC fractions confirmed these results (Figure 3.4B).  SNARE complex assembly using 
the full cytoplasmic regions of Tlg2p, Tlg1p, and Vti1p in the presence of -octyl-
glucoside was also tested, but no complex assembly was detected (Figure 3.5A).   
Vps45p does not stimulate Tlg2p, Tlg1p, Vti1p, Snc2p assembly in the presence of 
detergent 
 We next tested whether Vps45p could stimulate SNARE complex assembly in the 
presence of detergent.  First, assembly of Tlg2pCyto, Tlg1pCyto, Vti1pCyto, and Snc2p was 
monitored in the presence and absence of Vps45p.  SNAREs and Vps45p were incubated 
for 24 h at 18°C in buffer containing Kphos, 10% glycerol, and 0.1% -octyl-glucoside; 
the concentration of detergent was decreased because Vps45p precipitated at higher 
detergent concentrations.  SEC analysis revealed the formation of the Vps45p-Tlg2p 
complex, but not the SNARE complex, indicating that Vps45p does not stimulate the 
assembly of Tlg2pCyto, Tlg1pCyto, Vti1pCyto, and Snc2p, even in the presence of low 
concentrations of -octyl-glucoside (Figure 3.5B).   
 We also investigated whether Vps45p stimulates assembly of the SNARE motifs.  
Tlg2pHabc, Tlg1pHabc, Vti1pHabc, and Snc2p were incubated in the presence of 
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Figure 3.5.  Vps45p does not stimulate the assembly of cytoplasmic SNAREs or 
SNARE motifs in the presence of detergent.  (A)  SNARE complex assembly of the 
cytoplasmic SNAREs was monitored by SEC as in Figure 3.2B in Kphos buffer, 10% 
glycerol, and 0.1% -octyl-glucoside.  Concentration of -octyl-glucoside was decreased 
from Figure 3.4B because Vps45p precipitates in higher concentrations of detergent.  (B)  
SNARE complex assembly was investigated as in (A) in the presence of Vps45p.  (C)  
SNARE complex assembly of the SNARE motifs in the presence of Vps45p was 
monitored by SEC as in (A).  (D)  As in (C) but in the absence of Vps45p.  * This peak is 
due to a baseline anomaly of the SEC run, not due to SNARE assembly 
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Vps45p for 24 h at 18°C in buffer containing Kphos, 10% glycerol, 0.1% -octyl 
glucoside.  Interestingly, no SNARE complex was observed under these conditions 
(Figure 3.5C).  Analysis of SNARE assembly in the absence of Vps45p, indicated very 
little SNARE assembly under these conditions; similar results were obtained using higher 
concentrations of the SNARE motifs (Figure 3.5D).  SNARE assembly in the presence of 
other detergents, including Triton X-100 and NP-40, yielded only minor amounts of  
SNARE complex (data not shown).  These results led to the conclusion that the SNARE 
assembly detected earlier, using 1% -octyl-glucoside, was dependent on the -octyl-
glucoside concentration. 
The N-terminal region of Tlg2p inhibits SNARE assembly 
 Because SNARE assembly could not be monitored by SEC, another assay was 
developed.  GST pull-down assays were used to monitor SNARE complex formation.  
Equal concentrations (5-10 M) of Tlg2pHabc, Vti1pHabc and Snc2p were incubated 
with GST or GST-Tlg1pHabc bound to glutathione agarose resin, for 24 h at 18°C in 
Kphos buffer and 0.5% NP-40.  After washing the resin, unbound and bound samples 
were analyzed by SDS-PAGE and Coomassie staining.  Increased amounts of 
Tlg2pHabc, Vti1pHabc, and Snc2p were bound to GST-Tlg1pHabc, as compared to the 
GST control, indicating SNARE complex formation (Figure 3.6A).   
 To test whether the N-terminal region of Tlg2p inhibited SNARE assembly, a 
similar assay was developed with our collaborators, the Bryant lab (University of 
Glasgow).  In this experiment, they monitored the assembly of SNARE complexes 
containing either Tlg2p or Tlg2pHabc.  GST, Tlg2p-GST or Tlg2pHabc-GST bound to  
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Figure 3.6.  The N-terminal region of Tlg2p negatively regulates SNARE complex 
assembly.  (A)  GST pull-down assay of assembled SNARE motifs.  GST or 
GSTTlg1pHabc bound to glutathione resin was incubated with Tlg2pHabc, Vti1pHabc, 
and Snc2p for 24 h at 18°C in buffer containing Kphos and 0.5% NP-40.  The unbound 
material was extracted and saved.  Bound material was washed.  Unbound and bound 
fractions were analyzed by SDS-PAGE and stained with Coomassie blue.  (B)  Assembly 
of SNARE complexes containing Tlg2p or Tlg2pHabc was monitored by GST pull-
down.  Snc2p, Tlg1p, and Vti1 were incubated for 20 min or 120 min with resin bound 
GST, Tlg2p-GST, or Tlg2pHabc-GST.  Bound samples washed and analyzed by SDS-
PAGE and stained with Coomassie blue or immunoblotted with -Snc to monitor the 
assembly of SNARE complexes. 
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resin was incubated with Tlg1p, Vti1p, and Snc2p for 20 min or 120 min.  After washing, 
bound material was analyzed by SDS-PAGE and either stained with Coomassie blue or 
immunoblotted with -Snc2 antibodies (Figure 3.6B).  Tlg2p does not interact with 
Snc2p outside of the assembled SNARE complex, therefore an increase in Snc2p  
binding indicates an increase of SNARE complexes
105
.  As indicated by the binding of 
Snc2p at 20 min, SNARE complexes containing Tlg2pHabc assembled faster than 
SNARE complexes containing cytoplasmic Tlg2p.  Similar binding of both types of 
SNARE complexes by 120 min indicates that the difference at 20 min is due to the rate of 
SNARE assembly.  These results support the hypothesis that the Habc domain is 
autoinhibitory. 
DISCUSSION 
 The goal of this study was to determine the role of the SM protein Vps45p in the 
assembly of Tlg2p, Tlg1p, Vti1p, and Snc2p.  SNARE complex formation was monitored 
by SEC.  Several conditions were tested including:  assembly of the cytoplasmic proteins 
vs. the SNARE motifs; assembly in the presence or absence of various detergents; 
addition of Vps45p in the presence or absence of detergent.  The only condition that 
resulted in significant SNARE assembly was the SNARE motifs in the presence of 1% -
octyl-glucoside, which is above the critical micelle concentration for -octyl-glucoside.  
This result is -octyl-glucoside concentration dependent; decreasing the concentration of 
-octyl-glucoside, or the use of other types of detergents, significantly decreased the 
amount of SNARE complexes formed.  The assembly of Tlg2p, Tlg1p, Vti1p, and Snc2p 
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likely involves many factors; under these conditions, Vps45p does not stimulate SNARE 
complex assembly.   
 There are multiple explanations as to why SNARE assembly was not detected 
under the above conditions.  1) These SNAREs do not form a functional SNARE 
complex in vivo.  This is unlikely, as multiple groups have shown that Tlg2p, Tlg1p, 
Vti1p, and Snc2p form a functional SNARE complex using a variety of assays including:  
co-immunoprecipitation from yeast lysates, GST pull-down assays with recombinant 
proteins, and liposome fusion assays
72-74, 105, 170, 173
.  2) Vps45p does not interact with this 
set of SNAREs.  Multiple experiments, including co-immunoprecipitation from yeast 
lysates and GST pull-down assays with recombinant proteins, indicate that Vps45p does 
bind to the syntaxin t-SNARE Tlg2p, the v-SNARE Snc2p and the SNARE complex 
consisting of Tlg2p, Tlg1p, Vti1p, and Snc2p
86, 105, 173
.  3)  The N-terminal region of one 
or more of the SNAREs inhibits SNARE assembly.  Tlg2p, Tlg1p, and Vti1p contain Habc 
domains which may act as autoinhibitory elements in some SNAREs
43, 70, 81, 83, 84, 86, 193
.  
Also, co-immunoprecipitations from yeast lysates indicate that, in the absence of Vps45p, 
deletion of the N-terminal Habc region in Tlg2p facilitates SNARE complex formation, 
indicating a negative role for this N-terminal region
170
.  Liposome fusion assays indicate 
that the N-terminal regions of Tlg2p, Tlg1p, and Vti1p also negatively affect membrane 
fusion
73
. 
 To determine whether any of the N-terminal regions inhibited SNARE assembly, 
the assembly of the SNARE motifs alone was monitored.  In the presence of detergent, 
the SNARE motifs formed a complex while the cytoplasmic regions did not, suggesting 
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that at least one N-terminal region has a negative effect on SNARE assembly.  
Corroborating this hypothesis, GST pull-down assays of recombinant SNAREs indicated 
an increase in SNARE complex formation in the absence of the Tlg2p N-terminal Habc 
region (Figure 3.6B).  4) The SNAREs are self-associating, which may inhibit SNARE 
complex assembly.  Supporting this hypothesis, our SEC results indicate that both the 
cytoplasmic regions and the SNARE motifs elute as higher molecular weight species 
(Figure 3.2B & 3.3A).  Also, light scattering data indicates that cytoplasmic Vti1p can 
form multimers in vitro
196
.  However, our AUC analysis of the SNARE motifs of Tlg2p, 
Tlg1p, and Vti1p suggests that these constructs are monomeric (Figure 3.3C,D,E).  
Therefore, at least for the SNARE motifs, self-association is not inhibiting SNARE 
assembly.  5)  SNARE assembly is facilitated by the transmembrane domains.  While this 
hypothesis is plausible, SNAREs in other systems do not require the presence of their 
transmembrane domains to assemble.  6)  The SNARE motif region of at least one 
SNARE is truncated/degraded.  This hypothesis is quite possible as mass spectrometry 
data indicated that Vti1p(SM) is ~10% smaller than its calculated molecular weight 
(Figure 3.3A).  Truncation of the SNARE motif may destabilize the SNARE complex.  
 Many factors affect the assembly of recombinant Tlg2p, Tlg1p, Vti1p, and Snc2p 
into SNARE complexes.  Any of the above explanations may play a role in inhibiting 
SNARE assembly in vitro.  Based on my experiments and results from other groups, the 
most plausible scenarios appear to be inhibition by the N-terminal regions and truncation 
of at least one SNARE motif; the transmembrane domains may also play a role.  Future 
experiments will include the transmembrane domains.  To ensure that full-length SNARE 
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motifs are generated, different expression conditions and additional protease inhibitors 
will be used.  Assays other than SEC, such as GST pull-downs, or even quantitative 
assays such as surface plasmon resonance or CD will also be explored to monitor 
SNARE assembly and the effect of Vps45p on SNARE complex assembly in vitro. 
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DISCUSSION  
 In eukaryotes, cellular function, growth, and survival depend on the proper 
trafficking of cargo containing vesicles between organelles and the plasma membrane.  
Numerous protein families, including SNARE proteins and SM proteins, regulate vesicle 
trafficking and confer specificity between vesicles and their target membrane
1
.  Most 
trafficking proteins are essential, and defects in these proteins cause numerous human 
diseases
14-16
.  Understanding the mechanisms of vesicular trafficking requires the 
elucidation of interactions between trafficking proteins.  By characterizing the 
interactions between different proteins, determining the affinities of these interactions 
and whether or not multiple proteins compete for the same interaction site(s), functional 
models can be constructed and tested in vivo, leading to a greater understanding of 
vesicular trafficking. 
 Protein families work together to regulate vesicle trafficking.  For my thesis, I 
focused on elucidating the interactions between SM proteins and SNAREs.  SNAREs are 
the core component of the fusion machinery; interactions between v-SNAREs and t-
SNAREs form a SNARE complex that mediates membrane fusion
12, 50-52
.  SM proteins 
interact with SNAREs to regulate SNARE assembly and membrane fusion.  In vivo and 
in vitro assays suggest both negative and positive roles for SM proteins in SNARE 
assembly and membrane fusion.  However, due to the several distinct binding modes 
identified between SM proteins and the cognate SNARE(s), a mechanistic model has 
been difficult to construct and has led to the hypothesis that SM protein function is not 
conserved
120
. 
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 Multiple laboratories have worked to assemble a model for SM protein function.  
At the beginning of my dissertation research, most data came from in vivo studies and 
qualitative in vitro binding experiments.  Recently, more quantitative assays, including 
fluorescent electrophoretic mobility shift assays (EMSA), isothermal titration calorimetry 
(ITC), fluorescence anisotropy, and liposome fusion assays, have been used to determine 
the role SM proteins play in SNARE assembly and membrane fusion.  Liposome fusion 
assays indicate that Sec1p and Munc18a stimulate membrane fusion; in the case of 
Munc18a this effect is dependent on the syntaxin 1a N-peptide
46, 174
.  However, 
fluorescence anisotropy assays that monitor the assembly of SNARE complexes, indicate 
that Munc18a inhibits SNARE complex assembly; this effect is dependent on the 
syntaxin 1a N-peptide as well
106
.  The liposome fusion assays used pre-formed t-SNARE 
complexes, while the fluorescence anisotropy SNARE assembly assays did not
106, 174
.  
These assays allow the differentiation between two of Munc18a‟s roles:  its role in 
SNARE assembly and its role in membrane fusion.  The results from these assays suggest 
that Munc18a plays a negative role in t-SNARE complex assembly, but a positive role in 
fusion after t-SNARE complex assembly takes place (Figure 1.3B).  Munc18a may play a 
negative role by stabilizing the closed conformation of syntaxin 1a, but, after t-SNARE 
complex assembly, it stimulates fusion, possibly by accelerating SNARE complex 
assembly.  Determining whether other SM proteins play a similar role in SNARE 
assembly and fusion would reveal if SM protein function is conserved. 
 In my thesis, I investigated the function of the endosomal SM protein Vps45p, by 
examining its effect on SNARE complex assembly.  Vps45p interacts with the SNARE 
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complex consisting of Tlg2p, Tlg1p, Vti1p, and Snc2p
105
.  Several in vitro assays indicate 
that these SNAREs form a functional SNARE complex, and the interaction with Vps45p 
is primarily mediated by the Tlg2p N-peptide
72, 73, 105, 170, 173
.  Based on the data for Sec1p 
and Munc18a, I hypothesized that Vps45p would have both a negative and positive effect 
on SNARE assembly and membrane fusion.  Working with our collaborator, Nia Bryant 
(University of Glasgow), we investigated the role of Vps45p in these events.  Using the 
cytoplasmic regions and the SNARE motifs of Tlg2p, Tlg1p, Vti1p, and Snc2p, I used 
SEC to monitor the effect of Vps45p on SNARE assembly.  Although I tested several 
different conditions, Vps45p did not stimulate SNARE complex formation of the 
cytoplasmic SNAREs.  Curiously, the SNARE motifs themselves did not readily 
assemble.  Assembly of the SNARE motifs could be induced with the addition of 1% -
octyl-glucoside.  However, Vps45p precipitated under these conditions, which precluded 
testing its role in SNARE assembly. 
 My results may not fully reflect the function of Vps45p, as SNARE complex 
formation may also be inhibited by other factors.  The assembly of the cytoplasmic 
SNAREs may be inhibited by one or more of the other N-terminal domains, which may 
not be responsive to Vps45p action.  However, this hypothesis does not explain why the 
SNARE motifs did not assemble.  The SNARE motifs should have assembled quickly as 
they contain no inhibitory elements; indeed, the SNARE motifs in other systems readily 
assemble into SNARE complexes
70
. One explanation of these results is that one of the 
SNARE motifs is truncated.  Vti1pHabc seems a likely candidate as mass spectrometry 
analysis indicated a smaller molecular weight than the one calculated.  Without a full 
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SNARE motif, Vti1p would be unable to interact tightly with the other SNAREs, thus 
precluding stable SNARE complex assembly.  Another explanation could be that another 
domain in the SNAREs, such as their transmembrane domains, is required for optimal 
SNARE assembly.  Future studies will need to test proteins containing full SNARE 
motifs and/or the transmembrane domains.  Using these types of experiments, the effect 
of Vps45p can be examined and its role in SNARE assembly determined. 
 To elucidate the role of SM proteins in SNARE assembly and fusion their specific 
interactions with the SNAREs need to be understood.  SM proteins function through 
interactions with their SNAREs and SNARE complexes
26, 88
.  Their mechanism is 
unclear, however, because of the distinct binding modes identified between SM proteins 
and their cognate syntaxins (Table 1.2 and Figure 4.1).  Most SM proteins interact with 
SNARE complexes.  This interaction is through two distinct modes.  The first, requires 
the syntaxin N-peptide; Munc18a, Munc18c, Vps45p, and Sly1p use this mode (Table 1.2 
and Figure 4.1A)
105, 140, 154, 174, 175
. The second mode does not require the syntaxin N-
peptide; Sec1p, Munc18a, and Vps45p have been shown to bind using this mode (Table 
1.2 and Figure 4.1B)
105, 110, 112, 174
.  Most SM proteins also interact with their cognate 
syntaxins.  Munc18c-Syntxin 4 (mammalian exocytosis), Sly1p-Sed5p (trafficking 
between the ER and Golgi), and Vps45p-Tlg2p (endosomal trafficking) interact through 
the SM protein domain 1 conserved hydrophobic pocket-syntaxin N-peptide interface 
(Figure 4.1C)
86, 102, 103, 105, 140, 156
.  The neuronal Munc18a-syntaxin 1a interaction shows a 
N-peptide mode and also has a Munc18a cleft-closed syntaxin 1a interface (Figure 
4.1D)
80
.  In contrast, the yeast Sec1p does not interact with its cognate syntaxin, Sso1p
112
,  
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Figure 4.1.  Interaction modes between SM proteins and their cognate syntaxin t-
SNARE or SNARE complex.  (A)  Binding to the assembled SNARE complex through 
the syntaxin N-peptide.  (B)  Model of the interaction between the SM protein and the 
assembled SNARE complex.  Although the SM protein is modeled to interact with the 
assembled SNARE complex through the cleft, this mode of interaction has not been 
confirmed; it is unclear which regions of the SM protein mediate this interaction. (C)  
Binding to the syntaxin N-peptide only.  (D)  Binding to the syntaxin closed 
conformation and the syntaxin N-peptide. 
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and the vacuolar Vps33 interacts with the syntaxin Vam3p as a member of the HOPS 
complex
144
 .  The only mode of interaction that appeared conserved is the N-peptide.  The 
apparent discrepancies in the binding modes have made it difficult to construct a model 
for SM protein function. 
 The N-peptide interaction has been hypothesized to be the only conserved mode 
of binding between SM-syntaxin pairs.  The binding between Munc18a and the closed 
conformation of syntaxin 1a was hypothesized to be specific for the neuronal system
108
.  
However, as we examined the data supporting this hypothesis, we began to question 
whether this was truly the case.  In the Sly1p-Sed5p interaction, binding through the 
closed conformation was only examined using yeast-2-hybrid analysis and abrogation of  
the N-peptide interaction indicated that this interface is not essential for function in 
vivo
156, 162
.  Further examination of the Sly1p-closed Sed5p interaction using other assays 
is needed to confirm the negative result.  Also, the in vivo results suggest another mode of 
interaction between Sly1p and Sed5p.  In the Munc18c-syntaxin 4 interaction, although 
GST pull-down assays indicated no interaction with the closed conformation, limited 
proteolysis experiments suggested that syntaxin 4 can form a closed conformation, and 
mutational analyses of syntaxin 4 indicated the presence of two binding modes between 
Munc18c and syntaxin 4
140, 178
.  As discussed previously, the GST-tag may have blocked 
binding of closed syntaxin 4 to the Munc18c cleft.  For Sly1p and Munc18c, the affinity 
for the closed conformation interaction mode may be significantly weaker than the N-
peptide mode; more quantitative assays, such as ITC or EMSA, therefore, will be needed 
to definitively rule out the closed conformation.   
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 In the case of Vps45p, its interaction with Tlg2p was originally mapped by GST 
pull-down assays
86
.  These assays indicated that the N-peptide of Tlg2p is sufficient for 
the interaction with Vps45p
86
.  However, because NMR analysis of a Tlg2p construct 
lacking the entire SNARE motif indicated that Tlg2p does not form a closed 
conformation, this binding mode was not tested by these assays
86
.  However, as discussed 
previously, although this construct was highly soluble, the closed conformation of Tlg2p 
may have been destabilized due to the absence of its full SNARE motif.  A mutation in 
the domain 1 hydrophobic pocket of Vps45p, L117R, also appeared to abrogate the 
binding between Vps45p and Tlg2p
105
.  In vitro binding assays using a Tlg2p construct 
lacking the N-peptide, and C-terminally tagged with Protein A, also failed to bind 
Vps45p from yeast lysates
105
.  However, these results may have been due to the low 
protein concentrations used, or the Protein A tag may have interfered with binding to 
Vps45p.  Similar to Sly1p-Sed5p, the N-peptide interaction does not appear to be 
necessary for the function of Vps45p or Tlg2p
105
.  Recently, ITC experiments using 
mVps45 and syntaxin 16 (the mammalian homologue of Tlg2p) indicated that the region 
corresponding to the closed conformation of syntaxin 16 increases the affinity of the 
mVps45-syntaxin 16 interaction
106
.  The in vivo and ITC results suggested the presence 
of a second interaction site and prompted us to speculate whether other SM proteins, 
besides Munc18a, also interact with their cognate syntaxin closed conformation. 
 In order to determine if the closed conformation is specific for the neuronal 
system, I investigated the interaction between Vps45p and its cognate syntaxin t-SNARE, 
Tlg2p.  In many of the previous SM studies, interactions were tested employing pull-
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down assays using bulky fusion tags, which may negatively affect protein structure and 
interaction interfaces.  To address these issues, the recombinantly expressed proteins used 
during our studies were N-terminally fused with a His6-tag.  This tag should have little 
impact on protein structure or binding interfaces; CD and SEC analyses indicate that the 
truncations used for this study are well-folded and monomeric.  Using several Tlg2p 
truncations that contained different domains of Tlg2p, I systematically mapped the 
interactions between Vps45p and Tlg2p using SEC.  I discovered a second binding site 
corresponding to the closed conformation of Tlg2p and concluded that Vps45p and Tlg2p 
interact through two distinct sites. 
 I went on to further characterize the second interaction site.  Characterization of 
the interaction by methods such as ITC and surface plasmon resonance were hindered 
due to low yields of purified Vps45p and full-length Tlg2p as well as the tendency of 
both to precipitate at higher concentrations (i.e. above 10-25 M).  To characterize the 
second interaction site, I developed a quantitative fluorescent electrophoretic mobility 
shift assay.  Using this assay, I examined the interactions between Vps45p and several 
Tlg2p constructs, including the N-peptide.  Through direct titration EMSA, I determined 
that the second binding site on Tlg2p interacts with Vps45p with a relatively strong 
affinity (~150 nM).  Competition EMSA, which measures the ability of various Tlg2p 
truncations to compete for binding to Vps45p, indicated that binding through the second 
site requires the entire cytoplasmic region of Tlg2p, a region that corresponds to the 
closed conformation.  Using mutational analysis, I further showed that Vps45p interacts 
with the Tlg2p closed conformation, similarly to Munc18a-syntaxin 1a.  A mutation in 
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the SNARE motif of syntaxin 1a decreases Munc18a-syntaxin 1a affinity; the analogous 
mutation in Tlg2p also disrupts binding to the closed conformation.  My results indicate 
that the closed conformation is not specific to the neuronal system and substantiates the 
need for more quantitative analyses of other SM-syntaxin pairs. 
 I also examined the relationship between the N-peptide and the closed 
conformation binding modes.  Competition EMSA experiments indicated that the N-
peptide competes for binding to Vps45p and that Vps45p has a stronger affinity for the 
N-peptide than for the closed conformation.  The N-peptide also appears to modulate the 
interaction between the closed conformation and Vps45p, as the affinity for full-length 
Tlg2p is not significantly stronger than the affinity for a Tlg2p construct lacking the N-
peptide.  The interaction of Vps45p with these two binding sites may serve to control 
Tlg2p function by regulating the closed and open conformations and therefore inhibiting 
or promoting t-SNARE assembly.  These results suggest a role for SM proteins in 
regulating the open/closed states of their cognate syntaxin and thereby regulating SNARE 
assembly and membrane fusion.   
 My studies have further elucidated the interaction between SM proteins and their 
cognate syntaxin.  Based on my results, and other recently published data, common 
modes of interaction can be identified in the various trafficking systems.  Direct SM-
syntaxin interactions use the syntaxin N-peptide mode; at least two SM-syntaxin 
interactions also use the syntaxin closed conformation mode; and most SM proteins 
interact with their cognate SNARE complex through one of two distinct modes (Figure 
4.1)
80, 86, 102, 103, 105, 106, 110, 112, 140, 154, 156, 158, 174, 175
.  In vitro assays indicate that SM 
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proteins function as inhibitors and stimulators of specific steps in SNARE assembly and 
membrane fusion and that the syntaxin N-peptide modulates these functions
46, 106, 174
.  
Data presented in this thesis indicate that the N-peptide and closed conformation binding 
modes do not occur simultaneously and suggests a role for SM proteins in opening their 
cognate syntaxin. 
 Previously, a model for SM protein function had been difficult to construct; 
results from this study, and data from other groups, have resulted in the development of a 
more unifying model for SM protein function in SNARE complex assembly and 
membrane fusion.  This model is summarized in Figure 4.2.  In this new model, the SM 
protein is recruited to the target membrane by its interaction with the syntaxin N-peptide 
(A).  The N-peptide interaction, which has been identified for most SM-syntaxin pairs, 
may help to stabilize the syntaxin; in several systems the levels of syntaxin correlate with 
the levels of the SM proteins
117, 120, 121, 134, 170, 171
.  Once at the target membrane, the SM 
protein may interact to stabilize the closed conformation of syntaxin, thus inhibiting t-
SNARE complex formation (B).  Prior to t-SNARE complex assembly, the SM protein 
dissociates from the closed conformation (C).  The dissociation may be caused by the SM 
protein binding to another protein (such as a small GTPase or an effector of a small 
GTPase) or it may be an aspect of the SM protein function (such as in the case of Vps45p 
which does not bind the N-peptide and closed conformation simultaneously).  After 
dissociating from the closed conformation, the SM protein may continue to interact with 
the N-peptide, thus remaining tethered to the sight of membrane fusion.  After syntaxin 
opens and its SNARE motif interacts with the other t-SNAREs, forming the t-SNARE  
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Figure 4.2.  A new model for SM protein function.  (A)  The SM protein is recruited to 
the target membrane and stabilizes syntaxin through interactions with the syntaxin N-
peptide.  (B)  At the membrane the SM protein stabilizes the closed conformation of 
syntaxin and precludes t-SNARE complex assembly.  (C)  Prior to t-SNARE complex 
assembly, the SM protein dissociates from closed syntaxin, but remains tethered to sites 
of membrane fusion through its interaction with the syntaxin N-peptide.  The syntaxin 
opens, and the SNARE motif interacts with the other t-SNAREs forming the t-SNARE 
complex.  (D)  The t-SNARE complex interacts with the v-SNARE, forming a functional 
SNARE complex.  The SM protein remains associated with the SNARE complex through 
the syntaxin N-peptide and interactions with the assembled SNARE complex.  The SM 
protein may act to stimulate membrane fusion through its interaction with the assemble 
SNARE complex.  Although the SM protein is modeled to interact with the assembled 
SNARE complex through the cleft, this mode of interaction has not been confirmed; it is 
unclear which regions of the SM protein mediate this interaction. 
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complex, the v-SNARE on the vesicle associates with the t-SNARE complex to form a 
functional SNARE complex.  Several SM proteins interact with the syntaxin N-peptide 
while syntaxin is part of the SNARE complex
105, 140, 154, 155, 162, 174, 175
.  Several SM 
proteins also interact with the assembled SNARE complex in a manner that does not 
require the N-peptide
105, 110, 112, 174
 (D).  While liposome fusion assays indicate that SM 
proteins stimulate membrane fusion after formation of the t-SNARE complex
113, 174
, they 
do not reveal at what point this takes place.  SM proteins may be stimulating SNARE 
complex assembly to stimulate membrane fusion, they could be stimulating membrane 
fusion after SNARE complex assembly, or they could play a role in both processes.  
Also, the affinity of different interactions during each step may vary depending on the 
specific characteristics of each trafficking pathway.  For example in neuronal secretion, 
the Munc18a-syntaxin 1a N-peptide affinity is much weaker than the closed 
conformation, although in the Sly1p-Sed5p and Vps45p-Tlg2p interactions, the N-peptide 
affinity is quite strong (nM)
106, 158
.  The co-crystal structure of Munc18a-syntaxin 1a 
indicates that the N-peptide and closed conformation can bind simultaneously, whereas 
this is not the case for the Vps45p-Tlg2p interaction
106
.  In the case of Munc18a, binding 
to a second protein may be needed to release syntaxin 1a.  Although much more research 
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is needed to elucidate the details of each step, this new model suggests a general 
mechanism for SM protein function in SNARE assembly and membrane fusion. 
FUTURE DIRECTIONS 
 Several interesting questions pertaining to SM protein function remain.  Although 
Munc18a and Vps45p interact with the closed conformation of their syntaxin partner, it is 
unclear whether Munc18c and Sly1p interact in a similar fashion.  Also, the interactions 
between SM proteins and their SNARE complexes need to be examined in more detail; 
two distinct modes of binding have been observed.  Munc18c and Sly1p interact with 
SNARE complexes through the syntaxin N-peptide
140, 154
.  Sec1p binds to assembled 
SNARE complexes independently of the syntaxin N-peptide
112
.  Munc18a and Vps45p 
appear to use both modes
105, 174
.  Experiments are needed to determine whether Sly1p and 
Munc18c are capable of binding to the assembled SNARE complexes as well.  Future 
biochemical and structural characterization of the assembled SNARE complex mode of 
binding is required.  I indicated in the model figures in this thesis that the assembled 
SNARE complex may bind in the cleft of the SM protein.  However, there is little data to 
support this. Binding analyses between SM protein cleft mutants and the assembled 
SNARE complexes and/or crystallographic analyses would indicate whether or not the 
SNARE complex does bind within the SM protein cleft.   
 The specific role that each SM protein plays in SNARE assembly and fusion is 
also an area of future focus.  The results presented here have made a substantial 
contribution to understanding the Vps45p-Tlg2p interaction, and SM-syntaxin 
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interactions in general, however, many interesting questions remain pertaining to Vps45p 
function and its interactions with its cognate SNAREs.  One area of focus is the effect of 
Vps45p on SNARE assembly and membrane fusion.  Although I attempted to address 
this topic using SEC, my results were limited.  Future studies monitoring the effect of 
Vps45p on SNARE assembly should use SNARE constructs that contain their 
transmembrane domains.  To monitor membrane fusion  in vitro, our collaborator, N. 
Bryant, will use a liposome fusion assay, similar to the one described in Paumet et al 
2001
72
.  Using this assay, and several truncations/mutants of both Vps45p and the 
SNAREs, several questions can be addressed:  whether Vps45p stimulates membrane 
fusion, which domain(s) of Vps45p is responsible for its role in membrane fusion, and 
whether the Tlg2p N-peptide plays a role in membrane fusion.  These types of 
experiments would elucidate the role Vps45p plays in both SNARE assembly and 
membrane fusion.   
 Specific details about theVps45p-Tlg2p interactions remain to be determined, 
including which residues in Vps45p and Tlg2p are important for their interactions; 
whether Tlg2p forms a closed conformation in the absence of Vps45p; whether an open 
mutant of Tlg2p affects its affinity to Vps45p; the in vivo consequences of losing the 
closed conformation interaction; whether the Vps45p interaction with Tlg2p inhibits 
SNARE assembly, and if so which domain(s) regulates the inhibition.  Quantitative 
EMSA will be very useful in characterizing the protein-protein interactions.  Other 
techniques including size exclusion chromatography, circular dichroism, and in vivo 
assays monitoring CPY secretion, will also be used.  
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 Moreover, determination of the crystal structures of Vps45p, Tlg2p, or the 
Vps45p-Tlg2p interaction would answer several of these questions.  However, it is 
difficult to obtain significant concentrations of the full-length proteins for 
crystallographic studies.  In fact, Tlg2p precipitates at concentrations higher than 10 M, 
even in the presence of glycerol.  Truncation of the N-peptide, however, results in a 
construct that is soluble even at > 100 M.  Determination of the crystal structure of this 
construct will establish if Tlg2p adopts a closed conformation.  In the absence of a crystal 
structure, a homology model using structure-based sequence alignments with other 
syntaxin Habc domains has been made by M. Munson.  This homology model is currently 
being used to make mutations in the Habc domain of Tlg2p that are hypothesized to 
disrupt the closed state.  Analyses of these mutations, when present in a construct lacking 
the N-peptide, will determine if the closed conformation has been disrupted; dissociation 
from the Habc domain should cause the SNARE motif to unfold, resulting in a decrease in 
helicity as monitored by CD and a change in the elution profile using SEC.  The mutants‟ 
affinities to Vps45p will be measured using EMSA.  Because defects in Vps45p function 
result in missorting of vacuolar proteins, those mutations that affect binding to Vps45p 
will be analyzed using in vivo assays, which monitor the secretion of the vacuolar protein 
CPY.   
 Mutational analysis of Vps45p in a similar manner would elucidate which 
domains and residues are important for its interactions with SNAREs and the SNARE 
complex.  Vps45p interacts with Tlg2p and Snc2p; these interactions are mutually 
exclusive and the affinity of Vps45p for Snc2p is lower than for Tlg2p
105
.  The 
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interaction between Vps45p and Snc2p does not appear to be through the same interface 
as the Vps45p-Tlg2p N-peptide interaction, although more quantitative assays are needed 
to confirm this.  Using mutational analysis and quantitative binding assays, such as 
EMSA and/or surface plasmon resonance, the Vps45p-Snc2p interaction can be mapped 
and the effect of abrogating this interaction analyzed in vivo.  Although Vps45p interacts 
with the SNARE complex through the N-peptide of Tlg2p, a mutation (W244R) in the 
hinge region of the Vps45p cleft results in binding to the core SNARE complex.  This 
mutation may have stabilized a normally transient interaction in vivo.  The effects of this 
mutation, or similar mutations, on the affinity of the Vps45p-Tlg2p, Vps45p-Snc2p and 
Vps45p-core complex interactions need to be quantitatively analyzed.  Mutations in 
conserved residues within the cleft region of Vps45p and their affect on Tlg2p binding 
and SNARE assembly and fusion is another area that needs to be pursued.  With a 
SNARE assembly assay and/or a liposome fusion assay, the effect of Vps45p mutants on 
either SNARE assembly or membrane fusion can be monitored.  The results from these 
experiments would be specifically applicable to our understanding of Vps45p function, as 
well as generally applicable to the understanding of SM protein function.   
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FINAL CONCLUSIONS 
 The work presented in my thesis has significantly contributed to understanding 
the role of Sec1/Munc18 proteins in vesicular trafficking.  Apparent discrepancies in the 
field about the interaction modes between SM proteins and their cognate syntaxins led to 
much confusion over the mechanism of SM protein function.  Focusing on the endosomal 
SM protein Vps45p, I identified a second binding site on its cognate syntaxin, Tlg2p.  
This second site corresponds to the closed conformation mode of binding observed in the 
Munc18a-syntaxin 1a system, indicating that this binding mode is conserved.  I 
developed a quantitative electrophoretic mobility shift assay to characterize the 
interaction between Vps45p and the second site.  Using EMSA, I discovered that the 
closed conformation has a weaker affinity than the N-peptide, and that the N-peptide 
modulates the affinity between Vp45p and the closed conformation.  The relationship of 
these binding modes may reflect specific aspects of Vps45p function.  My results have 
provided a better understanding of the Vps45p-Tlg2p interaction and contributed to the 
construction of a new mechanistic model for Sec1/Munc18 protein function. 
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APPENDIX 1: 
 
 
Supplemental Material for Chapter II: 
-  Concentration determination of proteins used for EMSA 
-  Equilibrium Analytical Ultracentrifugation of Tlg2p(37-318) 
-  Mass Spectrometry of labeled Tlg2p(37-318) 
-  Protocols for labeling protein with Alexa 488, direct EMSA, 
and competition EMSA 
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Concentration determination of proteins used for EMSA experiments 
 Different methods of protein concentration determination were tested to 
determine which gave the most accurate results.  Concentration was determined by A280, 
a quantitative ninhydrin protocol
186
, and quantitative amino acid analysis (QAA) (Keck 
Biotechnology Resource Laboratory, Yale University).  Two proteins were examined, 
Vps45p and Vti1pHabc (a.a. 111-187), to determine if the accuracy of either of the 
methods varied due to molecular weight or residue number. 
Materials and Methods 
Concentration by A280: 
 The concentrations of Vps45p and Vti1pHabc were calculated using a protocol 
adapted from Edelhoch et al 1967
197
.  Aliquots of purified Vps45p and Vti1pHabc were 
removed from the -80 °C freezer and thawed.  Vti1pHabc was either diluted in buffer 
containing Kphos pH 7.4 (for folded samples) or buffer containing 20 mM potassium 
phosphate and 6 M guanidine HCl, pH 6.5 (KOH) (for unfolded samples).  Vps45p was 
diluted in either buffer containing Kphos and 10% glycerol pH 7.4 (folded samples) or 
the guanidine buffer described above (unfolded samples).  A280 values were recorded and 
concentrations determined based on their extinction coefficient at A280 using Beer‟s Law:  
clA   where “A” is the absorbance, “” is the extinction coefficient (M-1cm-1), “c” is 
the concentration (M), and “l” is the path-length (cm).  Two dilutions were made of each 
protein; their values were averaged to give the final concentration (dilution values varied 
by less than 4%). 
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Concentration by ninhydrin: 
 The concentrations of Vps45p and Vti1Habc were determined by ninhydrin 
assay
186
.  Vti1pHabc was diluted 1:10 and Vps45p was diluted 1:3 in Kphos buffer. A 10 
mM leucine solution was used as a standard.  Samples of 5 L, 7 L, 10 L, 12.5 L, and 
20 L were mixed separately with 150 L 13N NaOH.  Samples were autoclaved to 
cleave the peptide bond and generate single amino acids.  Reactions were neutralized 
using 250 L acetic acid.  400 L of a CN-ninhydrin solution containing 1.5% ninhydrin 
(w/v), 50% methoxyethanol, and 0.1 mM NaCN, was added to each reaction; reactions 
were boiled for 15 min. 2 mL of 50% isopropanol were added to dilute each sample.  A570 
was recorded for each sample.  Sample volume vs. A570 value was plotted and fit to a 
linear function using Excel software.  Concentrations were determined using equations 
(1) and (2) where “10 mM” is the concentration of the leucine standard, “sample slope” 
and “leucine slope” are the slope values for the sample or leucine standard lines 
respectively, and “# residues” is the number of amino acids in the protein.  The 
concentrations of two Vps45p preps were determined using this method. 
(1)                    residuesmM
slopeleucine
slopesamplemM

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(2)                     proteinmM
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
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Concentration by QAA: 
 Vps45p and Vti1pHabc concentrations were determined by QAA at the Keck 
Biotechnology Resource Laboratory, Yale University.  Vps45p was diluted 1:5 in Kphos 
buffer so that the final glycerol concentration was 2%.  Vti1p was diluted 1:20 in Kphos 
buffer as well.  Analysis was performed as described on the Keck Biotechnology 
Resource Laboratory, Amino Acid Analysis Home Page 
(http://keck.med.yale.edu/prochem/procprot.htm#aaa).  Briefly, proteins underwent 
hydrolysis for 16 h at 115°C in 6N HCl, 0.2% phenol, and 2 nmol norleucine (internal 
standard).  Amino acids were purified using a Beckman Model 7300 ion-exchange 
instrument.  Data was analyzed using Perkin Elmer/Nelson data acquisition software.  
Total “g of sample” and “nmol of sample” are calculated and reported.  Values were 
corrected for the number of cysteines and tyrosines in the amino acid sequence of each 
protein.  Protein concentration was determined using the equation below: 
     
 
 
proteinmM
Lsentvolume
nmolcalculatedproteinnmoltotal


 
The concentration of two Vps45p preps were also determined using this method. 
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Results and Discussion 
 The concentrations of Vps45p and Vti1pHabc were determined by three different 
methods to determine which method(s) is most accurate.  For the A280 measurements, 
both folded and unfolded proteins were tested, in case the tryptophan absorbance was 
altered in the folded protein.  Vti1pHabc does not contain any tryptophans; its A280 is due 
to one tyrosine and one phenylalanine.  Vps45p contains three tryptophans.  The A280 
values for folded and unfolded Vti1pHabc differed by ~ 20%.  However, unfolded and 
folded Vps45p values only differed by ~ 5%; the unfolded/folded values for another 
protein, Tlg2p(37-318) only differed by ~ 5% as well, indicating that the difference for 
Vti1pHabc may be specific to that protein.  The concentrations of the unfolded proteins 
were used for the comparisons below. 
 To determine which concentration method(s) was most accurate, the values from 
the different methods were compared.  In both Vti1pHabc and Vps45p, the 
concentrations determined by A280 were significantly different (25-30%) from both 
ninhydrin and QAA.  In fact, the concentrations determined by ninhydrin and QAA for 
Vps45p were almost identical (2-8% difference).  The difference between the ninhydrin 
and QAA values for Vti1pHabc (~26%) may be due to the number of residues in the 
protein (98); ninhydrin may be less accurate for smaller proteins.  Because the ninhydrin 
and QAA assay yielded similar concentrations, and ninhydrin is faster and less expensive 
to use, we decided to determine the concentrations of all proteins in this thesis, except the 
Tlg2p(1-33c) peptide, by using the ninhydrin assay. 
146 
Equilibrium Analytical Ultracentrifugation (AUC) of Tlg2p(37-318) 
 Because the Tlg2p(37-318) protein eluted with an apparent higher molecular 
weight from SEC, I analyzed its oligomeric state by AUC.  
Material and Methods 
 Purified Tlg2p(37-318) at 108.3 M was diluted 2:5 into buffer containing Kphos 
and 2 mM TCEP.  Protein was exchanged into buffer containing Kphos and 2 mM TCEP.  
Protein concentrations ranged between 42.5 M and 14.2 M.  Proteins were centrifuged 
at 12,000 rpm, 15,000 rpm, and 22,000 rpm until equilibrium was reached using an 
Optima XLI analytical ultracentrifuge (Beckman) at 4 °C.  Absorbance was monitored at 
280 nm.  Six scans at different speeds and concentrations were analyzed by nonlinear 
least-squares fitting using WinNonlin software (version 1.06, University of Connecticut), 
although the scans at 22,000 rpm were the best.  The partial specific volume of Tlg2p(37-
318), and the density of the Kphos buffer were calculated by SednTerp (version 1.09, 
University of New Hampshire).  The data fit best to a monomeric species with a 
molecular weight of 41,300 Da (Calculated = 35,252 Da).  Data could not be fit to either 
a dimer or trimer species.  Three plots of data taken at 22,000 rpm at various 
concentrations, along with their residual plots, are shown in Figure A1.1. 
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Figure A1.1.  AUC data indicates that Tlg2p(37-318) is a monomer in solution.  (A)  
Plot of AUC data at 22,000 rpm for Tlg2p(37-318) at 42.5 M.  Residual plot of the 
deviations is shown as well.  Table indicates the concentration of the sample, its 
calculated molecular weight, the experimental molecular weight determined by the 
indicated data, and the oligomeric state of the protein.  (B,C)  Similar to (A) but at lower 
protein concentrations. 
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Mass Spectrometry of labeled Tlg2p(37-318) 
 Because Tlg2p(37-318) contains multiple cysteines (a.a. 129 and 316) I used mass 
spectrometry to ensure that only one cysteine had reacted with the Alexa 488 maleimide 
dye during the labeling reaction.  Labeled Tlg2p(37-318) was prepared and purified as 
described in Chapter II.  The molecular weight of unlabeled Tlg2p(37-318) and labeled 
Tlg2p(37-318) were determined by MALDI TOF Mass spectrometry (University of 
Massachusetts Proteomic and Mass Spectrometry Core) (Figure A1.2).  The calculated 
molecular weight of Tlg2p(37-318) is 35,252 Da.  Mass spectrometry indicates that two 
major species are present in the unlabeled protein sample:  one at 35,298 Da and the other 
at 35,123 Da.  The higher molecular weight species corresponds to full-length protein, 
while the lower molecular weight species corresponds to the truncation of an amino acid, 
possibly the start methionine (Figure A1.2A).  The molecular weight of Alexa 488 Dye is 
697.66 Da.  Mass spectrometry revealed the presence of one Alexa 488 molecule per 
Tlg2p(37-318) molecule indicating that only one cysteine is labeled (697.66 Da + 
35,123.3 Da = 35,820.96) (Figure A1.2B).  Sequence alignments between the Tlg2p Habc 
domain and other syntaxin t-SNARE Habc domains suggest that the cysteine located at 
position 129 is buried, leading us to hypothesize that the cysteine at position 316 is 
labeled.   
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Figure A1.2.  Mass Spectrometry analysis indicates that Tlg2p(37-318) is labeled 
with one Alexa 488.  (A)  MS data of unlabeled Tlg2p(37-318).  Calculated molecular 
weight is 35,252 Da.  The higher molecular weight peak corresponds to full-length 
protein while the lower molecular weight peak corresponds to the truncation of one 
amino acid, possibly the start methionine.  (B)  MS data of labeled Tlg2p(37-318).  
Molecular weight of Alexa 488 Dye is 697.66 Da.  The results indicate that each species 
of Tlg2p(37-318) is labeled with one Alexa 488 molecule.
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Protocol:  Fluorescent Labeling of Protein for EMSA 
Overview 
-  When deciding which protein to fluorescently label, select the lower molecular weight 
one.  Labeling the smaller protein results in a more distinct shift from unbound to bound 
species. 
-  Label with Alexa Fluor 488 C5-maleimide dye (Invitrogen-Mol. Probes Cat.#A10254) 
 -  This dye reacts with free cysteines; if you have more than one accessible   
   cysteine, you should use mass spec. after labeling to determine whether multiple  
   cysteines are labeled. 
 -  Protein was labeled following the general directions included with the dye.   
  -  Labeling reaction was done at room temp and in the dark. 
Storage of Dye:   
 -  Resuspend 1 mg dye in 1 mL DMSO 
 -  Make aliquots (I usually make 50 nmol aliquots; you don‟t want to resuspend  
   the dye multiple times) 
 -  Dry using speed vac; store in desicator at  20°C; protect from light  
  -  Dye is stable for 6-12months; when it becomes unstable, the labeling  
    efficiency decreases significantly 
Preparation of Protein: 
 -  The labeling reaction works best in a buffer of 10-100 mM phosphate, Tris, or  
   Hepes at a pH of 7-7.5 
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 -  After purification, exchange the protein into a buffer containing 0.5 mM TCEP    
   instead of DTT; DTT may hinder the labeling reaction 
  -  Use a PD10/Nap5 column or dialysis 
 -  I usually store the protein in a buffer of 10 mM potassium phosphate + 140 mM 
   KCl + 10% glycerol + 0.5 mM TCEP 
 - Flash freeze using (l) N2 and store at -80°C 
Labeling Reaction: 
 -  Reaction:  10-20 moles dye : 1mole protein  
 -  Final concentration of protein during reaction:  50-100 M  
 -  Incubate protein for ~ 1hr in buffer containing 2 mM TCEP to reduce disulfides 
  -  See above for the best types of buffer to use during the labeling reaction 
  -  My reaction buffer is 10mM potassium phosphate + 140 mM KCl +  
    10% glycerol + 2 mM TCEP 
 -  Resuspend dye in reaction buffer and add drop-wise to protein; invert to mix 
 -  Incubate for 2 h @ room temp.; protect from light 
 -  Spin the reaction @ 4°C for 10 min to pellet any precipitate. 
 -  Separate the un-reacted dye from the labeled protein using SEC 
  -  I use a Superdex 200 10/30; Buffer: reaction buffer + 0.5 mM TCEP 
  -  For my experiments I usually see ~85% labeling of my protein, unless  
    the dye is becoming less stable 
 -  Analyze fractions using a 6% vertical native gel (see recipe below) 
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  -  Visualize the presence of dye and labeled protein (I use a FLA-5000  
    Fujifilm Imaging System) 
  -  Use Coomassie staining to visualize both labeled and unlabeled protein 
 -  Pool fractions that have labeled protein (without free dye) 
 -  Concentrate protein to ~ 300-500 L and make 5 L aliquots 
 -  Flash freeze in (l) N2 and store @ -80°C (protect from light) 
 -  I determine the total protein concentration using the Ninhydrin protein assay
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  -  To calculate the % labeling efficiency: (493abs/280abs) * 100 
6% Vertical Native Gel recipe (12mL) 
2.4 mL 5x Native Gel buffer (43mM Imidazole + 35mM Hepes) 
1.8 mL 40% Acrylamide mix 
0.6 mL 50% glycerol 
7.1 mL H2O 
84 L 10% APS 
8.5 L TEMED 
Running Buffer: 1x Native Gel Buffer (pre-run for 15 min before loading) 
Loading Dye:  Bromocresol Green Dye  
Run at 4°C for 1-2 h at 30 mA/gel 
 
155 
Protocol:  Affinity Determination using Direct EMSA 
Experiment overview: 
-  Make sure that all pipettes have been calibrated and protein concentrations are accurate 
 -  This includes multichannel pipettes, which are used throughout the experiment 
-  Data is fit to the Hill equation to generate an apparent dissociation constant.  The   
  labeled protein concentration needs to be in “trace”- i.e. the concentration should be at 
  least 10fold lower than the apparent affinity.   
-  For direct EMSA two proteins are used.   
 -  The one labeled with Alexa dye, is in “trace”; its concentration remains      
   constant.   
  -  Use a high enough concentration so that the “free” species is detectable 
 -  The other protein is not labeled; its concentration changes. 
  -  Concentration range depends on its affinity for the labeled species 
   -  You need several minimum bound and maximum bound points 
-  One “Experiment” is composed of 3 replicates.  Each replicate contains 24 points.   
 -  A “PDS” (see below) of unlabeled protein is made in a clear 96-well round-  
   bottom plate (3 replicates/plate)  
 -  The PDS is transferred into another clear 96-well round-bottom plate that  
   contains the labeled protein. (The “Reaction” plate) 
 -  After the “Reaction” plate is set-up, it incubates for 3 h @ room temperature to  
   reach equilibrium; protect from light. 
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  -  You will need to determine if 3 h is enough time for your reaction to  
    reach equilibrium (Try 1 h, 3 h, and ON incubations and compare their  
    calculated apparent affinities) 
-  The unbound/bound material is separated using native gel electrophoresis 
-  The directions below are for a single replicate-repeat twice for a complete experiment    
  and to generate an average apparent affinity and standard deviation. 
 -  Run each replicate in a separate tank (Sub-Cell GT System from BioRad) 
 -  Labeled protein detected using the FLA-5000 Fujifilm Imaging System 
 -  Data analyzed using Multi Gauge, X-Cell, and IGOR software 
Buffers 
5x Binding Buffer (store at room temp)
 50 mM K2HPO4 
 50 mM KH2PO4  
 700 mM KCl    
 50% Glycerol    
 pH to 7.4 with KOH 
1x BB (Make fresh with 5x BB) 
10 mM K2HPO4 
10 mM KH2PO4 
140 mM KCl 
10 % Glycerol 
0.01% NP-40, 1 mM TCEP 
Buffer preparation: 
-  Make 50 mL of stock 5x Binding Buffer (see above); save and use for future 
experiments. 
-  Using 5x BB make fresh 1x Binding Buffer (see above); i.e. if 5 mL 1x BB is made:   
 -1 mL 5x BB + 25 L 200 mM TCEP + 50 L 1:100 NP-40 + 3925 L H2O 
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PDS preparation (Protein Dilution Series): 
-  Prepared in a clear 96-well round bottom plate 
-  The details for preparing the PDS will vary depending on the concentration of your  
  unlabeled protein and what dilution series you want to use.   
-  The example below uses a 3:5 dilution series (i.e. 3 parts previous well + 2 parts 1xBB) 
 -  For well #1:  Begin with 10 M unlabeled protein (final volume = 60 L) 
 -  For wells #2-#19 use a 3:5 dilution series (Final volume of each well is 60 L) 
  - 1 part = 12 L; therefore 3 parts = 36 L and 2 parts = 24 L 
 -  For a 3:5 dilution series:  36 L previous well + 24 L of 1x BB = 60 L 
  -  First, use a multichannel pipettor to add 24 L 1x BB to each well 
  -  Then, take 36 L from the previous well and add it to the next well;  
    pipette up and down multiple times to mix; DON’T make bubbles! 
 -  For well #20:  Add 24 L of 1x BB 
  -  DO NOT add any unlabeled protein (this is your “free labeled protein”  
    control) 
-  PDS:  10,000 nM to 1 nM over 19 pts in a 3:5 dilution series 
Reaction:   
-  Set-up in a new clear 96-well round-bottom plate 
-  Set-up will vary depending on the desired concentration range of the unlabeled protein  
-  The labeled protein concentration is in “trace” - enough to detect “free” in the gel 
-  The following is an example of a “Reaction” 
 -  Labeled protein (protein*) concentration is 14.7 nM 
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 -  The concentration range for the unlabeled protein is from 5 M-0.5 nM over 19  
   points 
-  A 2x Master Mix is made (protect from light)  
 -  Concentration of protein* = 29.4 nM in 1x BB; i.e. to make 500 L of 2x M.M.  
  -  5x BB + TCEP + 1:100 NP-40 + protein* + H2O = 500 L 
-  Final volume of the reaction in each well is 30 L (use multichannel pipette): 
 -  The PDS and M.M. are diluted 1:2 (i.e. 1 part PDS and 1 part 2x M.M.) 
  -  Add 15 L of 2x M.M. to each well 
  -  Transfer 15 L of the PDS into the corresponding reaction well. 
-  Protect from light and incubate for 3 h at room temperature to reach equilibrium 
 -  Incubation time may need to be adjusted depending on how fast equilibrium is 
reached 
-  Dilution Series:  5000 nM to 0.5 nM of unlabeled protein over 19pts (3:5 dilution) 
Native gel set-up:   
-  Set up a 6% slab native gel while reaction is incubating;  
 -  Binding is determined by the shift of the labeled protein. 
-  We use the Sub-Cell GT System from BioRad (Catalog # 1704483) 
-  Set up the Sub-Cell GT System Horizontal Gel Caster; make sure it is level 
 -  Place three combs in the gel tray:  One comb in the 1
st
 slot, 5
th
 slot, and 9
th
 slot  
-  Pour the gel mix into the tray; make sure there are no bubbles and the mix is evenly  
  distributed. 
 -  6% Native Gel Recipe: 400 mL 
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  80 mL 5x Native Gel Buffer (43 mM Imidazole + 35 mM Hepes; pH 7.4) 
  60 mL 40% Acrylamide Mix 
  20 mL 50% Glycerol 
  236.4 mL H2O 
  2.80 mL 10% (w/v) APS 
  0.283 mL TEMED 
-  Allow the gel to sit for 1 h at room temp to polymerize 
-  Make 1x Running Buffer:  Dilute 5x Native Gel Buffer with H2O (~2L/tank); store 4°C 
-  After 1 h, pour off the liquid on the surface of the native gel; cut the gel in equal thirds. 
 -  Cut below the slot above the 2
nd
 and 3
rd
 combs; place each into a separate tray 
-  Place each gel tray into a separate tank; fill with 1x Running Buffer; keep in cold room 
Resolving bound/unbound labeled protein: 
-  Prepare Bromocresol Green (BCG) loading dye 
 -  Make saturated BCG:  add BCG to 30% glycerol until no more dissolves; filter  
  -  The color should be orange/rust 
 -  Mix 20 L saturated BCG with 500 L 30% glycerol (light green color) 
-  Add the loading dye to each sample in a 1:9 dilution (1 part dye + 8 parts sample) 
-  Load 25 L of each sample; each replicate is loaded into a separate gel (up to 50 L  
  can be loaded) 
-  Run the gel at 125 volts (25-28 watts) for 4 h and 45 min. @ 4°C 
-  Cover tanks with aluminum foil to protect from light. 
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Detection of labeled protein: 
-  Labeled protein is detected using the FLA 5000 Fujifilm Phosphoimager 
-  Place gels on a clear imaging plate (FLA FLUOR Stage 4046) and place in FLA-5000 
 -  Make sure they are straight, in a vertical orientation, and there are no bubbles 
-  Open “Image Reader FLA 5000” software 
 -  Select the “1 Laser/1 Image” option under “Fluorescence” 
-  Settings for 1 Laser/1 Image 
 -  CH 1 = 400v 
 -  Select the “FITC” mode 
 -  Resolution = 50 M 
 -  In “Sampling Area” (The Grid):  Drag the red box to the desired size 
 -  In “Root Folder” select “Change” and save to your USB or the desk-top 
  -  Under “File Name” make sure you save it without any symbols! 
-  Select “Read” 
 -  After the scan is done, make sure the files are saved to the USB.  Then “Eject” 
Quantifying the data: 
-  Open Multi Gauge (version 3.0) software (by Fujifilm). 
-  Select “Open” then “Multi Gauge raw-image” file without a “.” in the name (this file is  
  blue, green, and white; unlike the orange and white files) 
-  Under “Display” adjust the contrast of the image (I usually use the sigmoid method). 
-  Under “Process” rotate the gels so they are straight  
-  Under “Measure” select the icon with four equal boxes.  Draw a box encompassing the  
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  bound and free labeled protein.  Select 20 boxes in the first direction and 2 in the second 
direction.   
 -  The box should fit around the data with a minimum of empty space and divide  
   the unbound from bound 
 -  Another option is to draw two separate boxes-one for unbound and one for  
   bound 
-  For the “blank” correction, copy the above box and move it to an area without labeled  
  protein. 
-  Select “Analysis”.  Minimize the image window and the “table” appears.   
-  “Export” data and save as a text file 
Graphing the data and calculating the apparent affinity  
-  Open the exported text file in X-Cell 
-  Delete all columns right of “*LAU” 
-  The “Group” name is the box you drew (A, B, C ...); “Index” name designates whether  
  the signal corresponds to unbound or bound (“A-#” (the top row) is bound and “B-#”  
  (the bottom row) is unbound). 
-  Subtract the “blank” (“Group” B) 
- Calculate the “fraction bound” by:  “bound/ (free + bound)” equation 
-  Enter corresponding unlabeled protein concentrations (i.e. 5 M-0.5 nM; 3:5 dilution) 
-  Save this file as an Excel file 
-  Copy the “frac bound” and “protein conc.” columns (don‟t copy the “0” values) 
-  Open IGOR Software; paste the copied cells 
162 
-  Under “Windows” select “New Graphs”.  The “y-wave” is “frac bound” while the “x- 
  wave” is “protein conc” 
 -  Change the x-axis to a log-plot; double click on the x-axis and select “log” 
-  Under “Analysis” select “Curve Fitting”.   
 -  In “Function” select “Hill Equation”; the y and x data are the same as above. 
 -   = fraction bound; b = max unbound signal; m = max bound signal; P =  
   unlabeled protein concentration; n = apparent Hill coefficient 
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 -  You can float or hold the Hill coefficient @ “1” by selecting “coefficients” and 
   setting the “rate” to 1 
-  The fit gives you a “base”, “max”, “rate” (Hill coefficient), and “xhalf” (apparent Kd) 
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Protocol:  Affinity Determination using Competition EMSA 
Experiment overview: 
-  The set-up of a competition EMSA is similar to the direct EMSA 
-  For competition EMSA three proteins are used.   
 -  The labeled protein remains in trace for competition EMSA 
 -  The unlabelled protein, which interacts with the labeled protein, is used at a    
   specific constant concentration. 
  -  The concentration of unlabeled protein should = 60-80% bound based  
    on the Direct EMSA data 
 -  The other unlabeled protein, is labeled the “competitor”; its concentration varies  
-  Each experiment is set-up similarly to direct EMSA with the following differences:   
 -  A “PDS” is made of the competitor protein 
 -  The PDS is transferred to the “Reaction” plate, which contains a solution of the   
   labeled protein + unlabeled protein 
-  The directions below are for a single replicate-repeat twice for a complete experiment  
  and to generate an average apparent affinity and standard deviation. 
 -  Gels are run, labeled protein detected, and data analyzed as in “Direct EMSA” 
Buffers:   
Similar to those used in “Direct EMSA”
Buffer preparation: 
Similarly as explained in “Direct EMSA”
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PDS preparation (Protein Dilution Series): 
-  Prepared as described in the Direct EMSA protocol with the following specifics 
-  The competitor protein is used to make the PDS; its range depends on its ability to  
  compete for binding to the unlabeled protein (you may need to do multiple ranges)  
-  The example below uses a 2:3 dilution series (2 parts previous well + 1 part 1x BB) 
 -  For well #1:  Begin with 14 M competitor in 60 L 
 -  For wells #2-#18 use a 2:3 dilution series (Final volume of each well is 60 L) 
  - 1 part = 20 L; therefore 2 parts = 40 L and 1 part = 20 L 
 -  For a 2:3 dilution series:  40 L previous well + 20 L of 1x BB = 60 L 
  -  First, use a multichannel pipettor to add 20 L 1x BB to each well 
  -  Then, take 40 L of the previous well and add it to the next well 
 -  For wells #19 and #20:  ONLY Add 20 L of 1x Binding Buffer (control wells) 
-  PDS:  14,000 nM to 14.2 nM over 18 pts in a 2:3 dilution series; controls:  pts 19 & 20 
Reaction Set-up:   
-  Similar to the Direct EMSA assay with the following differences 
-  A 2x Master Mix is made of unlabeled protein and labeled protein;  
 -  The labeled protein is in trace (same conc. as used in direct EMSA) 
 -  Concentration of unlabeled protein = 60-80% bound to the labeled protein  
-  The following is an example of a competition “Reaction” 
 -  Final labeled protein (protein*) is 14.7 nM 
 -  Final unlabeled protein concentration is 500 nM 
 -  Concentration range of the competitor is from 7 M-7 nM over 18 points 
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- 2x Master Mix made (protect from light):   
 -  Concentration of protein* = 29.4 nM 
 -  Concentration of unlabeled protein = 1uM 
 -  Make in 1x B.B.:  i.e. for 500 L of 2x M.M.: 
  -  5x BB + TCEP + 1:100 NP-40 + unlabeled protein + protein* + H2O 
-  Final volume of the reaction in each well is 30 L (use a multichannel pipette): 
 -  The PDS and M.M. are diluted 1:2 (i.e. 1 part PDS and 1 part 2x M.M.) 
  -  Add 15 L of 2x M.M. to wells #1-19 
  -  Transfer 15 L of the PDS into corresponding reaction well 
 -  For control wells (#19, 20): 
  -  Well #19 (complex only):  15 L of well #19 from the PDS 
  -  Well #20 (free protein* only):  Make 2x M.M. without unlabeled protein 
   -  Add 15 L of the 2x M.M. and 15 L of well #20 from the PDS 
-  Protect from light and incubate for 3hrs at room temperature to reach equilibrium 
 -  May need to adjust incubation time depending on when equilibrium is reached 
-  Dilution Series:  7000 nM to 7 nM of competitor over 18pts (3:5 dilution);  
Native gel set-up, resolving bound/unbound labeled protein, detecting labeled 
protein, and quantifying the data:   
-  Same as described in the Direct EMSA assay  
Graphing the data and calculating the apparent affinity  
-  Open the exported text file in X-Cell; calculate fraction bound as in “Direct EMSA”. 
-  Open IGOR Software; graph fraction bound as described in the Direct EMSA assay 
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-  Under “Analysis” select “Curve Fitting” 
 -  The following equations are not included in the program-you need to add them 
-  The data is fit to the following equation to generate an IC50; “s” is the shape factor of  
  the curve: 
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- The apparent affinity (Kc, app) is calc. using the Lin and Riggs correction
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 -  P = concentration of unlabeled protein; T* = concentration of protein*; Kd, app =  
   apparent affinity of the unlabeled protein-protein* interaction (determined from  
   the Direct EMSA assay) 
  -  Hold “P”, “T*”, “IC50”, and “Kd, app” constant 
-  The fit gives you a “base”, “max”, “rate” (“s” curve shape factor), and “xhalf” (Kc, app) 
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APPENDIX 2: 
 
 
Characterization of exocyst subunits and their 
interactions 
168 
INTRODUCTION 
 The exocyst complex is the proposed tethering complex for exocytosis.  In yeast, 
it localizes to sites of polarized secretion:  the bud tip during growth and the 
mother/daughter neck during cytokinesis
31, 32
.  The exocyst is proposed to function as a 
tether because of its interactions with the small Rho family GTPases at the plasma 
membrane, Cdc42p, Rho3p, and Rho1p, and the small Rab family GTPase on secretory 
vesicles, Sec4p
21, 27-30
.  It also interacts with the SM protein Sec1p, although the function 
of this interaction is still unknown
46
. A subunit of the exocyst, Sec6p, interacts with the 
exocytic t-SNARE, Sec9p, and an in vitro SNARE assembly assay indicates that Sec6p 
inhibits assembly of the Sec9p and Sso1p SNARE complex
45
.  The exocyst is composed 
of eight subunits:  Sec3p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo70p, and Exo84p
33, 
34
.  Based on binding data from yeast-2-hybrid assays, binding experiments using in vitro 
translated proteins, GST or MBP pull-down assays, SEC, and co-immunoprecipitation 
from yeast lysates, a model of exocyst subunit interactions has been constructed  (Figure 
A2.1)
9
.  All of the subunits, except Sec3p, are essential for growth; defects in other 
exocyst subunits result in an accumulation of secretory vesicles at the bud tip, indicating 
a failure to fuse with the plasma membrane
35, 36
.  Subunits of the exocyst have less than 
10% sequence identity to each other, and to other proteins, but the crystal structures of 
several subunits reveal a high degree of structural similarity, suggesting the presence of a 
conserved function
39-41
.  Although the exocyst is proposed to function as a tether, it is 
likely to have additional roles in cellular function.  The function of each subunit in the  
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Figure A2.1.  Model of the exocyst interactions.  Model of the exocyst based on the 
interactions detected through multiple techniques
9
.  The exocyst is proposed to act as a 
tether by associating with small GTPases on the secretory vesicle and the plasma 
membrane. 
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assembly and function of the exocyst, and the roles they play to regulate vesicular 
trafficking are areas of focus within the trafficking field. 
 To elucidate the roles that individual exocyst subunits play in exocyst function 
and vesicle trafficking, I attempted to characterize two of the subunits:  Sec10p and 
Sec15p.  Yeast-2-hybrid analyses and co-immunoprecipitation from yeast lysates 
indicated that Sec15p interacts with the GTPase, Sec4p, on secretory vesicles; this 
interaction is proposed to act as a bridge between the secretory vesicle and the rest of the 
exocyst
21
.  The crystal structure of the C-terminal domain from Drosophila revealed a 
helical bundle topology that is conserved in other exocyst subunits
39-41
.  Binding studies 
using in vitro translated proteins revealed that Sec15p interacts with Sec10p; differential 
centrifugation and co-immunoprecipitation assays indicate that these two proteins form a 
sub-complex outside of the exocyst
21
.  The overexpression of Sec15p results in an 
accumulation of vesicles
21, 38, 198
.  Overexpressing Sec15p may saturate the binding 
between Sec15p and a partner, such as Sec10p, resulting in unbound Sec15p that 
aggregates.  Sec10p has been shown to interact with multiple subunits of the exocyst 
including Sec15p, Sec6p, Sec8p, and Exo70p
34, 39, 199, 200
.  An N-terminal construct of 
Sec10p (a.a. 1-589) interacts with Sec15p and precludes the association of wild-type 
Sec10p into the exocyst complex, resulting in a dominant negative phenotype
38
.  A C-
terminal construct of Sec10p (a.a. 590-872) does not interact with Sec15p; 
overexpression of this construct results in cells with an elongated shape, suggesting that 
this region of Sec10p may play a role in polarizing cell-growth
38
.  These results 
suggested that Sec10p plays multiple roles in the cell and that the C-terminal region of 
172 
Sec10 is not necessary for the Sec15p interaction.  At the beginning of my thesis research 
the interaction between Sec10p and Sec15p had not been examined in molecular detail. 
 I set out to characterize the interaction between Sec10p and Sec15p in order to 
understand exocyst assembly and what role the Sec10p-Sec15p interaction plays in 
complex assembly.  I hypothesized that the Sec10p-Sec15p interaction would facilitate 
the interaction between Sec15p and the GTPase Sec4p, thus activating the assembly of 
the other exocyst subunits.  I planned to test my hypothesis by expressing and purifying 
soluble domains of Sec15p and Sec10p.  Using these domains, I would map the Sec10p-
Sec15p interaction, determine the interaction affinity, and determine its affect on exocyst 
subunit interactions.  I attempted to generate soluble well-folded domains of both Sec15p 
and Sec10p using a variety of methods.  However, I was unable to obtain a functional 
domain of either protein.  I also examined the interaction between Sec10p and Sec15p, 
but was unable to fully map the binding due to an inability to obtain soluble constructs 
and problems with non-specific binding.  After testing several methods, I concluded that 
new methods would be needed to generate soluble, well-folded, domains of either 
protein. 
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MATERIAL AND METHODS  
Expression and purification of Sec15p constructs 
 Sec15p truncations were generated by PCR and cloned into the NdeI and BamHI 
sites of pET15b (Novagen), introducing an N-terminal His6-tag.  Sec15p constructs were 
expressed in BL21(DE) E. coli cells.  1 L cultures were grown at 37°C until OD600 0.3-
0.4 and then shifted to 20°C.  Protein expression was induced at OD600 0.6-0.8 with 0.1 
mM IPTG for 3 h at 20°C.  All buffers contained 5 mM ME.  Cells were lysed using a 
Microfluidizer cell-disrupter (model 110S) (Microfluidics Corp, Newton, MA) in buffer 
containing 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, DNase (Sigma) and 
protease inhibitors.  Lysate was spun for 30 min at 13,000 rpm and the supernatant bound 
to 100 L nickel-NTA resin (Qiagen) for 1 h at 4°C.  After binding, resin was washed 
with buffer containing 50 mM NaH2PO4, 300 mM NaCl, and 20 mM imidazole.  Protein 
was eluted 10 times with 1 column volume of elution buffer containing 50 mM NaH2PO4, 
300 mM NaCl and 200 mM imidazole.  Samples of each elution fraction (5 L) were 
applied to whatman paper and stained with Coomassie blue.  The most concentrated 
fractions were pooled.  Samples at different steps during the purification, including the 
elution, were taken and analyzed by SDS-PAGE and either stained with Coomassie blue 
or transferred to nitrocellulose and blotted with -His5 antibodies (Qiagen).  Western 
blots were developed using horseradish peroxidase-conjugated α-mouse IgG (Roche) and 
detected using ECL (Amersham) and autoradiography (data not shown).  The relative 
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solubility of each construct was determined based on their concentration in the elution 
sample, with NT58 as the most soluble and NT94 as the least soluble. 
 NT58 and NT65 were further purified and their secondary structure analyzed.  For 
NT58, the elution fractions from the affinity column were concentrated using an Amicon 
Centrifugal Concentrator with a MWCO of 10,000 (Millipore) and purified using an 
analytical Superdex 200 10/30 size exclusion column (G.E. Healthcare).  Fractions 
containing NT58 were diluted and purified using a Mono Q 5/5 anion exchange column 
(G.E. Healthcare) in buffer containing 20 mM Tris pH 7.5 and an increasing gradient of 
NaCl.  NT58 was concentrated and exchanged into Kphos buffer (10 mM K2HPO4, 100 
mM KH2PO4, and 140 mM KCl, pH 7.4).  CD analyses were performed as in Sivaram et 
al 2005
45
 at 10 M protein concentration. 
 For NT65, after the affinity chromatography step, the protein was further purified 
using a Mono Q 5/5 anion-exchange column (G.E. Healthcare) and then purified using a 
Superdex 75 size exclusion column in Kphos buffer.  CD analysis was performed as 
above. 
Expression and purification of Sec10p constructs 
 The Sec10p truncations highlighted in purple in Figure A2.4 were generated by 
PCR and cloned into the NdeI and BamHI sites of pET15b (Novagen), creating an N-
terminal His6-tag.  Sec10p constructs were expressed in BL21(DE) E. coli cells.  The 
constructs were expressed at 20°C and 15°C, and checked for solubility:  1 L cultures 
were grown at 37°C until OD600 0.3-0.4 and then shifted to 20°C or 15°C.  Protein 
expression was induced at OD600 0.6-0.8 with 0.1 mM IPTG for 3 h at 20°C or 12-16 h at 
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15°C.  All buffers contained 5 mM ME.  Cells were lysed and affinity purified, similarly 
to the Sec15p constructs with the following specifics. The lysis buffer contained 20 mM 
Tris pH 8.0, 300 mM NaCl, 15 mM imidazole (final pH ~ 8.3), 0.1% Triton X-100 
(Sigma), DNase (Sigma) and protease inhibitors.  Wash buffer contained 20 mM Tris pH 
8.0, 300 mM NaCl, 15 mM imidazole (final pH ~ 8.3), and 0.1% Triton X-100 (Sigma).  
Elution buffer contained 20 mM Tris pH 8.0, 300 mM NaCl, 200 mM imidazole (final 
pH ~ 8.8), and 0.1% Triton X-100 (Sigma).  Samples were analyzed similarly to the 
Sec15p constructs except that no Western Blot analyses were done.  Relative solubility 
was determined as for Sec15p constructs with NT17 being the most soluble and NT12 the 
least soluble. 
Sec10p-Sec15p binding by co-expression 
 Sec15p constructs were generated by PCR and cloned into the BamHI and XmnI 
sites of pMalC2x vector, creating an N-terminal MBP-tag on each.  Sec10p constructs 
were generated by PCR and cloned into the pACYC DUET vector (Novagen).  MBP or 
MBPSec15p constructs were expressed in BL21(DE3) E. coli cells already containing the 
appropriate Sec10p clone.  Expression was induced for 3 h at 20°C with 0.1 mM IPTG.  
Cells were lysed and affinity chromatography was performed similarly to above, with the 
following specifics.  All buffers contained 1 mM DTT, Lysis and Wash buffers contained 
20 mM Tris pH 7.4, 200 mM NaCl, and 1 mM EDTA.  Lysate was bound to amylose 
resin (New England Biolabs), and Elution buffer contained 20 mM Tris pH 7.4, 200 mM 
NaCl, 1 mM EDTA, and 10 mM maltose.  Samples were analyzed by SDS-PAGE and 
stained with Coomassie blue. 
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Exocyst subunit interactions by MBP pull-downs 
 For Sec10p-Sec6p and Sec10p-Sec15p interactions, full-length His6-Sec10p was 
expressed in BL21(DE3) E. coli for 12-16 h at 15°C with 0.1 mM IPTG.  MBP-tagged 
Sec6p or Sec15p truncations were expressed in BL21 E. coli for 3 h at 20°C or 12-16 h at 
15°C respectively with 0.1 mM IPTG.  His6-Sec10p was affinity purified similarly as 
described above for the Sec10p solubility studies.  MBP-tagged proteins were affinity 
purified as described above except that the proteins were not eluted from the amylose 
resin.  Equal concentrations (1-5 M) of His6-Sec10p and MPB-tagged proteins were 
incubated for 1-2 h at 4°C.  The unbound material was extracted and resin washed with 
binding buffer (20 mM Hepes pH 7.0, 100 mM NaCl, 1 mM EDTA, 0.1% NP-40, 5 mM 
βME final pH 6.83).  Bound samples, and 10% of the load as “input”, were analyzed by 
SDS-PAGE, transferred to nitrocellulose, and blotted with -His5 antibodies (Qiagen) or 
-MBP antibodies (Invitrogen).  Western blots were developed using horseradish 
peroxidase-conjugated α-mouse or α-rabbit IgG (Roche) and detected using ECL 
(Amersham) and autoradiography.   
 For the Sec6p-Exo70p interaction, His6-Sec6p or His6-Sec6CT2 (a.a. 411-805) 
was expressed and purified as in Sivaram et al 2006
40
.  MBP-tagged Exo70 was 
expressed in BL21 E. coli for 3 h at 20°C 0.1 mM IPTG.  Binding reactions were similar 
to the Sec10p-Sec6p and Sec10p-Sec15p experiments above.  Data was analyzed as 
above using Sec6 antibodies
45
 and α-rabbit IgG (Roche). 
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RESULTS 
The search for a functional domain of Sec15p and Sec10p 
 To generate a soluble, well-folded, domain of Sec15p, I recombinantly expressed 
Sec15p constructs in E. coli fused to a variety of tags for affinity purification.  Sec15p is 
a 105 kD protein and the full-length protein was difficult to express in E. coli.  The 
majority of His6-tagged Sec15p was insoluble when expressed at 20°C.  Expression with 
an MBP-tag solubilizes full-length Sec15p, but cleavage of the tag resulted in 
precipitation of full-length Sec15p (data not shown).  For my first attempt at generating a 
functional domain of Sec15p, I expressed several MBP-Sec15p truncations.  These 
constructs were purified by affinity chromatography and the MBP-tag was cleaved.  After 
cleavage, most of these truncations did not precipitate and were further purified by anion 
exchanged chromatography.  However, analyses of their oligomeric state by SEC 
indicated that these constructs aggregated.  Indeed, analyses of multiple Sec15p 
constructs using this method indicated that all of the constructs were aggregated (data not 
shown).  Co-expression with Sec10p did not aid in obtaining well-folded Sec15p (data 
not shown).  These results led us to conclude that solubilization by MBP (or GST) does 
not always results in a well-folded protein.  We decided to use another method to 
generate a functional domain of Sec15p. 
 We made further truncations of Sec15p that were designed using secondary 
structure predictions.  Numerous constructs of Sec15p were designed based on the 
secondary structure predicted by NPS@
201
.  These constructs were His6-tagged instead of 
MBP-tagged.  The His6-tag is 2 kD and should not affect the solubility of the protein.  
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Sec15p constructs were expressed and partially purified using affinity chromatography.  
The constructs I designed and their relative solubilities are shown in Figure A2.2.  
Preliminary characterization of these truncations yielded many constructs with varying 
degrees of solubility.  The most soluble were NT58 and NT65.  Purification and 
characterization by SEC and CD indicated that although these constructs are soluble, they 
are unfolded in vitro and have a propensity to aggregate (Figure A2.3A,B).  These 
regions of Sec15p may be unfolded in the full-length protein, or they may become helical 
upon association with other Sec15p regions.  The next set of constructs I focused on 
included NT74, NT75, and NT76.  Although these constructs were less soluble than 
NT58 and NT65, they are larger and may constitute a functional domain.  However, 
initial SEC results indicated that these constructs self-associate, and I was unable to 
obtain pure protein to analyze their secondary structures (Figure A2.3C).  I attempted to 
fully characterize several other Sec15p truncations but was unable to identify a functional 
domain. 
 Using a similar methodology to Sec15p, I attempted to identify a functional 
domain of Sec10p, except that initial purification of Sec10p constructs used buffer 
containing 0.1% NP-40; in the case of Sec15p, no glycerol or detergent was used (Figure 
A2.4).  Although solubility tests indicated that several of the constructs were soluble, 
further purification of these constructs, such as NT13 and NT14, was hindered by 
aggregation issues (data not shown). 
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Figure A2.2.  List of Sec15p truncations generated based on secondary structure 
predictions.  Cartoon of the Sec15p truncations analyzed in the solubility screen.  The 
length of each construct and the predicted secondary structures it contains are indicated.  
Constructs were designed based on their predicted secondary structure, and their relative 
solubility determined as described in Materials and Methods.  The relative solubility of 
each construct is shown; darker purple indicates greater solubility. 
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Figure A2.3.  Characterization of several Sec15p truncations.  (A)  SEC analyses of 
NT58 and NT65.  Samples were analyzed using a Superdex 200 10/30 analytical size 
exclusion column.  The apparent molecular weights of the standards are indicated.  Table:  
the calculated and apparent molecular weights as determined by SEC.  Both NT58 and 
NT65 elute as higher molecular weight species and may indicate aggregation or unfolded 
structure.  (B)  Secondary structure analysis of NT58 and NT65 by CD.  Although 
soluble, both proteins appear unfolded by CD analyses.  (C)  SEC analysis of moderately 
soluble constructs:  NT74, NT75, NT76 was performed as in (A).  Table: calculated and 
apparent molecular weights; each construct elutes at multiple points indicating several 
aggregating species of each protein. 
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Figure A2.4.  List of Sec10p truncations generated based on secondary structure 
predictions.  Similar to Figure A2.2.  Different shades of purple are used to indicate the 
relative solubility of each truncation. 
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 Analysis of exocyst subunit interactions 
 In my attempt to map the interaction between Sec10p and Sec15p I used several 
methods.  I first co-expressed truncations of Sec10p and Sec15p in E. coli.  In these 
experiments Sec15p constructs were fused with MBP while Sec10p constructs were 
untagged.  Sec10p or Sec10p(51-485) was expressed in the presence of MBP or 
MBPSec15p(75-305).  Lysates were bound to amylose resin and then eluted.  The 
presence of Sec10p/Sec10p(51-485) in the elution was determined by SDS-PAGE 
analysis and Coomassie blue staining.  My results indicated that full-length Sec10p and 
Sec10p(51-485) bound to MBPSec15p(75-305) above background (Figure A2.5A).  
Interestingly, in the absence of Sec15p(75-305), Sec10p(51-485) was completely 
insoluble. This result suggested that Sec15p(75-305) may stabilize Sec10p(51-485); 
however, this complex still aggregated, as indicated by SEC (data not shown).  To further 
map the Sec10p-Sec15p interaction, various MBP-Sec15p constructs were expressed and 
bound to amylose resin.  Full-length His6-Sec10p was expressed in E. coli, affinity 
purified, and bound to MBP-Sec15p constructs.  After washing, the bound sample was 
analyzed by SDS-PAGE and Western blot analyses using -His5 antibodies to visualize 
His6-Sec10p binding.  Results indicated that His6-Sec10p interacts with multiple regions 
of Sec15p (Figure A2.5B).  Because this could have been due to non-specific binding, I 
also examined the interaction between the Sec15p constructs and Sec6p.  No interaction 
between Sec6p and Sec15p has been reported; however Sec6p bound to each 
MBPSec15p construct.  These results suggested that Sec10p is also non-specifically 
binding to the MBPSec15p constructs.  Therefore, this was not a valid assay to examine 
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Figure A2.5.  Exocyst subunit interactions.  (A) Mapping the Sec10p-Sec15p 
interaction through co-expression.  Untagged Sec10p or Sec10p(51-485) was co-
expressed with MBP or MBPSec15p(75-305).  MBP and MBPSec15p(75-305) were 
affinity purified using amylose resin.  The presence of Sec10p or Sec10p(51-485) in the 
elution was analyzed by SDS-PAGE and stained with Coomassie blue.  The presence of 
Sec10p or Sec10p(51-485) in the MBPSec15p(75-305) elution, but not in the MBP 
elution, suggested an interaction between Sec10p and Sec15p.  (B)  Mapping the Sec10p-
Sec15p interaction through MBP pull-down assays.  Binding experiments were 
performed as described in Materials and Methods.  Briefly, affinity purified His6-Sec10p 
was incubated with MBPSec15p constructs bound to amylose resin.  After washing the 
resin, bound material was analyzed by Western Blot and blotted with -His5 or -MBP 
antibodies.  (C)  Mapping the Sec10-Sec6p interaction.  Similar to (B) except that Sec6p 
and Sec6CT2 are bound to MBP.  (D)  Mapping the Sec6p-Exo70p interaction.  Similar 
to (B) except that purified His6-Sec6p or His6-Sec6CT2 and MBPExo70p are used and 
detected using Sec6p antibodies 
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 the interaction between Sec10p and Sec15p.  Other assays will need to be developed, but 
the unavailability of soluble Sec10p or Sec15p constructs has precluded further 
investigation. 
 During the course of my research, I also substantially contributed to the 
characterization of another exocyst subunit, Sec6p, by examining its interactions with 
other exocyst subunits.  The mammalian Sec10 and Sec6 proteins were previously shown 
to interact by GST pull-down assays
200
.  Using MBP pull-down assays, I showed that 
yeast Sec10p interacts with Sec6p and that a C-terminal construct of Sec6p, a.a. 411-805, 
(Sec6CT2) is sufficient for this interaction (Figure A2.5C)
40
 .  Soluble His6-Sec10p was 
obtained by expression at 15° for 12-16 h followed by affinity purification.  Although 
His6-Sec10p is soluble, it still aggregates as indicated by SEC analysis.  I also mapped 
the interaction between Sec6p and Exo70p; this interaction was also shown by Dong et al 
2005
39
.  Using MBP pull-down assays I further mapped the interaction between Sec6p 
and Exo70p.  MBP pull-down assays indicated that the C-terminal domain (a.a. 411-805) 
of Sec6p is sufficient for the Exo70p interaction (Figure A2.5D)
40
. 
CONCLUSIONS 
 I set out to investigate the interactions between the exocyst subunits and to 
determine how these interactions affect exocyst assembly and function in vivo.  Although 
I focused primarily on the interactions between Sec10p and Sec15p, my research did 
result in identification of the Sec10p-Sec6p and Sec6p-Exo70p interacting domains.  
Both Sec10p and Exo70p interact with the C-terminal domain of Sec6p.  Further mapping 
of these interactions is needed, including whether the N-terminal region of Sec6p also 
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interacts with these proteins and what domain(s) of Sec10p interact with Sec6p.  
Elucidating the binding between these proteins will allow the creation and in vivo 
analyses of mutations that affect these interactions and provide a greater understanding of 
exocyst function. 
 The focus of my exocyst investigation centered upon the interaction(s) between 
Sec10p and Sec15p.  Because I was unable to generate a soluble, well-folded construct of 
either Sec10p or Sec15p, I could not examine their interactions through quantitative 
binding methods.  I decided to use MBP pull-down assays with recombinant proteins to 
map the Sec10p-Sec15p interaction.  This did not prove to be a valid method as control 
experiments indicated that Sec10p bound non-specifically to various MBPSec15p 
constructs.  Until other methods can be used to generate functional domains of Sec10p 
and Sec15p, studying their interaction will be difficult. 
 Much of my research of Sec10p and Sec15p focused on generating a functional 
domain of either protein.  Various methods were tested, but none resulted in a well-folded 
construct.  One method I used involved fusing constructs to MBP.  Although, MBP did 
solubilize many constructs, this method did not aid in identifying a well-folded construct 
as all of the MBP-tagged constructs were misfolded and either precipitated or aggregated.  
Therefore, we learned that although a protein is soluble, this does not indicate that it is 
well-folded.  We also attempted to obtain soluble Sec10p/Sec15p by co-expressing these 
proteins in E. coli.  Both proteins are ~100 kD and likely contain multiple domains.  In 
vivo, Sec10p and Sec15p interact in a sub-complex; this interaction may serve to stabilize 
the two proteins
21
.  My co-expression studies did indicate that these two proteins form a 
190 
complex.  However, their solubility was not improved by this interaction; it is possible 
that they need the presence of other partners such as Sec6p.  We finally used secondary 
structure predictions to design a vast array of constructs N-terminally fused to a His6-tag.  
While we obtained numerous constructs, all with varying degrees of solubility, we were 
not able to identify a well-folded domain.  The most promising of the constructs were 
unfolded in vitro while other less soluble constructs were not readily purifiable.  Our 
studies indicate that another method will be needed to identify a functional domain.  
Indeed, recently a new method combining, secondary structure predictions, known 
structures, sequence alignments, and other bioinformatics from all exocyst members has 
led to the preliminary identification of a functional domain of Sec10p.  A similar method 
has been applied to Sec15p.  Studies are currently being conducted in the Munson lab to 
use the data from these new analyses to generate functional domains of Sec10p and 
Sec15p, as well as other exocyst subunits. 
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